Title: Effects of antiretroviral treatment on paraoxonase 1 (PON1) activity in rats.
Journal: Chemico-biological interactions 20161125
Title: Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.
Journal: Chemical research in toxicology 20150518
Title: Population-based in vitro hazard and concentration-response assessment of chemicals: the 1000 genomes high-throughput screening study.
Journal: Environmental health perspectives 20150501
Title: Evaluation of chitosan nanoformulations as potent anti-HIV therapeutic systems.
Journal: Biochimica et biophysica acta 20140101
Title: Early identification of clinically relevant drug interactions with the human bile salt export pump (BSEP/ABCB11).
Journal: Toxicological sciences : an official journal of the Society of Toxicology 20131201
Title: GRL-04810 and GRL-05010, difluoride-containing nonpeptidic HIV-1 protease inhibitors (PIs) that inhibit the replication of multi-PI-resistant HIV-1 in vitro and possess favorable lipophilicity that may allow blood-brain barrier penetration.
Journal: Antimicrobial agents and chemotherapy 20131201
Title: A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Journal: Toxicological sciences : an official journal of the Society of Toxicology 20131101
Title: Substrate envelope-designed potent HIV-1 protease inhibitors to avoid drug resistance.
Journal: Chemistry & biology 20130919
Title: Highly potent HIV-1 protease inhibitors with novel tricyclic P2 ligands: design, synthesis, and protein-ligand X-ray studies.
Journal: Journal of medicinal chemistry 20130912
Title: Modular construction of quaternary hemiaminal-based inhibitor candidates and their in cellulo assessment with HIV-1 protease.
Journal: Bioorganic & medicinal chemistry 20130901
Title: GRL-0519, a novel oxatricyclic ligand-containing nonpeptidic HIV-1 protease inhibitor (PI), potently suppresses replication of a wide spectrum of multi-PI-resistant HIV-1 variants in vitro.
Journal: Antimicrobial agents and chemotherapy 20130501
Title: In vitro and structural evaluation of PL-100 as a potential second-generation HIV-1 protease inhibitor.
Journal: The Journal of antimicrobial chemotherapy 20130101
Title: Dual inhibition of HIV-1 replication by integrase-LEDGF allosteric inhibitors is predominant at the post-integration stage.
Journal: Retrovirology 20130101
Title: Mimicking the intramolecular hydrogen bond: synthesis, biological evaluation, and molecular modeling of benzoxazines and quinazolines as potential antimalarial agents.
Journal: Journal of medicinal chemistry 20121213
Title: Relation between flexibility and positively selected HIV-1 protease mutants against inhibitors.
Journal: Proteins 20121201
Title: Role of FAP48 in HIV-associated lipodystrophy.
Journal: Journal of cellular biochemistry 20121101
Title: Novel method to assess antiretroviral target trough concentrations using in vitro susceptibility data.
Journal: Antimicrobial agents and chemotherapy 20121101
Title: Therapeutic potential of nitric oxide-modified drugs in colon cancer cells.
Journal: Molecular pharmacology 20121001
Title: Short communication: Phenotypic protease inhibitor resistance and cross-resistance in the clinic from 2006 to 2008 and mutational prevalences in HIV from patients with discordant tipranavir and darunavir susceptibility phenotypes.
Journal: AIDS research and human retroviruses 20120901
Title: Stereoselective evasion of P-glycoprotein, cytochrome P450 3A, and hydrolases by peptide prodrug modification of saquinavir.
Journal: Journal of pharmaceutical sciences 20120901
Title: Effectiveness and safety of saquinavir/ritonavir in HIV-infected pregnant women: INEMA cohort.
Journal: Medecine et maladies infectieuses 20120901
Title: Optimization of 4-aminoquinoline/clotrimazole-based hybrid antimalarials: further structure-activity relationships, in vivo studies, and preliminary toxicity profiling.
Journal: Journal of medicinal chemistry 20120809
Title: Carbonylhydrazide-based molecular tongs inhibit wild-type and mutated HIV-1 protease dimerization.
Journal: Journal of medicinal chemistry 20120809
Title: Boosting of HIV protease inhibitors by ritonavir in the intestine: the relative role of cytochrome P450 and P-glycoprotein inhibition based on Caco-2 monolayers versus in situ intestinal perfusion in mice.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20120801
Title: Utility of drug depletion-time profiles in isolated hepatocytes for accessing hepatic uptake clearance: identifying rate-limiting steps and role of passive processes.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20120801
Title: Microemulsions for oral administration and their therapeutic applications.
Journal: Expert opinion on drug delivery 20120801
Title: Unique antineoplastic profile of Saquinavir-NO, a novel NO-derivative of the protease inhibitor Saquinavir, on the in vitro and in vivo tumor formation of A375 human melanoma cells.
Journal: Oncology reports 20120801
Title: Investigation on the stability of saquinavir loaded liposomes: implication on stealth, release characteristics and cytotoxicity.
Journal: International journal of pharmaceutics 20120715
Title: Activity of human immunodeficiency virus type 1 protease inhibitors against the initial autocleavage in Gag-Pol polyprotein processing.
Journal: Antimicrobial agents and chemotherapy 20120701
Title: Viral protease inhibitors affect the production of virulence factors in Cryptococcus neoformans.
Journal: Canadian journal of microbiology 20120701
Title: Mechanism-based inactivation (MBI) of cytochrome P450 enzymes: structure-activity relationships and discovery strategies to mitigate drug-drug interaction risks.
Journal: Journal of medicinal chemistry 20120614
Title: The effect of HIV protease inhibitors on amyloid-β peptide degradation and synthesis in human cells and Alzheimer's disease animal model.
Journal: Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 20120601
Title: Overall benefit of antiretroviral treatment on the risk of fracture in HIV: nested case-control analysis in a health-insured population.
Journal: AIDS (London, England) 20120601
Title: Perspectives on addressing ionization matrix effects in LC-MS bioanalysis.
Journal: Bioanalysis 20120601
Title: Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Journal: Journal of medicinal chemistry 20120524
Title: Ritonavir or saquinavir impairs the invasion of cervical intraepithelial neoplasia cells via a reduction of MMP expression and activity.
Journal: AIDS (London, England) 20120515
Title: HIV protease inhibitors to prevent progression of cervical intraepithelial neoplasia to cervical cancer: therapeutic opportunities and challenges.
Journal: AIDS (London, England) 20120515
Title: Saquinavir in steroid-dependent and -resistant nephrotic syndrome: a pilot study.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20120501
Title: Quantification of human hepatocyte cytochrome P450 enzymes and transporters induced by HIV protease inhibitors using newly validated LC-MS/MS cocktail assays and RT-PCR.
Journal: Biopharmaceutics & drug disposition 20120501
Title: HIV-1 protease with 20 mutations exhibits extreme resistance to clinical inhibitors through coordinated structural rearrangements.
Journal: Biochemistry 20120403
Title: Thorough QT/QTc study of ritonavir-boosted saquinavir following multiple-dose administration of therapeutic and supratherapeutic doses in healthy participants.
Journal: Journal of clinical pharmacology 20120401
Title: The invasion of tobacco mosaic virus RNA induces endoplasmic reticulum stress-related autophagy in HeLa cells.
Journal: Bioscience reports 20120401
Title: Prediction and in vitro evaluation of selected protease inhibitor antiviral drugs as inhibitors of carboxylesterase 1: a potential source of drug-drug interactions.
Journal: Pharmaceutical research 20120401
Title: Viremia and HIV-1 drug resistance mutations among patients receiving second-line highly active antiretroviral therapy in Chennai, Southern India.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20120401
Title: Resistance to TRAIL and how to surmount it.
Journal: Immunologic research 20120401
Title: Sialyllactose in viral membrane gangliosides is a novel molecular recognition pattern for mature dendritic cell capture of HIV-1.
Journal: PLoS biology 20120401
Title: Nanotechnology and the treatment of HIV infection.
Journal: Viruses 20120401
Title: Library-based discovery and characterization of daphnane diterpenes as potent and selective HIV inhibitors in Daphne gnidium.
Journal: Journal of natural products 20120323
Title: Synthesis, X-ray analysis, and biological evaluation of a new class of stereopure lactam-based HIV-1 protease inhibitors.
Journal: Journal of medicinal chemistry 20120322
Title: Saquinavir-NO-targeted S6 protein mediates sensitivity of androgen-dependent prostate cancer cells to TRAIL.
Journal: Cell cycle (Georgetown, Tex.) 20120315
Title: Expression of P-glycoprotein and multidrug resistance-associated protein on human brain-microvascular endothelial cells with electromagnetic stimulation.
Journal: Colloids and surfaces. B, Biointerfaces 20120301
Title: Modulation of efflux proteins by electromagnetic field for delivering azidothymidine and saquinavir into the brain.
Journal: Colloids and surfaces. B, Biointerfaces 20120301
Title: In vitro anti-neuroblastoma activity of saquinavir and its association with imatinib.
Journal: Oncology reports 20120301
Title: Critical differences in HIV-1 and HIV-2 protease specificity for clinical inhibitors.
Journal: Protein science : a publication of the Protein Society 20120301
Title: Living on three time scales: the dynamics of plasma cell and antibody populations illustrated for hepatitis a virus.
Journal: PLoS computational biology 20120301
Title: Exploring the complexity of the HIV-1 fitness landscape.
Journal: PLoS genetics 20120301
Title: High sodium butyrate levels induce MDR1 activation in colorectal cells: Impact of 15-deoxy-Δ(12,14)-prostaglandin J(2) on the resistance to saquinavir.
Journal: Biochemical and biophysical research communications 20120224
Title: Rational approaches to improving selectivity in drug design.
Journal: Journal of medicinal chemistry 20120223
Title: Terminal interface conformations modulate dimer stability prior to amino terminal autoprocessing of HIV-1 protease.
Journal: Biochemistry 20120207
Title: Methylmethacrylate-sulfopropylmethacrylate nanoparticles with surface RMP-7 for targeting delivery of antiretroviral drugs across the blood-brain barrier.
Journal: Colloids and surfaces. B, Biointerfaces 20120201
Title: Interaction of calf thymus DNA with the antiviral drug Lamivudine.
Journal: DNA and cell biology 20120101
Title: Protease inhibitor-containing antiretroviral treatment and tuberculosis: can rifabutin fill the breach?
Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20120101
Title: Hypertriglyceridemia, Metabolic Syndrome, and Cardiovascular Disease in HIV-Infected Patients: Effects of Antiretroviral Therapy and Adipose Tissue Distribution.
Journal: International journal of vascular medicine 20120101
Title: Preparation and solid-state characterization of ball milled saquinavir mesylate for solubility enhancement.
Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20120101
Title: The influence of AT1002 on the nasal absorption of molecular weight markers and therapeutic agents when co-administered with bioadhesive polymers and an AT1002 antagonist, AT1001.
Journal: The Journal of pharmacy and pharmacology 20120101
Title: The pathophysiology of HIV-/HAART-related metabolic syndrome leading to cardiovascular disorders: the emerging role of adipokines.
Journal: Experimental diabetes research 20120101
Title: Determinants of sustained viral suppression in HIV-infected patients with self-reported poor adherence to antiretroviral therapy.
Journal: PloS one 20120101
Title: Probing amphotericin B single channel activity by membrane dipole modifiers.
Journal: PloS one 20120101
Title: Special aspects of the treatment of HIV-2-infected patients.
Journal: Intervirology 20120101
Title: A flexible model of HIV-1 latency permitting evaluation of many primary CD4 T-cell reservoirs.
Journal: PloS one 20120101
Title: Suppression of pre adipocyte differentiation and promotion of adipocyte death by anti-HIV drugs.
Journal: In vivo (Athens, Greece) 20120101
Title: Self-microemulsifying drug-delivery system for improved oral bioavailability of probucol: preparation and evaluation.
Journal: International journal of nanomedicine 20120101
Title: Size- and charge-dependent non-specific uptake of PEGylated nanoparticles by macrophages.
Journal: International journal of nanomedicine 20120101
Title: Switching virally suppressed, treatment-experienced patients to a raltegravir-containing regimen does not alter levels of HIV-1 DNA.
Journal: PloS one 20120101
Title: Rosuvastatin: a review of the pharmacology and clinical effectiveness in cardiovascular disease.
Journal: Clinical Medicine Insights. Cardiology 20120101
Title: Assessment of liver fibrosis and associated risk factors in HIV-infected individuals using transient elastography and serum biomarkers.
Journal: BMC gastroenterology 20120101
Title: Associations between HIV and human pathways revealed by protein-protein interactions and correlated gene expression profiles.
Journal: PloS one 20120101
Title: HIV-1 phenotypic reverse transcriptase inhibitor drug resistance test interpretation is not dependent on the subtype of the virus backbone.
Journal: PloS one 20120101
Title: Therapeutic potential of HIV protease-activable CASP3.
Journal: Scientific reports 20120101
Title: HIV-Antiretroviral Therapy Induced Liver, Gastrointestinal, and Pancreatic Injury.
Journal: International journal of hepatology 20120101
Title: The frequency of malaria is similar among women receiving either lopinavir/ritonavir or nevirapine-based antiretroviral treatment.
Journal: PloS one 20120101
Title: Ethanol-mediated regulation of cytochrome P450 2A6 expression in monocytes: role of oxidative stress-mediated PKC/MEK/Nrf2 pathway.
Journal: PloS one 20120101
Title: Stereoselective regulations of P-glycoprotein by ginsenoside Rh2 epimers and the potential mechanisms from the view of pharmacokinetics.
Journal: PloS one 20120101
Title: Pharmacokinetics and Pharmacodynamics of Darunavir and Etravirine in HIV-1-Infected, Treatment-Experienced Patients in the Gender, Race, and Clinical Experience (GRACE) Trial.
Journal: AIDS research and treatment 20120101
Title: Suboptimal immune reconstitution in vertically HIV infected children: a view on how HIV replication and timing of HAART initiation can impact on T and B-cell compartment.
Journal: Clinical & developmental immunology 20120101
Title: An overview of the evidence and mechanisms of herb-drug interactions.
Journal: Frontiers in pharmacology 20120101
Title: Failure to Control Caries in an AIDS-Affected Individual: A Case Report.
Journal: Case reports in dentistry 20120101
Title: Impact of low-level-viremia on HIV-1 drug-resistance evolution among antiretroviral treated-patients.
Journal: PloS one 20120101
Title: Trends in Decline of Antiretroviral Resistance among ARV-Experienced Patients in the HIV Outpatient Study: 1999-2008.
Journal: AIDS research and treatment 20120101
Title: Human immunodeficiency virus and leprosy coinfection: challenges in resource-limited setups.
Journal: Case reports in medicine 20120101
Title: Antiretroviral simplification with darunavir/ritonavir monotherapy in routine clinical practice: safety, effectiveness, and impact on lipid profile.
Journal: PloS one 20120101
Title: Receptor-independent interaction of bacterial lipopolysaccharide with lipid and lymphocyte membranes; the role of cholesterol.
Journal: PloS one 20120101
Title: Malaria and hiv in adults: when the parasite runs into the virus.
Journal: Mediterranean journal of hematology and infectious diseases 20120101
Title: Risk of diabetes mellitus in persons with and without HIV: a Danish nationwide population-based cohort study.
Journal: PloS one 20120101
Title: Differential effects of ethanol on spectral binding and inhibition of cytochrome P450 3A4 with eight protease inhibitors antiretroviral drugs.
Journal: Alcoholism, clinical and experimental research 20111201
Title: Expression of ornithine decarboxylase during the transport of saquinavir across the blood-brain barrier using composite polymeric nanocarriers under an electromagnetic field.
Journal: Colloids and surfaces. B, Biointerfaces 20111201
Title: Solid lipid nanoparticles comprising internal Compritol 888 ATO, tripalmitin and cacao butter for encapsulating and releasing stavudine, delavirdine and saquinavir.
Journal: Colloids and surfaces. B, Biointerfaces 20111201
Title: Pharmacokinetic study of saquinavir 500 mg plus ritonavir (1000/100 mg twice a day) in HIV-positive pregnant women.
Journal: Therapeutic drug monitoring 20111201
Title: Qualitative prediction of blood-brain barrier permeability on a large and refined dataset.
Journal: Journal of computer-aided molecular design 20111201
Title: Protease inhibitor-associated QT interval prolongation.
Journal: The Annals of pharmacotherapy 20111201
Title: Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Journal: PLoS computational biology 20111201
Title: Nef decreases HIV-1 sensitivity to neutralizing antibodies that target the membrane-proximal external region of TMgp41.
Journal: PLoS pathogens 20111201
Title: Factors predicting the efficacy of adefovir dipivoxil on treatment-naïve chronic hepatitis B patients at 48 weeks.
Journal: Gut and liver 20111201
Title: Diagnosis & treatment of tuberculosis in HIV co-infected patients.
Journal: The Indian journal of medical research 20111201
Title: Estimation of P-glycoprotein-mediated efflux in the oral absorption of P-gp substrate drugs from simultaneous analysis of drug dissolution and permeation.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20111120
Title: How much do antiretroviral drugs penetrate into the central nervous system?
Journal: Journal of medicine and life 20111114
Title: Polyethyleneimine/poly-(γ-glutamic acid)/poly(lactide-co-glycolide) nanoparticles for loading and releasing antiretroviral drug.
Journal: Colloids and surfaces. B, Biointerfaces 20111101
Title: Randomized comparison of metabolic and renal effects of saquinavir/r or atazanavir/r plus tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients.
Journal: HIV medicine 20111101
Title: Prediction of drug-resistance in HIV-1 subtype C based on protease sequences from ART naive and first-line treatment failures in North India using genotypic and docking analysis.
Journal: Antiviral research 20111101
Title: In vitro activity of antiretroviral drugs against Plasmodium falciparum.
Journal: Antimicrobial agents and chemotherapy 20111101
Title: Penetration of anti-infective agents into pulmonary epithelial lining fluid: focus on antifungal, antitubercular and miscellaneous anti-infective agents.
Journal: Clinical pharmacokinetics 20111101
Title: Synthesis and antimalarial activity of thioetherhydroxyethylsulfonamides, potential aspartyl protease inhibitors, Part 3.
Journal: European journal of medicinal chemistry 20111101
Title: Evolution of a species-specific determinant within human CRM1 that regulates the post-transcriptional phases of HIV-1 replication.
Journal: PLoS pathogens 20111101
Title: Evaluation of metabolism-mediated herb-drug interactions.
Journal: Archives of pharmacal research 20111101
Title: In situ study of the effect of naringin, talinolol and protein-energy undernutrition on intestinal absorption of saquinavir in rats.
Journal: Basic & clinical pharmacology & toxicology 20111001
Title: Kinetic characterization of rat hepatic uptake of 16 actively transported drugs.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20111001
Title: Population pharmacokinetics of lopinavir/ritonavir (Kaletra) in HIV-infected patients.
Journal: Therapeutic drug monitoring 20111001
Title: [Vitamin D and drugs].
Journal: Medizinische Monatsschrift fur Pharmazeuten 20111001
Title: Transport of saquinavir across human brain-microvascular endothelial cells by poly(lactide-co-glycolide) nanoparticles with surface poly-(γ-glutamic acid).
Journal: International journal of pharmaceutics 20110915
Title: Mother-to-fetus transfer of antiviral drugs and the involvement of transporters at the placental barrier.
Journal: Journal of pharmaceutical sciences 20110901
Title: Physiologically based pharmacokinetic modeling of intestinal first-pass metabolism of CYP3A substrates with high intestinal extraction.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20110901
Title: The new and less toxic protease inhibitor saquinavir-NO maintains anti-HIV-1 properties in vitro indistinguishable from those of the parental compound saquinavir.
Journal: Antiviral research 20110901
Title: Design of HIV-1 protease inhibitors with C3-substituted hexahydrocyclopentafuranyl urethanes as P2-ligands: synthesis, biological evaluation, and protein-ligand X-ray crystal structure.
Journal: Journal of medicinal chemistry 20110825
Title: HIV-protease inhibitors block the replication of both vesicular stomatitis and influenza viruses at an early post-entry replication step.
Journal: Virology 20110815
Title: Early identification of availability issues for poorly water-soluble microbicide candidates in biorelevant media: a case study with saquinavir.
Journal: Antiviral research 20110801
Title: Activation of HIV transcription by the viral Tat protein requires a demethylation step mediated by lysine-specific demethylase 1 (LSD1/KDM1).
Journal: PLoS pathogens 20110801
Title: Targeting SVCT for enhanced drug absorption: synthesis and in vitro evaluation of a novel vitamin C conjugated prodrug of saquinavir.
Journal: International journal of pharmaceutics 20110729
Title: Cytotoxic and immune-sensitizing properties of nitric oxide-modified Saquinavir in iNOS-positive human melanoma cells.
Journal: Journal of cellular physiology 20110701
Title: The HIV protease inhibitor nelfinavir inhibits Kaposi's sarcoma-associated herpesvirus replication in vitro.
Journal: Antimicrobial agents and chemotherapy 20110601
Title: Predicting binding to p-glycoprotein by flexible receptor docking.
Journal: PLoS computational biology 20110601
Title: The influence of high-dose simvastatin and diltiazem on myocardium in rabbits: a haemodynamic study.
Journal: Archives of medical science : AMS 20110601
Title: The L76V drug resistance mutation decreases the dimer stability and rate of autoprocessing of HIV-1 protease by reducing internal hydrophobic contacts.
Journal: Biochemistry 20110531
Title: Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study.
Journal: HIV medicine 20110501
Title: [Characteristics of antiretroviral drugs].
Journal: Enfermedades infecciosas y microbiologia clinica 20110501
Title: CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope.
Journal: PLoS pathogens 20110501
Title: Inhibition of both HIV-1 reverse transcription and gene expression by a cyclic peptide that binds the Tat-transactivating response element (TAR) RNA.
Journal: PLoS pathogens 20110501
Title: Proper laboratory notebook practices: protecting your intellectual property.
Journal: Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 20110401
Title: Novel HIV-1 protease inhibitors (PIs) containing a bicyclic P2 functional moiety, tetrahydropyrano-tetrahydrofuran, that are potent against multi-PI-resistant HIV-1 variants.
Journal: Antimicrobial agents and chemotherapy 20110401
Title: Pharmacokinetic interaction of vicriviroc with other antiretroviral agents: results from a series of fixed-sequence and parallel-group clinical trials.
Journal: Clinical pharmacokinetics 20110401
Title: The International Interlaboratory Quality Control Program for Measurement of Antiretroviral Drugs in Plasma: a global proficiency testing program.
Journal: Therapeutic drug monitoring 20110401
Title: Drug discovery using chemical systems biology: weak inhibition of multiple kinases may contribute to the anti-cancer effect of nelfinavir.
Journal: PLoS computational biology 20110401
Title: A HPLC-MS method for the simultaneous quantification of fourteen antiretroviral agents in peripheral blood mononuclear cell of HIV infected patients optimized using medium corpuscular volume evaluation.
Journal: Journal of pharmaceutical and biomedical analysis 20110325
Title: Marginal increase of sunitinib exposure by grapefruit juice.
Journal: Cancer chemotherapy and pharmacology 20110301
Title: In vitro assessment of the adverse effects of antiretroviral drugs on the human male gamete.
Journal: Toxicology in vitro : an international journal published in association with BIBRA 20110301
Title: Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methods.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20110301
Title: A Janus molecule provides a rational reshape to a multi-functional drug.
Journal: Cell cycle (Georgetown, Tex.) 20110301
Title: The impact of the nelfinavir resistance-conferring mutation D30N on the susceptibility of HIV-1 subtype B to other protease inhibitors.
Journal: Memorias do Instituto Oswaldo Cruz 20110301
Title: A pharmacokinetic model for evaluating the impact of hepatic and intestinal first-pass loss of saquinavir in the rat.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20110201
Title: Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20110201
Title: The use of the SAEM algorithm in MONOLIX software for estimation of population pharmacokinetic-pharmacodynamic-viral dynamics parameters of maraviroc in asymptomatic HIV subjects.
Journal: Journal of pharmacokinetics and pharmacodynamics 20110201
Title: Impact of HIV-1 group O genetic diversity on genotypic resistance interpretation by algorithms designed for HIV-1 group M.
Journal: Journal of acquired immune deficiency syndromes (1999) 20110201
Title: In vitro and in vivo anticancer action of Saquinavir-NO, a novel nitric oxide-derivative of the protease inhibitor saquinavir, on hormone resistant prostate cancer cells.
Journal: Cell cycle (Georgetown, Tex.) 20110201
Title: Elite suppressors harbor low levels of integrated HIV DNA and high levels of 2-LTR circular HIV DNA compared to HIV+ patients on and off HAART.
Journal: PLoS pathogens 20110201
Title: Episomal viral cDNAs identify a reservoir that fuels viral rebound after treatment interruption and that contributes to treatment failure.
Journal: PLoS pathogens 20110201
Title: Monoboosted lopinavir/ritonavir as simplified second-line maintenance therapy in virologically suppressed children.
Journal: AIDS (London, England) 20110128
Title: Design and synthesis of potent HIV-1 protease inhibitors incorporating hexahydrofuropyranol-derived high affinity P(2) ligands: structure-activity studies and biological evaluation.
Journal: Journal of medicinal chemistry 20110127
Title: [Pharmacovigilance update].
Journal: Revue medicale suisse 20110112
Title: Human immunodeficiency virus protease inhibitors reduce the growth of human tumors via a proteasome-independent block of angiogenesis and matrix metalloproteinases.
Journal: International journal of cancer 20110101
Title: Determination of the antiretroviral drug nevirapine in diluted alkaline electrolyte by adsorptive stripping voltammetry at the mercury film electrode.
Journal: Combinatorial chemistry & high throughput screening 20110101
Title: The anti-tumor effects of human immunodeficiency virus protease inhibitors: ready for real time?
Journal: International journal of cancer 20110101
Title: Transwell-grown HepG2 cell monolayers as in vitro permeability model to study drug-drug or drug-food interactions.
Journal: Journal of medicinal food 20110101
Title: The HIV type 1 protease L10I minor mutation decreases replication capacity and confers resistance to protease inhibitors.
Journal: AIDS research and human retroviruses 20110101
Title: Flipping the switches: CD40 and CD45 modulation of microglial activation states in HIV associated dementia (HAD).
Journal: Molecular neurodegeneration 20110101
Title: Understanding diabetes in patients with HIV/AIDS.
Journal: Diabetology & metabolic syndrome 20110101
Title: Single-Boosted Protease Inhibitor versus Double-Boosted Protease Inhibitors for the Salvage Therapy in HIV-Infected Patients.
Journal: Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 20110101
Title: The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir: is there a clinical advantage?
Journal: AIDS research and therapy 20110101
Title: Development of Buffalo Hump in the course of antiretroviral therapy including raltegravir and unboosted atazanavir: a case report and review of the literature.
Journal: Journal of medical case reports 20110101
Title: Penicillium marneffei Infection in AIDS.
Journal: Pathology research international 20110101
Title: Management of HIV-1 associated hepatitis in patients with acquired immunodeficiency syndrome: role of a successful control of viral replication.
Journal: AIDS research and therapy 20110101
Title: Time for gender mainstreaming in editorial policies.
Journal: Journal of the International AIDS Society 20110101
Title: 'Dynamic range' of inferred phenotypic HIV drug resistance values in clinical practice.
Journal: PloS one 20110101
Title: Genome-wide analysis of primary CD4+ and CD8+ T cell transcriptomes shows evidence for a network of enriched pathways associated with HIV disease.
Journal: Retrovirology 20110101
Title: Acute toxicity of second generation HIV protease-inhibitors in combination with radiotherapy: a retrospective case series.
Journal: Radiation oncology (London, England) 20110101
Title: Effects of anti-VEGF on predicted antibody biodistribution: roles of vascular volume, interstitial volume, and blood flow.
Journal: PloS one 20110101
Title: High efficacy of lopinavir/r-based second-line antiretroviral treatment after 24 months of follow up at ESTHER/Calmette Hospital in Phnom Penh, Cambodia.
Journal: Journal of the International AIDS Society 20110101
Title: Machine learning on normalized protein sequences.
Journal: BMC research notes 20110101
Title: Changes in lipid profiles after switching to a protease inhibitor-containing cART--unfavourable effect of fosamprenavir in obese patients.
Journal: European journal of medical research 20110101
Title: Saquinavir: prolongation of PR and QT intervals.
Journal: Prescrire international 20110101
Title: The rainbow cohort: 96 week follow-up of saquinavir-containing regimens in previously antiretroviral therapy (ART)-naive and pre-treated but protease inhibitor (PI)-naive HIV-infected patients.
Journal: European journal of medical research 20110101
Title: Antiretroviral Therapy for HIV-2 Infection: Recommendations for Management in Low-Resource Settings.
Journal: AIDS research and treatment 20110101
Title: Ixabepilone as monotherapy or in combination with capecitabine for the treatment of advanced breast cancer.
Journal: Breast cancer : basic and clinical research 20110101
Title: Strength of hydrogen bond network takes crucial roles in the dissociation process of inhibitors from the HIV-1 protease binding pocket.
Journal: PloS one 20110101
Title: The aspartic proteinase family of three Phytophthora species.
Journal: BMC genomics 20110101
Title: Marked increase in etravirine and saquinavir plasma concentrations during atovaquone/proguanil prophylaxis.
Journal: Malaria journal 20110101
Title: Safety and tolerability of antiretrovirals during pregnancy.
Journal: Infectious diseases in obstetrics and gynecology 20110101
Title: HIV Protease Inhibitors: Effect on the Opportunistic Protozoan Parasites.
Journal: The open medicinal chemistry journal 20110101
Title: Contraception in HIV-positive female adolescents.
Journal: AIDS research and therapy 20110101
Title: A Multicenter, Open Labeled, Randomized, Phase III Study Comparing Lopinavir/Ritonavir Plus Atazanavir to Lopinavir/Ritonavir Plus Zidovudine and Lamivudine in Naive HIV-1-Infected Patients: 48-Week Analysis of the LORAN Trial.
Journal: The open AIDS journal 20110101
Title: HIV and HAART-Associated Dyslipidemia.
Journal: The open cardiovascular medicine journal 20110101
Title: Prevalence and factors associated with darunavir resistance mutations in multi-experienced HIV-1-infected patients failing other protease inhibitors in a referral teaching center in Brazil.
Journal: The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 20110101
Title: The preparation of 3,5-dihydroxy-4-isopropylstilbene nanoemulsion and in vitro release.
Journal: International journal of nanomedicine 20110101
Title: Clinical predictors of immune reconstitution following combination antiretroviral therapy in patients from the Australian HIV Observational Database.
Journal: PloS one 20110101
Title: Novel natural inhibitors of CYP1A2 identified by in silico and in vitro screening.
Journal: International journal of molecular sciences 20110101
Title: Tolvaptan, hyponatremia, and heart failure.
Journal: International journal of nephrology and renovascular disease 20110101
Title: Efficacy of intravenous amphotericin B-polybutylcyanoacrylate nanoparticles against cryptococcal meningitis in mice.
Journal: International journal of nanomedicine 20110101
Title: Solid lipid nanoparticles and nanosuspension formulation of Saquinavir: preparation, characterization, pharmacokinetics and biodistribution studies.
Journal: Journal of microencapsulation 20110101
Title: Improved survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapy.
Journal: PloS one 20110101
Title: Improvement of colchicine oral bioavailability by incorporating eugenol in the nanoemulsion as an oil excipient and enhancer.
Journal: International journal of nanomedicine 20110101
Title: Clinical therapeutics in pregnancy.
Journal: Journal of biomedicine & biotechnology 20110101
Title: Impact of small body weight on tenofovir-associated renal dysfunction in HIV-infected patients: a retrospective cohort study of Japanese patients.
Journal: PloS one 20110101
Title: Effectiveness of protease inhibitor monotherapy versus combination antiretroviral maintenance therapy: a meta-analysis.
Journal: PloS one 20110101
Title: [Evidence-based therapeutic drug monitoring for saquinavir].
Journal: Therapie 20110101
Title: Buyer beware? Does the information provided with herbal products available over the counter enable safe use?
Journal: BMC medicine 20110101
Title: Recent developments of peptidomimetic HIV-1 protease inhibitors.
Journal: Current medicinal chemistry 20110101
Title: HIV-1 protease inhibitor mutations affect the development of HIV-1 resistance to the maturation inhibitor bevirimat.
Journal: Retrovirology 20110101
Title: HIV-Associated Venous Thromboembolism.
Journal: Mediterranean journal of hematology and infectious diseases 20110101
Title: HIV drug resistance (HIVDR) in antiretroviral therapy-naïve patients in Tanzania not eligible for WHO threshold HIVDR survey is dramatically high.
Journal: PloS one 20110101
Title: Clinical herbal interactions with conventional drugs: from molecules to maladies.
Journal: Current medicinal chemistry 20110101
Title: Lyme neuroborreliosis in HIV-1 positive men successfully treated with oral doxycycline: a case series and literature review.
Journal: Journal of medical case reports 20110101
Title: A randomized, placebo controlled, double masked phase IB study evaluating the safety and antiviral activity of aprepitant, a neurokinin-1 receptor antagonist in HIV-1 infected adults.
Journal: PloS one 20110101
Title: Bioequivalence study of two oral tablet formulations containing saquinavir mesylate boosted with ritonavir in healthy male subjects.
Journal: Arzneimittel-Forschung 20110101
Title: Primary cutaneous B-cell lymphoma successfully treated with highly active antiretroviral therapy alone: a case report and review of the literature.
Journal: Indian journal of dermatology 20110101
Title: Formulation and characterization of lipid-based drug delivery system of raloxifene-microemulsion and self-microemulsifying drug delivery system.
Journal: Journal of pharmacy & bioallied sciences 20110101
Title: Meet me on the other side: trans-bilayer modulation of a model voltage-gated ion channel activity by membrane electrostatics asymmetry.
Journal: PloS one 20110101
Title: Resource utilization and cost-effectiveness of counselor- vs. provider-based rapid point-of-care HIV screening in the emergency department.
Journal: PloS one 20110101
Title: Saxagliptin: A dipeptidyl peptidase-4 inhibitor in the treatment of type 2 diabetes mellitus.
Journal: Journal of pharmacology & pharmacotherapeutics 20110101
Title: South Asian Consensus Guidelines for the rational management of diabetes in human immunodeficiency virus/acquired immunodeficiency syndrome.
Journal: Indian journal of endocrinology and metabolism 20110101
Title: Human immunodeficiency virus endocrinopathy.
Journal: Indian journal of endocrinology and metabolism 20110101
Title: Choosing a gliptin.
Journal: Indian journal of endocrinology and metabolism 20110101
Title: In situ formation of nanocrystals from a self-microemulsifying drug delivery system to enhance oral bioavailability of fenofibrate.
Journal: International journal of nanomedicine 20110101
Title: Drugs for malaria: something old, something new, something borrowed.
Journal: F1000 biology reports 20110101
Title: Impact of comorbidities and drug therapy on development of renal impairment in a predominantly African American and Hispanic HIV clinic population.
Journal: HIV/AIDS (Auckland, N.Z.) 20110101
Title: Can linear regression modeling help clinicians in the interpretation of genotypic resistance data? An application to derive a lopinavir-score.
Journal: PloS one 20110101
Title: Wild-type Drosophila melanogaster as a model host to analyze nitrogen source dependent virulence of Candida albicans.
Journal: PloS one 20110101
Title: AtriplaR/anti-TB combination in TB/HIV patients. Drug in focus.
Journal: BMC research notes 20110101
Title: Elevated pressure downregulates ZO-1 expression and disrupts cytoskeleton and focal adhesion in human trabecular meshwork cells.
Journal: Molecular vision 20110101
Title: Prolonged control of replication-competent dual- tropic human immunodeficiency virus-1 following cessation of highly active antiretroviral therapy.
Journal: Retrovirology 20110101
Title: Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the male and female genital tract.
Journal: Antiviral therapy 20110101
Title: Ribavirin and interferon alter MMP-9 abundance in vitro and in HIV-HCV-coinfected patients.
Journal: Antiviral therapy 20110101
Title: Rate and determinants of treatment response to different antiretroviral combination strategies in subjects presenting at HIV-1 diagnosis with advanced disease.
Journal: BMC infectious diseases 20110101
Title: A multifaceted analysis of HIV-1 protease multidrug resistance phenotypes.
Journal: BMC bioinformatics 20110101
Title: Mutations affecting interaction of integrase with TNPO3 do not prevent HIV-1 cDNA nuclear import.
Journal: Retrovirology 20110101
Title: Risk of herpes zoster in patients prescribed inhaled corticosteroids: a cohort study.
Journal: BMC pulmonary medicine 20110101
Title: Nanomedicine as an emerging approach against intracellular pathogens.
Journal: International journal of nanomedicine 20110101
Title: Critical appraisal of ticagrelor in the management of acute coronary syndrome.
Journal: Therapeutics and clinical risk management 20110101
Title: Comparative manufacture and cell-based delivery of antiretroviral nanoformulations.
Journal: International journal of nanomedicine 20110101
Title: Two-way pharmacokinetic interaction studies between saxagliptin and cytochrome P450 substrates or inhibitors: simvastatin, diltiazem extended-release, and ketoconazole.
Journal: Clinical pharmacology : advances and applications 20110101
Title: Multidrug resistance in breast cancer: from in vitro models to clinical studies.
Journal: International journal of breast cancer 20110101
Title: Evaluation of the use of partition coefficients and molecular surface properties as predictors of drug absorption: a provisional biopharmaceutical classification of the list of national essential medicines of Pakistan.
Journal: Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 20110101
Title: Simple, precise and accurate HPLC method of analysis for nevirapine suspension from human plasma.
Journal: Indian journal of pharmaceutical sciences 20110101
Title: Garlic extract induces intestinal P-glycoprotein, but exhibits no effect on intestinal and hepatic CYP3A4 in humans.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20101223
Title: Effects of HIV aspartyl-proteinase inhibitors on Leishmania sp.
Journal: Experimental parasitology 20101201
Title: Comparative efflux of saquinavir, ritonavir and lopinavir from primary human cells.
Journal: Drug metabolism letters 20101201
Title: Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Journal: Toxicological sciences : an official journal of the Society of Toxicology 20101201
Title: Comparative use of isolated hepatocytes and hepatic microsomes for cytochrome P450 inhibition studies: transporter-enzyme interplay.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20101201
Title: Nicotine and cotinine increases the brain penetration of saquinavir in rat.
Journal: Journal of neurochemistry 20101201
Title: Anticancer effects of the nitric oxide-modified saquinavir derivative saquinavir-NO against multidrug-resistant cancer cells.
Journal: Neoplasia (New York, N.Y.) 20101201
Title: HIV-2 goes global: an unaddressed issue in Indian anti-retroviral programmes.
Journal: The Indian journal of medical research 20101201
Title: FDA notifications. New risk information added to label of antiviral saquinavir.
Journal: AIDS alert 20101201
Title: Anti-HIV-1 activity of the neurokinin-1 receptor antagonist aprepitant and synergistic interactions with other antiretrovirals.
Journal: AIDS (London, England) 20101127
Title: Enhanced oral absorption of saquinavir with Methyl-Beta-Cyclodextrin-Preparation and in vitro and in vivo evaluation.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20101120
Title: HIV protease inhibitors differentially inhibit adhesion of Candida albicans to acrylic surfaces.
Journal: Mycoses 20101101
Title: Prediction of the intestinal first-pass metabolism of CYP3A substrates in humans using cynomolgus monkeys.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20101101
Title: Impact of drug transporters on cellular resistance towards saquinavir and darunavir.
Journal: The Journal of antimicrobial chemotherapy 20101101
Title: Outcomes of patients on dual-boosted PI regimens: experience of the Swiss HIV cohort study.
Journal: AIDS research and human retroviruses 20101101
Title: Broadening the perspective when assessing evidence on boosted protease inhibitor-based regimens for initial antiretroviral therapy.
Journal: Advances in therapy 20101101
Title: HIV protease inhibitors: garlic supplements and first-pass intestinal metabolism impact on the therapeutic efficacy.
Journal: Biopharmaceutics & drug disposition 20101101
Title: Molecular Basis for Drug Resistance in HIV-1 Protease.
Journal: Viruses 20101101
Title: Chronic exposure to nicotine and saquinavir decreases endothelial Notch-4 expression and disrupts blood-brain barrier integrity.
Journal: Journal of neurochemistry 20101001
Title: Incidence of atazanavir-associated hyperbilirubinemia in Korean HIV patients: 30 months follow-up results in a population with low UDP-glucuronosyltransferase1A1*28 allele frequency.
Journal: Journal of Korean medical science 20101001
Title: HPLC-MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditions.
Journal: Journal of pharmaceutical and biomedical analysis 20100905
Title: Modulation of endocrine and transport functions in human trophoblasts by saquinavir and nelfinavir.
Journal: European journal of obstetrics, gynecology, and reproductive biology 20100901
Title: Ultrafast and high-throughput mass spectrometric assay for therapeutic drug monitoring of antiretroviral drugs in pediatric HIV-1 infection applying dried blood spots.
Journal: Analytical and bioanalytical chemistry 20100901
Title: Saquinavir/ritonavir monotherapy as a new nucleoside-sparing maintenance strategy in long-term virologically suppressed HIV-infected patients.
Journal: Current HIV research 20100901
Title: Amprenavir complexes with HIV-1 protease and its drug-resistant mutants altering hydrophobic clusters.
Journal: The FEBS journal 20100901
Title: Novel protease inhibitors (PIs) containing macrocyclic components and 3(R),3a(S),6a(R)-bis-tetrahydrofuranylurethane that are potent against multi-PI-resistant HIV-1 variants in vitro.
Journal: Antimicrobial agents and chemotherapy 20100801
Title: A less sensitive detector does not necessarily result in a less sensitive method: fast quantification of 13 antiretroviral analytes in plasma with liquid chromatography coupled with tandem mass spectrometry.
Journal: Clinical chemistry and laboratory medicine 20100801
Title: Methadone, buprenorphine, and street drug interactions with antiretroviral medications.
Journal: Current HIV/AIDS reports 20100801
Title: Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus-infected patients: a case-control study nested within the French Hospital Database on HIV ANRS cohort CO4.
Journal: Archives of internal medicine 20100726
Title: Impact of hyperlipidemia on plasma protein binding and hepatic drug transporter and metabolic enzyme regulation in a rat model of gestational diabetes.
Journal: The Journal of pharmacology and experimental therapeutics 20100701
Title: Prediction of human intestinal first-pass metabolism of 25 CYP3A substrates from in vitro clearance and permeability data.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20100701
Title: Enhancing the delivery of anti retroviral drug 'Saquinavir' across the blood brain barrier using nanoparticles.
Journal: Current HIV research 20100701
Title: Simian immunodeficiency virus-infected macaques treated with highly active antiretroviral therapy have reduced central nervous system viral replication and inflammation but persistence of viral DNA.
Journal: The Journal of infectious diseases 20100701
Title: Effect of electromagnetic field on endocytosis of cationic solid lipid nanoparticles by human brain-microvascular endothelial cells.
Journal: Journal of drug targeting 20100701
Title: Role of Gag in HIV Resistance to Protease Inhibitors.
Journal: Viruses 20100701
Title: Resveratrol protects against protease inhibitor-induced reactive oxygen species production, reticulum stress and lipid raft perturbation.
Journal: AIDS (London, England) 20100619
Title: Insights into the mechanism of drug resistance: X-ray structure analysis of G48V/C95F tethered HIV-1 protease dimer/saquinavir complex.
Journal: Biochemical and biophysical research communications 20100611
Title: Validation of a rapid and sensitive high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) assay for the simultaneous determination of existing and new antiretroviral compounds.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20100601
Title: Potential impact of cytochrome P450 3A5 in human liver on drug interactions with triazoles.
Journal: British journal of clinical pharmacology 20100601
Title: Overcoming multidrug resistance in human cancer cells by natural compounds.
Journal: Toxins 20100601
Title: Accurate ensemble molecular dynamics binding free energy ranking of multidrug-resistant HIV-1 proteases.
Journal: Journal of chemical information and modeling 20100524
Title: Concentration-dependent effects and intracellular accumulation of HIV protease inhibitors in cultured CD4 T cells and primary human lymphocytes.
Journal: The Journal of antimicrobial chemotherapy 20100501
Title: Evaluating the substrate-envelope hypothesis: structural analysis of novel HIV-1 protease inhibitors designed to be robust against drug resistance.
Journal: Journal of virology 20100501
Title: Special issue: retroviral enzymes.
Journal: Viruses 20100501
Title: Relationship between plasma protease inhibitor concentrations and lipid elevations in HIV patients on a double-boosted protease inhibitor regimen (saquinavir/lopinavir/ritonavir).
Journal: Journal of clinical pharmacology 20100401
Title: Safety and efficacy of a saquinavir-containing antiretroviral regimen in previously ART-naïve or pretreated but protease inhibitor-naïve HIV-positive patients.
Journal: Infection 20100401
Title: Arrhythmia risk with saquinavir.
Journal: AIDS patient care and STDs 20100401
Title: Analysis of the effects of specific protease inhibitors on OPG/RANKL regulation in an osteoblast-like cell line.
Journal: The new microbiologica 20100401
Title: FDA notifications. Potential serious effect of combination saquinavir-ritonavir.
Journal: AIDS alert 20100401
Title: A dynamic model of HIV integrase inhibition and drug resistance.
Journal: Journal of molecular biology 20100326
Title: Interaction of HIV protease inhibitors with OATP1B1, 1B3, and 2B1.
Journal: Xenobiotica; the fate of foreign compounds in biological systems 20100301
Title: Effect of saquinavir/ritonavir on P-glycoprotein activity in healthy volunteers using digoxin as a probe.
Journal: International journal of clinical pharmacology and therapeutics 20100301
Title: Interaction of eight HIV protease inhibitors with the canalicular efflux transporter ABCC2 (MRP2) in sandwich-cultured rat and human hepatocytes.
Journal: Biopharmaceutics & drug disposition 20100301
Title: Synthesis of new thienyl ring containing HIV-1 protease inhibitors: promising preliminary pharmacological evaluation against recombinant HIV-1 proteases.
Journal: Journal of medicinal chemistry 20100225
Title: Mechanistic insight from in silico pharmacokinetic experiments: roles of P-glycoprotein, Cyp3A4 enzymes, and microenvironments.
Journal: The Journal of pharmacology and experimental therapeutics 20100201
Title: HIV protease inhibitors block oral epithelial cell DNA synthesis.
Journal: Archives of oral biology 20100201
Title: Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study.
Journal: The Journal of infectious diseases 20100201
Title: [The newest developments in anti-HIV-1 drugs].
Journal: Yao xue xue bao = Acta pharmaceutica Sinica 20100201
Title: HIV-1 protease inhibitors with a transition-state mimic comprising a tertiary alcohol: improved antiviral activity in cells.
Journal: Journal of medicinal chemistry 20100128
Title: Physiologically based predictions of the impact of inhibition of intestinal and hepatic metabolism on human pharmacokinetics of CYP3A substrates.
Journal: Journal of pharmaceutical sciences 20100101
Title: Diagnosis and monitoring of HIV-1 group O-infected patients in Cameroun.
Journal: Journal of acquired immune deficiency syndromes (1999) 20100101
Title: Successful applications of computer aided drug discovery: moving drugs from concept to the clinic.
Journal: Current topics in medicinal chemistry 20100101
Title: Analysis of CYP3A4-HIV-1 protease drugs interactions by computational methods for Highly Active Antiretroviral Therapy in HIV/AIDS.
Journal: Journal of molecular graphics & modelling 20100101
Title: The accumulation and metabolism of zidovudine in 3T3-F442A pre-adipocytes.
Journal: British journal of pharmacology 20100101
Title: Pooling ARV Drug Patents: A Pro-Access Fitting Strategy?
Journal: The open AIDS journal 20100101
Title: Profile of etravirine for the treatment of HIV infection.
Journal: Therapeutics and clinical risk management 20100101
Title: Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.
Journal: Particle and fibre toxicology 20100101
Title: Designing ARVs Patent Pool Up to Trade & Policy Evolutionary Dynamics.
Journal: The open AIDS journal 20100101
Title: Successful treatment of HIV-associated multicentric Castleman's disease and multiple organ failure with rituximab and supportive care: a case report.
Journal: Journal of medical case reports 20100101
Title: Technology Development Through Pooling ARV Drug Patents: A Vision from China.
Journal: The open AIDS journal 20100101
Title: Response of a simian immunodeficiency virus (SIVmac251) to raltegravir: a basis for a new treatment for simian AIDS and an animal model for studying lentiviral persistence during antiretroviral therapy.
Journal: Retrovirology 20100101
Title: Efficacy, safety and pharmacokinetic of once-daily boosted saquinavir (1500/100 mg) together with 2 nucleos(t)ide reverse transcriptase inhibitors in real life: a multicentre prospective study.
Journal: AIDS research and therapy 20100101
Title: Raltegravir is a potent inhibitor of XMRV, a virus implicated in prostate cancer and chronic fatigue syndrome.
Journal: PloS one 20100101
Title: The protease inhibitors ritonavir and saquinavir influence lipid metabolism: a pig model for the rapid evaluation of new drugs.
Journal: Antiviral therapy 20100101
Title: Cyanobacterial cyclopeptides as lead compounds to novel targeted cancer drugs.
Journal: Marine drugs 20100101
Title: Development of a cell-based high-throughput assay to screen for inhibitors of organic anion transporting polypeptides 1B1 and 1B3.
Journal: Current chemical genomics 20100101
Title: Raltegravir, tenofovir, and emtricitabine in an HIV-infected patient with HCV chronic hepatitis, NNRTI intolerance and protease inhibitors-induced severe liver toxicity.
Journal: European journal of medical research 20100101
Title: Semen may harbor HIV despite effective HAART: another piece in the puzzle.
Journal: PloS one 20100101
Title: Rates and reasons for early change of first HAART in HIV-1-infected patients in 7 sites throughout the Caribbean and Latin America.
Journal: PloS one 20100101
Title: An assay to monitor HIV-1 protease activity for the identification of novel inhibitors in T-cells.
Journal: PloS one 20100101
Title: Dendritic cells/natural killer cross-talk: a novel target for human immunodeficiency virus type-1 protease inhibitors.
Journal: PloS one 20100101
Title: A decline in new HIV infections in South Africa: estimating HIV incidence from three national HIV surveys in 2002, 2005 and 2008.
Journal: PloS one 20100101
Title: Immunomodulation in female B₆C₃F₁ mice following treatment with the HIV protease inhibitor saquinavir for 28 days by gavage.
Journal: Journal of immunotoxicology 20100101
Title: Transmission of human immunodeficiency virus I drug resistance - a case report. What are the clinical implications?
Journal: European journal of medical research 20100101
Title: Generic and low dose antiretroviral therapy in adults and children: implication for scaling up treatment in resource limited settings.
Journal: AIDS research and therapy 20100101
Title: The influence of aged garlic extract on the uptake of saquinavir and darunavir into HepG2 cells and rat liver slices.
Journal: Drug metabolism and pharmacokinetics 20100101
Title: Development of a liposomal nanodelivery system for nevirapine.
Journal: Journal of biomedical science 20100101
Title: Ultra-fast analysis of plasma and intracellular levels of HIV protease inhibitors in children: a clinical application of MALDI mass spectrometry.
Journal: PloS one 20100101
Title: Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine.
Journal: Neuropsychiatric disease and treatment 20100101
Title: Severe leukoencephalopathy with fulminant cerebral edema reflecting immune reconstitution inflammatory syndrome during HIV infection: a case report.
Journal: Journal of medical case reports 20100101
Title: Identifying individuals with virologic failure after initiating effective antiretroviral therapy: The surprising value of mean corpuscular hemoglobin in a cross-sectional study.
Journal: AIDS research and therapy 20100101
Title: Stevens-Johnson syndrome associated with nevirapine use in an HIV-positive pregnant woman: a case report.
Journal: West African journal of medicine 20100101
Title: Viral decay kinetics in the highly active antiretroviral therapy-treated rhesus macaque model of AIDS.
Journal: PloS one 20100101
Title: Evaluation of HIV protease and nucleoside reverse transcriptase inhibitors on proliferation, necrosis, apoptosis in intestinal epithelial cells and electrolyte and water transport and epithelial barrier function in mice.
Journal: BMC gastroenterology 20100101
Title: Specific eradication of HIV-1 from infected cultured cells.
Journal: AIDS research and therapy 20100101
Title: Susceptibility of the human retrovirus XMRV to antiretroviral inhibitors.
Journal: Retrovirology 20100101
Title: Adverse events in a cohort of HIV infected pregnant and non-pregnant women treated with nevirapine versus non-nevirapine antiretroviral medication.
Journal: PloS one 20100101
Title: Assessing the performance of a computer-based policy model of HIV and AIDS.
Journal: PloS one 20100101
Title: Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk.
Journal: PloS one 20100101
Title: Clinical, virological and immunological responses in Danish HIV patients receiving raltegravir as part of a salvage regimen.
Journal: Clinical epidemiology 20100101
Title: Garlic flavonoids and organosulfur compounds: impact on the hepatic pharmacokinetics of saquinavir and darunavir.
Journal: Drug metabolism and pharmacokinetics 20100101
Title: Effects of Garlic on Cytochromes P450 2C9- and 3A4-Mediated Drug Metabolism in Human Hepatocytes.
Journal: Scientia pharmaceutica 20100101
Title: The global pediatric antiretroviral market: analyses of product availability and utilization reveal challenges for development of pediatric formulations and HIV/AIDS treatment in children.
Journal: BMC pediatrics 20100101
Title: Safety and efficacy after switch to a saquinavir-containing antiretroviral regimen in protease inhibitor pretreated HIV-positive patients.
Journal: European journal of medical research 20100101
Title: Progress in antiretroviral drug delivery using nanotechnology.
Journal: International journal of nanomedicine 20100101
Title: The interaction of N-acylhomoserine lactone quorum sensing signaling molecules with biological membranes: implications for inter-kingdom signaling.
Journal: PloS one 20100101
Title: Routine HIV screening in France: clinical impact and cost-effectiveness.
Journal: PloS one 20100101
Title: Saxagliptin: the evidence for its place in the treatment of type 2 diabetes mellitus.
Journal: Core evidence 20100101
Title: Antiretroviral therapy optimisation without genotype resistance testing: a perspective on treatment history based models.
Journal: PloS one 20100101
Title: In vitro susceptibility and virological outcome to darunavir and lopinavir are independent of HIV type-1 subtype in treatment-naive patients.
Journal: Antiviral therapy 20100101
Title: Early development of non-hodgkin lymphoma following initiation of newer class antiretroviral therapy among HIV-infected patients - implications for immune reconstitution.
Journal: AIDS research and therapy 20100101
Title: Trends in CD4 counts in HIV-infected patients with HIV viral load monitoring while on combination antiretroviral treatment: results from The TREAT Asia HIV Observational Database.
Journal: BMC infectious diseases 20100101
Title: Interchangeability of two 500 mg amoxicillin capsules with one 1000 mg amoxicillin tablet after a single oral administration.
Journal: Indian journal of pharmaceutical sciences 20100101
Title: Saxagliptin for type 2 diabetes.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy 20100101
Title: Incidence of Severe Hepatotoxicity Related to Antiretroviral Therapy in HIV/HCV Coinfected Patients.
Journal: AIDS research and treatment 20100101
Title: Tuberculosis of spine.
Journal: Journal of craniovertebral junction & spine 20100101
Title: Pharmacogenetics in the brazilian population.
Journal: Frontiers in pharmacology 20100101
Title: Novel strategies in the use of lopinavir/ritonavir for the treatment of HIV infection in children.
Journal: HIV/AIDS (Auckland, N.Z.) 20100101
Title: Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infection.
Journal: HIV/AIDS (Auckland, N.Z.) 20100101
Title: HIV reservoirs in vivo and new strategies for possible eradication of HIV from the reservoir sites.
Journal: HIV/AIDS (Auckland, N.Z.) 20100101
Title: Profile of maraviroc: a CCR5 antagonist in the management of treatment-experienced HIV patients.
Journal: HIV/AIDS (Auckland, N.Z.) 20100101
Title: Long-term treatment of patients with HIV-1: the role of atazanavir.
Journal: HIV/AIDS (Auckland, N.Z.) 20100101
Title: Antiplatelet therapy in acute coronary syndromes: focus on ticagrelor.
Journal: Journal of blood medicine 20100101
Title: Design, synthesis, protein-ligand X-ray structure, and biological evaluation of a series of novel macrocyclic human immunodeficiency virus-1 protease inhibitors to combat drug resistance.
Journal: Journal of medicinal chemistry 20091210
Title: Once-daily treatment with saquinavir mesylate (2000 mg) and ritonavir (100 mg) together with a fixed-dose combination of abacavir/lamivudine (600/300 mg) or tenofovir/emtricitabine (245/200 mg) in HIV-1-infected patients.
Journal: The Journal of antimicrobial chemotherapy 20091201
Title: Validation of an electrospray ionization LC-MS/MS method for quantitative analysis of raltegravir, etravirine, and 9 other antiretroviral agents in human plasma samples.
Journal: Therapeutic drug monitoring 20091201
Title: Montelukast is a potent and durable inhibitor of multidrug resistance protein 2-mediated efflux of taxol and saquinavir.
Journal: Biological & pharmaceutical bulletin 20091201
Title: Drug repositioning using in silico compound profiling.
Journal: Future medicinal chemistry 20091201
Title: HIV-1 Protease: Structural Perspectives on Drug Resistance.
Journal: Viruses 20091201
Title: Current and Novel Inhibitors of HIV Protease.
Journal: Viruses 20091201
Title: How much ritonavir is needed to boost protease inhibitors? Systematic review of 17 dose-ranging pharmacokinetic trials.
Journal: AIDS (London, England) 20091113
Title: Investigation of the micellar effect of pluronic P85 on P-glycoprotein inhibition: cell accumulation and equilibrium dialysis studies.
Journal: Journal of pharmaceutical sciences 20091101
Title: Antiretroviral protease inhibitors potentiate chloroquine antimalarial activity in malaria parasites by regulating intracellular glutathione metabolism.
Journal: Experimental parasitology 20091001
Title: A comparison of HIV-1 drug susceptibility as provided by conventional phenotyping and by a phenotype prediction tool based on viral genotype.
Journal: Journal of medical virology 20091001
Title: A liquid chromatography-tandem mass spectrometry assay for quantification of nevirapine, indinavir, atazanavir, amprenavir, saquinavir, ritonavir, lopinavir, efavirenz, tipranavir, darunavir and maraviroc in the plasma of patients infected with HIV.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20091001
Title: Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Journal: Bioorganic & medicinal chemistry 20091001
Title: Saquinavir, the pioneer antiretroviral protease inhibitor.
Journal: Expert opinion on drug metabolism & toxicology 20091001
Title: Effect of saquinavir-ritonavir on cytochrome P450 3A4 activity in healthy volunteers using midazolam as a probe.
Journal: Pharmacotherapy 20091001
Title: The role of transporters in the pharmacokinetics of orally administered drugs.
Journal: Pharmaceutical research 20090901
Title: The history of antiretrovirals: key discoveries over the past 25 years.
Journal: Reviews in medical virology 20090901
Title: Distribution of saquinavir, methadone, and buprenorphine in maternal brain, placenta, and fetus during two different gestational stages of pregnancy in mice.
Journal: Journal of pharmaceutical sciences 20090801
Title: Human immunodeficiency virus: 25 years of diagnostic and therapeutic strategies and their impact on hepatitis B and C virus.
Journal: Medical microbiology and immunology 20090801
Title: The effect of probenecid and MK-571 on the feto-maternal transfer of saquinavir in dually perfused human term placenta.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20090712
Title: Design of HIV-1 protease inhibitors with pyrrolidinones and oxazolidinones as novel P1'-ligands to enhance backbone-binding interactions with protease: synthesis, biological evaluation, and protein-ligand X-ray studies.
Journal: Journal of medicinal chemistry 20090709
Title: Cytotoxicological analysis of a gp120 binding aptamer with cross-clade human immunodeficiency virus type 1 entry inhibition properties: comparison to conventional antiretrovirals.
Journal: Antimicrobial agents and chemotherapy 20090701
Title: Effect of saquinavir/ritonavir (1000/100 mg bid) on the pharmacokinetics of methadone in opiate-dependent HIV-negative patients on stable methadone maintenance therapy.
Journal: Addiction biology 20090701
Title: Molecular dynamics and free energy studies on the wild-type and mutated HIV-1 protease complexed with four approved drugs: mechanism of binding and drug resistance.
Journal: Journal of chemical information and modeling 20090701
Title: Renal transplantation in a HIV positive patient.
Journal: Indian journal of nephrology 20090701
Title: Effectiveness of commercial inhibitors against subtype F HIV-1 protease.
Journal: Journal of enzyme inhibition and medicinal chemistry 20090601
Title: Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected patients and healthy volunteers.
Journal: The Journal of antimicrobial chemotherapy 20090601
Title: Reducing the boosting dose of ritonavir does not affect saquinavir plasma concentrations in HIV-1-infected individuals.
Journal: AIDS (London, England) 20090601
Title: Interactions of different inhibitors with active-site aspartyl residues of HIV-1 protease and possible relevance to pepsin.
Journal: Proteins 20090515
Title: Proteolytic cleavage of HIV-1 GFP-Vpr fusions at novel sites within virions and living cells: concerns for intracellular trafficking studies.
Journal: Journal of fluorescence 20090501
Title: The transport of anti-HIV drugs across blood-CNS interfaces: summary of current knowledge and recommendations for further research.
Journal: Antiviral research 20090501
Title: On-line desorption of dried blood spot: A novel approach for the direct LC/MS analysis of micro-whole blood samples.
Journal: Journal of pharmaceutical and biomedical analysis 20090501
Title: Saquinavir exposure in HIV-infected patients with chronic viral hepatitis.
Journal: The Journal of antimicrobial chemotherapy 20090501
Title: The antitumor properties of a nontoxic, nitric oxide-modified version of saquinavir are independent of Akt.
Journal: Molecular cancer therapeutics 20090501
Title: Harnessing nature's insight: design of aspartyl protease inhibitors from treatment of drug-resistant HIV to Alzheimer's disease.
Journal: Journal of medicinal chemistry 20090423
Title: Protonate3D: assignment of ionization states and hydrogen coordinates to macromolecular structures.
Journal: Proteins 20090401
Title: Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV.
Journal: International journal of antimicrobial agents 20090401
Title: Gemini: a noninferiority study of saquinavir/ritonavir versus lopinavir/ritonavir as initial HIV-1 therapy in adults.
Journal: Journal of acquired immune deficiency syndromes (1999) 20090401
Title: HIV-1 protease inhibitor induced oxidative stress suppresses glucose stimulated insulin release: protection with thymoquinone.
Journal: Experimental biology and medicine (Maywood, N.J.) 20090401
Title: A mass spectrometry based imaging method developed for the intracellular detection of HIV protease inhibitors.
Journal: Rapid communications in mass spectrometry : RCM 20090401
Title: Synthesis and antimalarial activity of hydroxyethylpiperazine derivatives.
Journal: European journal of medicinal chemistry 20090301
Title: GRL-02031, a novel nonpeptidic protease inhibitor (PI) containing a stereochemically defined fused cyclopentanyltetrahydrofuran potent against multi-PI-resistant human immunodeficiency virus type 1 in vitro.
Journal: Antimicrobial agents and chemotherapy 20090301
Title: Discordant genotypic interpretation and phenotypic role of protease mutations in HIV-1 subtypes B and G.
Journal: The Journal of antimicrobial chemotherapy 20090301
Title: The HIV protease inhibitor saquinavir induces endoplasmic reticulum stress, autophagy, and apoptosis in ovarian cancer cells.
Journal: Gynecologic oncology 20090301
Title: Gag mutations strongly contribute to HIV-1 resistance to protease inhibitors in highly drug-experienced patients besides compensating for fitness loss.
Journal: PLoS pathogens 20090301
Title: Quantification of HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in peripheral blood mononuclear cell lysate using liquid chromatography coupled with tandem mass spectrometry.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20090215
Title: Clearance and clearance inhibition of the HIV-1 protease inhibitors ritonavir and saquinavir in sandwich-cultured rat hepatocytes and rat microsomes.
Journal: Toxicology in vitro : an international journal published in association with BIBRA 20090201
Title: The impact of cytokines on the expression of drug transporters, cytochrome P450 enzymes and chemokine receptors in human PBMC.
Journal: British journal of pharmacology 20090201
Title: Warfarin-antiretroviral interactions.
Journal: The Annals of pharmacotherapy 20090201
Title: Role of NEDD8 in HIV-associated lipodystrophy.
Journal: Differentiation; research in biological diversity 20090201
Title: Entrapment and release of saquinavir using novel cationic solid lipid nanoparticles.
Journal: International journal of pharmaceutics 20090105
Title: Transport of diclofenac by breast cancer resistance protein (ABCG2) and stimulation of multidrug resistance protein 2 (ABCC2)-mediated drug transport by diclofenac and benzbromarone.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20090101
Title: Contraception and HIV infection in women.
Journal: Human reproduction update 20090101
Title: Quantification of 8 HIV-protease inhibitors and 2 nonnucleoside reverse transcriptase inhibitors by ultra-performance liquid chromatography with diode array detection.
Journal: Clinical chemistry 20090101
Title: HIV protease inhibitors inhibit the development of preerythrocytic-stage plasmodium parasites.
Journal: The Journal of infectious diseases 20090101
Title: Anti-HIV drugs for cancer therapeutics: back to the future?
Journal: The Lancet. Oncology 20090101
Title: Antiretroviral-related adipocyte dysfunction and lipodystrophy in HIV-infected patients: Alteration of the PPARγ-dependent pathways.
Journal: PPAR research 20090101
Title: Assessing drug distribution in tissues expressing P-glycoprotein through physiologically based pharmacokinetic modeling: model structure and parameters determination.
Journal: Theoretical biology & medical modelling 20090101
Title: Prescribing and using self-injectable antiretrovirals: how concordant are physician and patient perspectives?
Journal: AIDS research and therapy 20090101
Title: Raltegravir, elvitegravir, and metoogravir: the birth of 'me-too' HIV-1 integrase inhibitors.
Journal: Retrovirology 20090101
Title: Darunavir: a review of its use in the management of HIV infection in adults.
Journal: Drugs 20090101
Title: HIV aspartyl peptidase inhibitors interfere with cellular proliferation, ultrastructure and macrophage infection of Leishmania amazonensis.
Journal: PloS one 20090101
Title: Is PPARγ a prospective player in HIV-1-associated bone disease?
Journal: PPAR research 20090101
Title: Safety and efficacy of a double-boosted protease inhibitor combination, saquinavir and lopinavir/ritonavir, in pretreated children at 96 weeks.
Journal: Antiviral therapy 20090101
Title: Role of atazanavir in the treatment of HIV infection.
Journal: Therapeutics and clinical risk management 20090101
Title: The pharmacokinetics, safety and efficacy of boosted saquinavir tablets in HIV type-1-infected pregnant women.
Journal: Antiviral therapy 20090101
Title: Zidovudine/lamivudine for HIV-1 infection contributes to limb fat loss.
Journal: PloS one 20090101
Title: Pregnancy outcomes among HIV-infected women undergoing antiretroviral therapy.
Journal: The open AIDS journal 20090101
Title: Preparation and performance evaluation of saquinavir laden cationic submicron emulsions.
Journal: Drug delivery 20090101
Title: Low-abundance HIV drug-resistant viral variants in treatment-experienced persons correlate with historical antiretroviral use.
Journal: PloS one 20090101
Title: Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection.
Journal: PloS one 20090101
Title: The Impact of HIV and Malaria Coinfection: What Is Known and Suggested Venues for Further Study.
Journal: Interdisciplinary perspectives on infectious diseases 20090101
Title: Bosentan in the treatment of pulmonary arterial hypertension with the focus on the mildly symptomatic patient.
Journal: Vascular health and risk management 20090101
Title: Pharmacotherapy of pediatric and adolescent HIV infection.
Journal: Therapeutics and clinical risk management 20090101
Title: Managing treatment-experienced pediatric and adolescent HIV patients: role of darunavir.
Journal: Therapeutics and clinical risk management 20090101
Title: Primary HIV-1 drug resistance and polymorphic patterns among injecting drug users (IDUs) in Chennai, Southern India.
Journal: Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 20090101
Title: Pairwise and higher-order correlations among drug-resistance mutations in HIV-1 subtype B protease.
Journal: BMC bioinformatics 20090101
Title: Evidence for limited genetic compartmentalization of HIV-1 between lung and blood.
Journal: PloS one 20090101
Title: Perinatal acquisition of drug-resistant HIV-1 infection: mechanisms and long-term outcome.
Journal: Retrovirology 20090101
Title: Drugs associated with more suicidal ideations are also associated with more suicide attempts.
Journal: PloS one 20090101
Title: Estradiol and progesterone-mediated regulation of P-gp in P-gp overexpressing cells (NCI-ADR-RES) and placental cells (JAR).
Journal: Molecular pharmaceutics 20090101
Title: Inferring within-patient HIV-1 evolutionary dynamics under anti-HIV therapy using serial virus samples with vSPA.
Journal: BMC bioinformatics 20090101
Title: Oxidative imbalance in HIV-1 infected patients treated with antiretroviral therapy.
Journal: Journal of biomedicine & biotechnology 20090101
Title: RT-SHIV, an infectious CCR5-tropic chimeric virus suitable for evaluating HIV reverse transcriptase inhibitors in macaque models.
Journal: AIDS research and therapy 20090101
Title: The prognosis of late presenters in the era of highly active antiretroviral therapy in serbia.
Journal: The open virology journal 20090101
Title: Visualisation and quantitative analysis of the rodent malaria liver stage by real time imaging.
Journal: PloS one 20090101
Title: Dynamics of viral replication in blood and lymphoid tissues during SIVmac251 infection of macaques.
Journal: Retrovirology 20090101
Title: First-line boosted protease inhibitor-based regimens in treatment-naive HIV-1-infected patients--making a good thing better.
Journal: AIDS reviews 20090101
Title: German-Austrian recommendations for HIV1-therapy in pregnancy and in HIV1-exposed newborn, update 2008.
Journal: European journal of medical research 20090101
Title: HIV- 1 protease inhibits Cap- and poly(A)-dependent translation upon eIF4GI and PABP cleavage.
Journal: PloS one 20090101
Title: Functional role of p-glycoprotein and binding protein effect on the placental transfer of lopinavir/ritonavir in the ex vivo human perfusion model.
Journal: Obstetrics and gynecology international 20090101
Title: Combination antiretroviral drugs in PLGA nanoparticle for HIV-1.
Journal: BMC infectious diseases 20090101
Title: Hepatic profile analyses of tipranavir in Phase II and III clinical trials.
Journal: BMC infectious diseases 20090101
Title: Formulation preference, tolerability and quality of life assessment following a switch from lopinavir/ritonavir soft gel capsule to tablet in human immunodeficiency virus-infected patients.
Journal: AIDS research and therapy 20090101
Title: Treatment outcomes and plasma level of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who had NRTI and NNRTI failure.
Journal: AIDS research and therapy 20090101
Title: Disfiguring molluscum contagiosum in a HIV-positive patient responding to antiretroviral therapy.
Journal: Indian journal of dermatology 20090101
Title: A comprehensive review of immunosuppression used for liver transplantation.
Journal: Journal of transplantation 20090101
Title: Kinetics and determining factors of the virologic response to antiretrovirals during pregnancy.
Journal: Infectious diseases in obstetrics and gynecology 20090101
Title: Role of multidrug transporters in neurotherapeutics.
Journal: Annals of Indian Academy of Neurology 20090101
Title: Raltegravir: The evidence of its therapeutic value in HIV-1 infection.
Journal: Core evidence 20090101
Title: Immune reconstitution inflammatory syndrome in AIDS-related non-hodgkin's lymphoma.
Journal: Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology 20090101
Title: Profile of darunavir in the management of treatment-experienced HIV patients.
Journal: HIV/AIDS (Auckland, N.Z.) 20090101
Title: Role of darunavir in the management of HIV infection.
Journal: HIV/AIDS (Auckland, N.Z.) 20090101
Title: Pharmacologic and nonpharmacologic options for the management of HIV infection during pregnancy.
Journal: HIV/AIDS (Auckland, N.Z.) 20090101
Title: Limited-sampling strategies for anti-infective agents: systematic review.
Journal: The Canadian journal of hospital pharmacy 20090101
Title: Interactions of pluronic block copolymers on P-gp efflux activity: experience with HIV-1 protease inhibitors.
Journal: Journal of pharmaceutical sciences 20081201
Title: A model predicting delivery of saquinavir in nanoparticles to human monocyte/macrophage (Mo/Mac) cells.
Journal: Biotechnology and bioengineering 20081201
Title: Interaction between cat's claw and protease inhibitors atazanavir, ritonavir and saquinavir.
Journal: European journal of clinical pharmacology 20081201
Title: A double transgenic mouse model expressing human pregnane X receptor and cytochrome P450 3A4.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20081201
Title: Population pharmacokinetics of ritonavir-boosted saquinavir regimens in HIV-infected individuals.
Journal: The Journal of antimicrobial chemotherapy 20081201
Title: An HPLC-PDA method for the simultaneous quantification of the HIV integrase inhibitor raltegravir, the new nonnucleoside reverse transcriptase inhibitor etravirine, and 11 other antiretroviral agents in the plasma of HIV-infected patients.
Journal: Therapeutic drug monitoring 20081201
Title: PL-100, a novel HIV-1 protease inhibitor displaying a high genetic barrier to resistance: an in vitro selection study.
Journal: Journal of medical virology 20081201
Title: P-gp inhibition potential in cell-based models: which 'calculation' method is the most accurate?
Journal: The AAPS journal 20081201
Title: Once-daily fosamprenavir with ritonavir in the treatment of HIV infection in therapy-naïve patients.
Journal: Therapeutics and clinical risk management 20081201
Title: Platelet-leucocyte adhesion markers before and after the initiation of antiretroviral therapy with HIV protease inhibitors.
Journal: The Journal of antimicrobial chemotherapy 20081101
Title: Intracellular survival of Leishmania species that cause visceral leishmaniasis is significantly reduced by HIV-1 protease inhibitors.
Journal: The Journal of infectious diseases 20081101
Title: Evolution and predictors of change in total bone mineral density over time in HIV-infected men and women in the nutrition for healthy living study.
Journal: Journal of acquired immune deficiency syndromes (1999) 20081101
Title: Nucleoside-free boosted double PI regimen: significant CD4+ T-cell recovery in patients with poor immunologic response despite virologic suppression.
Journal: Current HIV research 20081101
Title: Cultured CD4T cells and primary human lymphocytes express hOATPs: intracellular accumulation of saquinavir and lopinavir.
Journal: British journal of pharmacology 20081101
Title: Clinical pharmacology of HIV protease inhibitors in pregnancy.
Journal: Current opinion in HIV and AIDS 20081101
Title: Solution kinetics measurements suggest HIV-1 protease has two binding sites for darunavir and amprenavir.
Journal: Journal of medicinal chemistry 20081023
Title: Flexible cyclic ethers/polyethers as novel P2-ligands for HIV-1 protease inhibitors: design, synthesis, biological evaluation, and protein-ligand X-ray studies.
Journal: Journal of medicinal chemistry 20081009
Title: Interaction of dipeptide prodrugs of saquinavir with multidrug resistance protein-2 (MRP-2): evasion of MRP-2 mediated efflux.
Journal: International journal of pharmaceutics 20081001
Title: Maraviroc: in vitro assessment of drug-drug interaction potential.
Journal: British journal of clinical pharmacology 20081001
Title: [Chemical characteristics, mechanism of action and antiviral activity of darunavir].
Journal: Enfermedades infecciosas y microbiologia clinica 20081001
Title: Lopinavir/ritonavir in the treatment of HIV-1 infection: a review.
Journal: Therapeutics and clinical risk management 20081001
Title: Impedance method for detecting HIV-1 protease and screening for its inhibitors using ferrocene-peptide conjugate/Au nanoparticle/single-walled carbon nanotube modified electrode.
Journal: Analytical chemistry 20080915
Title: MRP (ABCC) transporters-mediated efflux of anti-HIV drugs, saquinavir and zidovudine, from human endothelial cells.
Journal: Experimental biology and medicine (Maywood, N.J.) 20080901
Title: A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
Journal: Antiviral research 20080901
Title: Ultra-fast quantitation of saquinavir in human plasma by matrix-assisted laser desorption/ionization and selected reaction monitoring mode detection.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080901
Title: HIV infection in the elderly.
Journal: Clinical interventions in aging 20080901
Title: Inorganic polyhedral metallacarborane inhibitors of HIV protease: a new approach to overcoming antiviral resistance.
Journal: Journal of medicinal chemistry 20080814
Title: Relevance of the organic cation transporters 1 and 2 for antiretroviral drug therapy in human immunodeficiency virus infection.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20080801
Title: Pharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant women.
Journal: British journal of clinical pharmacology 20080801
Title: Effect of flap mutations on structure of HIV-1 protease and inhibition by saquinavir and darunavir.
Journal: Journal of molecular biology 20080801
Title: Determination of unbound antiretroviral drug concentrations by a modified ultrafiltration method reveals high variability in the free fraction.
Journal: Therapeutic drug monitoring 20080801
Title: Roche Labs update insert for saquinavir.
Journal: AIDS alert 20080801
Title: Two cases of multidrug-resistant human immunodeficiency virus infection treated with atazanavir and lopinavir/ritonavir combination therapy.
Journal: Journal of Korean medical science 20080801
Title: Combating HIV resistance - focus on darunavir.
Journal: Therapeutics and clinical risk management 20080801
Title: Synthesis and in vitro biological evaluation of valine-containing prodrugs derived from clinically used HIV-protease inhibitors.
Journal: European journal of medicinal chemistry 20080701
Title: Intracranial haemorrhage possibly related to Tipranavir in an HIV-1 patient with cryptococcal meningitis.
Journal: The Journal of infection 20080701
Title: Cellular accumulation of cholyl-glycylamido-fluorescein in sandwich-cultured rat hepatocytes: kinetic characterization, transport mechanisms, and effect of human immunodeficiency virus protease inhibitors.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20080701
Title: Rate-limiting steps in hepatic drug clearance: comparison of hepatocellular uptake and metabolism with microsomal metabolism of saquinavir, nelfinavir, and ritonavir.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20080701
Title: Pharmacokinetic analysis to assess forgiveness of boosted saquinavir regimens for missed or late dosing.
Journal: The Journal of antimicrobial chemotherapy 20080701
Title: Double boosted protease inhibitors, saquinavir, and lopinavir/ritonavir, in nucleoside pretreated children at 48 weeks.
Journal: The Pediatric infectious disease journal 20080701
Title: Quantitative analysis of antiretroviral drugs in lysates of peripheral blood mononuclear cells using MALDI-triple quadrupole mass spectrometry.
Journal: Analytical chemistry 20080701
Title: Impact on replicative fitness of the G48E substitution in the protease of HIV-1: an in vitro and in silico evaluation.
Journal: Journal of acquired immune deficiency syndromes (1999) 20080701
Title: Invirase package insert updated.
Journal: AIDS patient care and STDs 20080701
Title: (S)-1,5-Dibenzyl-3-tert-butyl-imidazol-idin-4-one.
Journal: Acta crystallographica. Section E, Structure reports online 20080701
Title: Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Journal: Journal of medicinal chemistry 20080612
Title: Differential effects of ketoconazole on exposure to temsirolimus following intravenous infusion of temsirolimus.
Journal: British journal of cancer 20080603
Title: Quality control of protease inhibitors.
Journal: Journal of pharmaceutical sciences 20080601
Title: Pharmacokinetics and safety of saquinavir/ritonavir and omeprazole in HIV-infected subjects.
Journal: Clinical pharmacology and therapeutics 20080601
Title: Changes in metabolic toxicity after switching from stavudine/didanosine to tenofovir/lamivudine--a Staccato trial substudy.
Journal: The Journal of antimicrobial chemotherapy 20080601
Title: Short communication: oral lesions in HIV/AIDS patients undergoing HAART including efavirenz.
Journal: AIDS research and human retroviruses 20080601
Title: Screening and Management of HIV-2-Infected Individuals in Northern Italy.
Journal: AIDS patient care and STDs 20080601
Title: In vitro evaluation of reversible and irreversible cytochrome P450 inhibition: current status on methodologies and their utility for predicting drug-drug interactions.
Journal: The AAPS journal 20080601
Title: Current industrial practices in assessing CYP450 enzyme induction: preclinical and clinical.
Journal: The AAPS journal 20080601
Title: Atriplatrade mark - HIV therapy in one pill.
Journal: Therapeutics and clinical risk management 20080601
Title: Quantitative analysis of HIV-1 protease inhibitors in cell lysates using MALDI-FTICR mass spectrometry.
Journal: Analytical chemistry 20080515
Title: An examination of the effect of intestinal first pass extraction on intestinal lymphatic transport of saquinavir in the rat.
Journal: Pharmaceutical research 20080501
Title: Differential roles of P-glycoprotein, multidrug resistance-associated protein 2, and CYP3A on saquinavir oral absorption in Sprague-Dawley rats.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20080501
Title: Pharmacokinetics and short-term efficacy of a double-boosted protease inhibitor regimen in treatment-naive HIV-1-infected adults.
Journal: The Journal of antimicrobial chemotherapy 20080501
Title: Validation and toxicity of PI3K/Akt pathway inhibition by HIV protease inhibitors in humans.
Journal: Cancer biology & therapy 20080501
Title: Inhibitory quotient in HIV pharmacology.
Journal: Current opinion in HIV and AIDS 20080501
Title: Differences in the pharmacokinetics of protease inhibitors between healthy volunteers and HIV-infected persons.
Journal: Current opinion in HIV and AIDS 20080501
Title: Accurate prediction of protonation state as a prerequisite for reliable MM-PB(GB)SA binding free energy calculations of HIV-1 protease inhibitors.
Journal: Journal of computational chemistry 20080415
Title: Pharmacokinetics, safety, and efficacy of tipranavir boosted with ritonavir alone or in combination with other boosted protease inhibitors as part of optimized combination antiretroviral therapy in highly treatment-experienced patients (BI Study 1182.51).
Journal: Journal of acquired immune deficiency syndromes (1999) 20080401
Title: Species-dependent transport and modulation properties of human and mouse multidrug resistance protein 2 (MRP2/Mrp2, ABCC2/Abcc2).
Journal: Drug metabolism and disposition: the biological fate of chemicals 20080401
Title: Characterization of a novel human immunodeficiency virus type 1 protease inhibitor, A-790742.
Journal: Antimicrobial agents and chemotherapy 20080401
Title: Inhibition of HIV-2 protease by HIV-1 protease inhibitors in clinical use.
Journal: Chemical biology & drug design 20080401
Title: Saquinavir plus lopinavir/ritonavir versus amprenavir plus lopinavir/ritonavir for treating highly resistant patients in Brazil.
Journal: Journal of acquired immune deficiency syndromes (1999) 20080401
Title: Effects of CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteers.
Journal: British journal of clinical pharmacology 20080401
Title: Effects of CYP3A4 inducers with and without CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteers.
Journal: British journal of clinical pharmacology 20080401
Title: Electromagnetic interference in the permeability of saquinavir across the blood-brain barrier using nanoparticulate carriers.
Journal: International journal of pharmaceutics 20080303
Title: Natural and synthetic polymers as inhibitors of drug efflux pumps.
Journal: Pharmaceutical research 20080301
Title: Pharmacokinetic interaction between efavirenz and dual protease inhibitors in healthy volunteers.
Journal: Biopharmaceutics & drug disposition 20080301
Title: Statins impair antitumor effects of rituximab by inducing conformational changes of CD20.
Journal: PLoS medicine 20080301
Title: Rapid and accurate prediction of binding free energies for saquinavir-bound HIV-1 proteases.
Journal: Journal of the American Chemical Society 20080227
Title: Structure-activity relationships of novel HIV-1 protease inhibitors containing the 3-amino-2-chlorobenzoyl-allophenylnorstatine structure.
Journal: Bioorganic & medicinal chemistry 20080201
Title: Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec, Gleevectrade mark).
Journal: Therapeutics and clinical risk management 20080201
Title: Improved oral bioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulations.
Journal: International journal of pharmaceutics 20080122
Title: Stereocontrolled synthesis and biological activity of two diastereoisomers of the potent HIV-1 protease inhibitor saquinavir.
Journal: Bioorganic & medicinal chemistry 20080115
Title: The prevalence and risk of hepatitis flares in a Serbian cohort of HIV and HCV co-infected patients treated with HAART.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20080101
Title: Long-distance interactive expert advice in highly treatment-experienced HIV-infected patients.
Journal: The Journal of antimicrobial chemotherapy 20080101
Title: Nelfinavir, a new anti-cancer drug with pleiotropic effects and many paths to autophagy.
Journal: Autophagy 20080101
Title: Pharmacokinetics of saquinavir after intravenous and oral dosing of saquinavir: hydroxybutenyl-beta-cyclodextrin formulations.
Journal: Biomacromolecules 20080101
Title: Plasma levels, safety, and 60-week efficacy of a once-daily double-boosted protease inhibitor regimen of atazanavir, saquinavir, and ritonavir.
Journal: Journal of acquired immune deficiency syndromes (1999) 20080101
Title: Drug interactions between HIV protease inhibitors and acid-reducing agents.
Journal: Clinical pharmacokinetics 20080101
Title: Multiple independent origins of a protease inhibitor resistance mutation in salvage therapy patients.
Journal: Retrovirology 20080101
Title: The incidence of multidrug and full class resistance in HIV-1 infected patients is decreasing over time (2001-2006) in Portugal.
Journal: Retrovirology 20080101
Title: Alterations in the Notch4 pathway in cerebral endothelial cells by the HIV aspartyl protease inhibitor, nelfinavir.
Journal: BMC neuroscience 20080101
Title: Functional diversity of HIV-1 envelope proteins expressed by contemporaneous plasma viruses.
Journal: Retrovirology 20080101
Title: Longitudinal microarray analysis of cell surface antigens on peripheral blood mononuclear cells from HIV+ individuals on highly active antiretroviral therapy.
Journal: Retrovirology 20080101
Title: Fosamprenavir or atazanavir once daily boosted with ritonavir 100 mg, plus tenofovir/emtricitabine, for the initial treatment of HIV infection: 48-week results of ALERT.
Journal: AIDS research and therapy 20080101
Title: Proteochemometric modeling of HIV protease susceptibility.
Journal: BMC bioinformatics 20080101
Title: Influence of adenosine triphosphate and ABCB1 (MDR1) genotype on the P-glycoprotein-dependent transfer of saquinavir in the dually perfused human placenta.
Journal: Human & experimental toxicology 20080101
Title: Pharmacokinetic monitoring of HIV-1 protease inhibitors in the antiretroviral therapy.
Journal: Acta poloniae pharmaceutica 20080101
Title: Long-term efficacy and safety of first-line therapy with once-daily saquinavir/ritonavir.
Journal: Antiviral therapy 20080101
Title: P-glycoprotein expression in HTLV-III cells after treatment with HIV-1 protease inhibitors.
Journal: Ethnicity & disease 20080101
Title: beta-Estradiol attenuates the anti-HIV-1 efficacy of Stavudine (D4T) in primary PBL.
Journal: Retrovirology 20080101
Title: Beneficial effects of HIV peptidase inhibitors on Fonsecaea pedrosoi: promising compounds to arrest key fungal biological processes and virulence.
Journal: PloS one 20080101
Title: Outcome of protease inhibitor substitution with nevirapine in HIV-1 infected children.
Journal: BMC infectious diseases 20080101
Title: Double-boosted protease inhibitor antiretroviral regimens: what role?
Journal: Drugs 20080101
Title: 25 years of HIV-1 research - progress and perspectives.
Journal: BMC medicine 20080101
Title: Human immunodeficiency virus seroconversion presenting with acute inflammatory demyelinating polyneuropathy: a case report.
Journal: Journal of medical case reports 20080101
Title: CD8+ T-cell interleukin-7 receptor alpha expression as a potential indicator of disease status in HIV-infected children.
Journal: PloS one 20080101
Title: Mechanistic simulations explain paradoxical saquinavir metabolism during in vitro vectorial transport study.
Journal: Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference 20080101
Title: Pharmacokinetics, safety and efficacy of saquinavir/ ritonavir 1,000/100 mg twice daily as HIV type-1 therapy and transmission prophylaxis in pregnancy.
Journal: Antiviral therapy 20080101
Title: Pharmacovigilance: effects of herbal components on human drugs interactions involving cytochrome P450.
Journal: Bioinformation 20080101
Title: Determinants of Treatment Access in a Population-based Cohort of HIV-positive Men and Women Living in Argentina.
Journal: Journal of the International AIDS Society 20080101
Title: Insights into a mutation-assisted lateral drug escape mechanism from the HIV-1 protease active site.
Journal: Biochemistry 20071225
Title: Overview of boosted protease inhibitors in treatment-experienced HIV-infected patients.
Journal: The Journal of antimicrobial chemotherapy 20071201
Title: Pharmacokinetic interaction between darunavir and saquinavir in HIV-negative volunteers.
Journal: Therapeutic drug monitoring 20071201
Title: Initiating highly active antiretroviral therapy with newer protease inhibitors is associated with better survival compared to first-generation protease inhibitors or nevirapine.
Journal: AIDS patient care and STDs 20071201
Title: HPLC-MS method for the simultaneous quantification of the new HIV protease inhibitor darunavir, and 11 other antiretroviral agents in plasma of HIV-infected patients.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20071115
Title: Insight into analysis of interactions of saquinavir with HIV-1 protease in comparison between the wild-type and G48V and G48V/L90M mutants based on QM and QM/MM calculations.
Journal: Journal of molecular graphics & modelling 20071101
Title: Direct effect of human immunodeficiency virus protease inhibitors on neutrophil function and apoptosis via calpain inhibition.
Journal: Clinical and vaccine immunology : CVI 20071101
Title: Pharmacokinetics of two randomized trials evaluating the safety and efficacy of indinavir, saquinavir and lopinavir in combination with low-dose ritonavir: the MaxCmin1 and 2 trials.
Journal: Basic & clinical pharmacology & toxicology 20071101
Title: Efficacy and tolerability of a double boosted protease inhibitor (lopinavir + saquinavir/ritonavir) regimen in HIV-infected patients who failed treatment with nonnucleoside reverse transcriptase inhibitors.
Journal: HIV medicine 20071101
Title: Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment.
Journal: PLoS medicine 20071101
Title: Tipranavir: the first nonpeptidic protease inhibitor for the treatment of protease resistance.
Journal: Clinical therapeutics 20071101
Title: The effect of ABCB1 polymorphism on the pharmacokinetics of saquinavir alone and in combination with ritonavir.
Journal: Clinical pharmacology and therapeutics 20071001
Title: Prevalence of darunavir resistance mutations in HIV-1-infected patients failing other protease inhibitors.
Journal: The Journal of antimicrobial chemotherapy 20071001
Title: Potent inhibition of HIV-1 replication by novel non-peptidyl small molecule inhibitors of protease dimerization.
Journal: The Journal of biological chemistry 20070928
Title: Combined tipranavir and enfuvirtide use associated with higher plasma tipranavir concentrations but not with increased hepatotoxicity: sub-analysis from RESIST.
Journal: AIDS (London, England) 20070912
Title: Design and synthesis of HIV-1 protease inhibitors incorporating oxazolidinones as P2/P2' ligands in pseudosymmetric dipeptide isosteres.
Journal: Journal of medicinal chemistry 20070906
Title: Nelfinavir, A lead HIV protease inhibitor, is a broad-spectrum, anticancer agent that induces endoplasmic reticulum stress, autophagy, and apoptosis in vitro and in vivo.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20070901
Title: Modulation of human cytochrome P450 3A4 (CYP3A4) and P-glycoprotein (P-gp) in Caco-2 cell monolayers by selected commercial-source milk thistle and goldenseal products.
Journal: Canadian journal of physiology and pharmacology 20070901
Title: MDR1 polymorphisms effect cyclosporine AUC0-4 values in Behçet's disease patients.
Journal: Clinical ophthalmology (Auckland, N.Z.) 20070901
Title: Immunomodulatory effects of two HIV protease inhibitors, Saquinavir and Ritonavir, on lymphocytes from healthy seronegative individuals.
Journal: Immunology letters 20070815
Title: Amodiaquine metabolism is impaired by common polymorphisms in CYP2C8: implications for malaria treatment in Africa.
Journal: Clinical pharmacology and therapeutics 20070801
Title: Transport of stavudine, delavirdine, and saquinavir across the blood-brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles.
Journal: International journal of pharmaceutics 20070801
Title: Activity against human immunodeficiency virus type 1, intracellular metabolism, and effects on human DNA polymerases of 4'-ethynyl-2-fluoro-2'-deoxyadenosine.
Journal: Antimicrobial agents and chemotherapy 20070801
Title: Clinical studies with oral lipid based formulations of poorly soluble compounds.
Journal: Therapeutics and clinical risk management 20070801
Title: Review of tipranavir in the treatment of drug-resistant HIV.
Journal: Therapeutics and clinical risk management 20070801
Title: Ketoconazole is inferior to ritonavir as an alternative booster for saquinavir in a once daily regimen in Thai HIV-1 infected patients.
Journal: AIDS (London, England) 20070731
Title: Development and validation of a reversed-phase liquid chromatographic method with fluorescence detection for the study of Saquinavir pharmacokinetics in rat plasma.
Journal: Analytica chimica acta 20070702
Title: Interindividual variability in the effect of atazanavir and saquinavir on the expression of lymphocyte P-glycoprotein.
Journal: The Journal of antimicrobial chemotherapy 20070701
Title: Forecast of demand for antiretroviral drugs in low and middle-income countries: 2007-2008.
Journal: AIDS (London, England) 20070701
Title: Bayesian network analysis of resistance pathways against HIV-1 protease inhibitors.
Journal: Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 20070601
Title: Doxorubicin cardiomyopathy via TLR-2 stimulation: potential for prevention using current anti-retroviral inhibitors such as ritonavir and nelfinavir.
Journal: Hematological oncology 20070601
Title: A novel bis-tetrahydrofuranylurethane-containing nonpeptidic protease inhibitor (PI), GRL-98065, is potent against multiple-PI-resistant human immunodeficiency virus in vitro.
Journal: Antimicrobial agents and chemotherapy 20070601
Title: HIV-1 protease inhibitors do not interfere with provirus transcription and host cell apoptosis induced by combined treatment TNF-alpha + TSA.
Journal: Biochemical pharmacology 20070601
Title: Clinical response and tolerability to and safety of saquinavir with low-dose ritonavir in human immunodeficiency virus type 1-infected mothers and their infants.
Journal: Antimicrobial agents and chemotherapy 20070601
Title: The safety, efficacy, and pharmacokinetic profile of a switch in antiretroviral therapy to saquinavir, ritonavir, and atazanavir alone for 48 weeks and a switch in the saquinavir formulation.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20070601
Title: Therapeutic issues in HIV/HCV-coinfected patients.
Journal: Journal of viral hepatitis 20070601
Title: Limited-sampling strategy for the prediction of boosted hard-gel saquinavir exposure at a dosage of 1000/100 mg twice daily in human immunodeficiency virus-infected individuals.
Journal: Therapeutic drug monitoring 20070601
Title: Higher-order oligomerization targets plasma membrane proteins and HIV gag to exosomes.
Journal: PLoS biology 20070601
Title: Intestinal absorption of novel-dipeptide prodrugs of saquinavir in rats.
Journal: International journal of pharmaceutics 20070524
Title: HIV protease inhibitors enhance the efficacy of irradiation.
Journal: Cancer research 20070515
Title: Determination of 19 antiretroviral agents in pharmaceuticals or suspected products with two methods using high-performance liquid chromatography.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070501
Title: CYP3A5 genotype has an impact on the metabolism of the HIV protease inhibitor saquinavir.
Journal: Clinical pharmacology and therapeutics 20070501
Title: Exploratory study comparing the metabolic toxicities of a lopinavir/ritonavir plus saquinavir dual protease inhibitor regimen versus a lopinavir/ritonavir plus zidovudine/lamivudine nucleoside regimen.
Journal: The Journal of antimicrobial chemotherapy 20070501
Title: Inhibitory quotient as a prognostic factor of response to a salvage antiretroviral therapy containing ritonavir-boosted saquinavir. The CIVSA Study.
Journal: HIV medicine 20070501
Title: Multidrug resistance proteins affect drug transmission across the placenta.
Journal: American journal of obstetrics and gynecology 20070501
Title: Absent reduction by HIV protease inhibitors of Candida albicans adhesion to endothelial cells.
Journal: Mycoses 20070501
Title: Combining resistance and pharmacology for optimum patient care.
Journal: Current opinion in HIV and AIDS 20070501
Title: Association of Gag cleavage sites to protease mutations and to virological response in HIV-1 treated patients.
Journal: The Journal of infection 20070401
Title: Absorption of poorly water soluble drugs subject to apical efflux using phospholipids as solubilizers in the Caco-2 cell model.
Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20070401
Title: An isocratic liquid chromatography method for determining HIV non-nucleoside reverse transcriptase inhibitor and protease inhibitor concentrations in human plasma.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070401
Title: Estimation of population pharmacokinetic parameters of saquinavir in HIV patients with the MONOLIX software.
Journal: Journal of pharmacokinetics and pharmacodynamics 20070401
Title: Atomic resolution crystal structures of HIV-1 protease and mutants V82A and I84V with saquinavir.
Journal: Proteins 20070401
Title: Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis.
Journal: The Journal of antimicrobial chemotherapy 20070401
Title: Efficacy of low-dose boosted saquinavir once daily plus nucleoside reverse transcriptase inhibitors in pregnant HIV-1-infected women with a therapeutic drug monitoring strategy.
Journal: Therapeutic drug monitoring 20070401
Title: Antimalarial activity of sera from subjects taking HIV protease inhibitors.
Journal: AIDS (London, England) 20070330
Title: High-performance liquid chromatography assay for the determination of the HIV-protease inhibitor tipranavir in human plasma in combination with nine other antiretroviral medications.
Journal: Journal of pharmaceutical and biomedical analysis 20070312
Title: Differential protein binding of indinavir and saquinavir in matched maternal and umbilical cord plasma.
Journal: British journal of clinical pharmacology 20070301
Title: Implementation of an antiretroviral access program for HIV-1-infected individuals in resource-limited settings: clinical results from 4 African countries.
Journal: Journal of acquired immune deficiency syndromes (1999) 20070301
Title: Saquinavir, nelfinavir and M8 pharmacokinetics following combined saquinavir, ritonavir and nelfinavir administration.
Journal: The Journal of antimicrobial chemotherapy 20070301
Title: Dyslipidemia in an Asian population after treatment for two years with protease inhibitor-containing regimens.
Journal: Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 20070301
Title: Evaluation of an International Pharmacopoeia method for the analysis of saquinavir (mesilate) bulk drugs by liquid chromatography.
Journal: Journal of pharmaceutical and biomedical analysis 20070219
Title: Modulation of human BCRP (ABCG2) activity by anti-HIV drugs.
Journal: The Journal of antimicrobial chemotherapy 20070201
Title: Pharmacokinetics of saquinavir with atazanavir or low-dose ritonavir administered once daily (ASPIRE I) or twice daily (ASPIRE II) in seronegative volunteers.
Journal: Journal of clinical pharmacology 20070201
Title: HIV protease inhibitors selectively induce gene expression alterations associated with reduced calcium deposition in primary human osteoblasts.
Journal: AIDS research and human retroviruses 20070201
Title: Dose reduction effective in alleviating symptoms of saquinavir toxicity.
Journal: International journal of STD & AIDS 20070201
Title: Update in HIV care.
Journal: Journal of general internal medicine 20070201
Title: Enhanced transport of P-glycoprotein substrate saquinavir in presence of thiolated chitosan.
Journal: Journal of drug targeting 20070201
Title: Simultaneous determination of 8 HIV protease inhibitors in human plasma by isocratic high-performance liquid chromatography with combined use of UV and fluorescence detection: amprenavir, indinavir, atazanavir, ritonavir, lopinavir, saquinavir, nelfinavir and M8-nelfinavir metabolite.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070101
Title: In silico prediction of pregnane X receptor activators by machine learning approaches.
Journal: Molecular pharmacology 20070101
Title: Evaluation of 384-well formatted sample preparation technologies for regulated bioanalysis.
Journal: Rapid communications in mass spectrometry : RCM 20070101
Title: The activity of protease inhibitors against Giardia duodenalis and metronidazole-resistant Trichomonas vaginalis.
Journal: International journal of antimicrobial agents 20070101
Title: A novel substrate-based HIV-1 protease inhibitor drug resistance mechanism.
Journal: PLoS medicine 20070101
Title: HIV/AIDS drugs for Sub-Saharan Africa: how do brand and generic supply compare?
Journal: PloS one 20070101
Title: Anti-HIV agents. Promising results from a saquinavir study.
Journal: TreatmentUpdate 20070101
Title: Anti-HIV agents. Starting therapy with saquinavir.
Journal: TreatmentUpdate 20070101
Title: Food consumption, cytochrome P450 3A4 (CYP3A4) presystemic inhibitors, and bioavailability of saquinavir.
Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20070101
Title: Clinical validation of saquinavir/ritonavir genotypic resistance score in protease-inhibitor-experienced patients.
Journal: Antiviral therapy 20070101
Title: TRIPS, the Doha declaration and paragraph 6 decision: what are the remaining steps for protecting access to medicines?
Journal: Globalization and health 20070101
Title: AIDS in the Third World: how to stop the HIV infection?
Journal: Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie 20070101
Title: Anti-HIV drugs.
Journal: Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie 20070101
Title: Injection drug use and patterns of highly active antiretroviral therapy use: an analysis of ALIVE, WIHS, and MACS cohorts.
Journal: AIDS research and therapy 20070101
Title: Predictive factors of virological success to salvage regimens containing protease inhibitors in HIV-1 infected children.
Journal: BMC infectious diseases 20070101
Title: Synergistic inhibition of protease-inhibitor-resistant HIV type 1 by saquinavir in combination with atazanavir or lopinavir.
Journal: Antiviral therapy 20070101
Title: Early prediction of median survival among a large AIDS surveillance cohort.
Journal: BMC public health 20070101
Title: Fast and simultaneous determination of darunavir and eleven other antiretroviral drugs for therapeutic drug monitoring: method development and validation for the determination of all currently approved HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in human plasma by liquid chromatography coupled with electrospray ionization tandem mass spectrometry.
Journal: Rapid communications in mass spectrometry : RCM 20070101
Title: Protease inhibitor associated mutations compromise the efficacy of therapy in human immunodeficiency virus-1 (HIV-1) infected pediatric patients: a cross-sectional study.
Journal: AIDS research and therapy 20070101
Title: Electrospray tandem mass spectroscopic characterisation of 18 antiretroviral drugs and simultaneous quantification of 12 antiretrovirals in plasma.
Journal: Rapid communications in mass spectrometry : RCM 20070101
Title: General framework for the quantitative prediction of CYP3A4-mediated oral drug interactions based on the AUC increase by coadministration of standard drugs.
Journal: Clinical pharmacokinetics 20070101
Title: First use of tamoxifen in an HIV patient with encapsulating peritoneal sclerosis.
Journal: Clinical drug investigation 20070101
Title: Utilization and spending trends for antiretroviral medications in the U.S. Medicaid program from 1991 to 2005.
Journal: AIDS research and therapy 20070101
Title: Stavudine but not didanosine as part of HAART contributes to peripheral lipoatrophy: a substudy from the Antiretroviral Regimen Evaluation Study (ARES).
Journal: HIV clinical trials 20070101
Title: Medicinal importance of grapefruit juice and its interaction with various drugs.
Journal: Nutrition journal 20070101
Title: Cost-effectiveness of tipranavir versus comparator protease inhibitor regimens in HIV infected patients previously exposed to antiretroviral therapy in the Netherlands.
Journal: Cost effectiveness and resource allocation : C/E 20070101
Title: Inhibitors of HIV-1 protease: current state of the art 10 years after their introduction. From antiretroviral drugs to antifungal, antibacterial and antitumor agents based on aspartic protease inhibitors.
Journal: Current medicinal chemistry 20070101
Title: Predictive factors for response to a boosted dual HIV-protease inhibitor therapy with saquinavir and lopinavir in extensively pre-treated patients.
Journal: Antiviral therapy 20070101
Title: Targeting receptors, transporters and site of absorption to improve oral drug delivery.
Journal: Drug target insights 20070101
Title: NFV, an HIV-1 protease inhibitor, induces growth arrest, reduced Akt signalling, apoptosis and docetaxel sensitisation in NSCLC cell lines.
Journal: British journal of cancer 20061218
Title: Better lipid profile for Invirase.
Journal: AIDS patient care and STDs 20061201
Title: Structural and dynamical properties of different protonated states of mutant HIV-1 protease complexed with the saquinavir inhibitor studied by molecular dynamics simulations.
Journal: Journal of molecular graphics & modelling 20061101
Title: The LOPSAQ study: 48 week analysis of a boosted double protease inhibitor regimen containing lopinavir/ritonavir plus saquinavir without additional antiretroviral therapy.
Journal: The Journal of antimicrobial chemotherapy 20061101
Title: Fusion-induced apoptosis contributes to thymocyte depletion by a pathogenic human immunodeficiency virus type 1 envelope in the human thymus.
Journal: Journal of virology 20061101
Title: Secretory aspartyl peptidase activity from mycelia of the human fungal pathogen Fonsecaea pedrosoi: effect of HIV aspartyl proteolytic inhibitors.
Journal: Research in microbiology 20061101
Title: Intracellular delivery of saquinavir in biodegradable polymeric nanoparticles for HIV/AIDS.
Journal: Pharmaceutical research 20061101
Title: Influence of atazanavir 200 mg on the intracellular and plasma pharmacokinetics of saquinavir and ritonavir 1600/100 mg administered once daily in HIV-infected patients.
Journal: The Journal of antimicrobial chemotherapy 20061101
Title: Viral decay dynamics in HIV-infected patients receiving ritonavir-boosted saquinavir and efavirenz with or without enfuvirtide: a randomized, controlled trial (HIV-NAT 012).
Journal: The Journal of infectious diseases 20061101
Title: Pharmacokinetics and safety of tenofovir disoproxil fumarate on coadministration with lopinavir/ritonavir.
Journal: Journal of acquired immune deficiency syndromes (1999) 20061101
Title: Saquinavir and rifampicin for tuberculosis and AIDS: new considerations.
Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20061101
Title: HPLC quantification of the HIV-1 protease inhibitor saquinavir in brain and testis of mice.
Journal: Biomedical chromatography : BMC 20061001
Title: Ritonavir, saquinavir, and efavirenz, but not nevirapine, inhibit bile acid transport in human and rat hepatocytes.
Journal: The Journal of pharmacology and experimental therapeutics 20060901
Title: HIV-1 viral envelope glycoprotein gp120 triggers an inflammatory response in cultured rat astrocytes and regulates the functional expression of P-glycoprotein.
Journal: Molecular pharmacology 20060901
Title: Monitoring the toxicity of antiretroviral therapy in resource limited settings: a prospective clinical trial cohort in Thailand.
Journal: The Journal of antimicrobial chemotherapy 20060901
Title: Rates of disease progression according to initial highly active antiretroviral therapy regimen: a collaborative analysis of 12 prospective cohort studies.
Journal: The Journal of infectious diseases 20060901
Title: Discontinuation of highly active antiretroviral therapy leads to cryptococcal meningitis/choroiditis in an AIDS patient.
Journal: Optometry (St. Louis, Mo.) 20060901
Title: Nelfinavir induces liposarcoma apoptosis and cell cycle arrest by upregulating sterol regulatory element binding protein-1.
Journal: Anti-cancer drugs 20060901
Title: Effect of quercetin on the plasma and intracellular concentrations of saquinavir in healthy adults.
Journal: Pharmacotherapy 20060901
Title: Structure-based design of novel HIV-1 protease inhibitors to combat drug resistance.
Journal: Journal of medicinal chemistry 20060824
Title: Microarray analysis during adipogenesis identifies new genes altered by antiretroviral drugs.
Journal: AIDS (London, England) 20060822
Title: Placental transfer and pharmacokinetics of lopinavir and other protease inhibitors in combination with nevirapine at delivery.
Journal: AIDS (London, England) 20060822
Title: Natural polymorphisms in the protease gene modulate the replicative capacity of non-B HIV-1 variants in the absence of drug pressure.
Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20060801
Title: Lack of in vivo correlation between indinavir and saquinavir exposure and cytochrome P450 3A phenotype as assessed with oral midazolam as a phenotype probe.
Journal: Pharmacotherapy 20060801
Title: Effect of food and ranitidine on saquinavir pharmacokinetics and gastric pH in healthy volunteers.
Journal: Pharmacotherapy 20060801
Title: Full validation of an analytical method for the HIV-protease inhibitor atazanavir in combination with 8 other antiretroviral agents and its applicability to therapeutic drug monitoring.
Journal: Therapeutic drug monitoring 20060801
Title: Pharmacokinetics of saquinavir hard-gel/ritonavir and atazanavir when combined once daily in HIV Type 1-infected individuals administered different atazanavir doses.
Journal: AIDS research and human retroviruses 20060801
Title: Establishment and characterization of the transformants stably-expressing MDR1 derived from various animal species in LLC-PK1.
Journal: Pharmaceutical research 20060701
Title: A comparison of intestinal lymphatic transport and systemic bioavailability of saquinavir from three lipid-based formulations in the anaesthetised rat model.
Journal: The Journal of pharmacy and pharmacology 20060701
Title: Nephrotoxicity as a complication of antiretroviral therapy.
Journal: Advances in chronic kidney disease 20060701
Title: A randomised trial comparing genotypic and virtual phenotypic interpretation of HIV drug resistance: the CREST study.
Journal: PLoS clinical trials 20060701
Title: Regimen-dependent variations in adherence to therapy and virological suppression in patients initiating protease inhibitor-based highly active antiretroviral therapy.
Journal: HIV medicine 20060701
Title: Effect of omeprazole on the pharmacokinetics of saquinavir-500 mg formulation with ritonavir in healthy male and female volunteers.
Journal: AIDS (London, England) 20060626
Title: Antiviral activity and cross-resistance profile of P-1946, a novel human immunodeficiency virus type 1 protease inhibitor.
Journal: Antiviral research 20060601
Title: Gated binding of ligands to HIV-1 protease: Brownian dynamics simulations in a coarse-grained model.
Journal: Biophysical journal 20060601
Title: Antiretroviral drug resistance and routine therapy, Cameroon.
Journal: Emerging infectious diseases 20060601
Title: Are plasma levels valid surrogates for cellular concentrations of antiretroviral drugs in HIV-infected patients?
Journal: Therapeutic drug monitoring 20060601
Title: High HIV type 1 subtype diversity and few drug resistance mutations among seropositive people detected during the 2005 second generation HIV surveillance in Madagascar.
Journal: AIDS research and human retroviruses 20060601
Title: Establishment of a new cell line inducibly expressing HIV-1 protease for performing safe and highly sensitive screening of HIV protease inhibitors.
Journal: Microbes and infection 20060601
Title: Analysis of HIV-1 CRF_01 A/E protease inhibitor resistance: structural determinants for maintaining sensitivity and developing resistance to atazanavir.
Journal: Biochemistry 20060502
Title: Natural polymorphism in protease and reverse transcriptase genes and in vitro antiretroviral drug susceptibilities of non-B HIV-1 strains from treatment-naive patients.
Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20060501
Title: Biological characterization of human immunodeficiency virus type 1 subtype C protease carrying indinavir drug-resistance mutations.
Journal: The Journal of general virology 20060501
Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.
Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Title: Incidence and risk factors of bacterial pneumonia requiring hospitalization in HIV-infected patients started on a protease inhibitor-containing regimen.
Journal: HIV medicine 20060501
Title: Sensory neuropathy in human immunodeficiency virus/acquired immunodeficiency syndrome patients: protease inhibitor-mediated neurotoxicity.
Journal: Annals of neurology 20060501
Title: Docosahexaenoic acid (DHA) inhibits saquinavir metabolism in-vitro and enhances its bioavailability in rats.
Journal: The Journal of pharmacy and pharmacology 20060501
Title: The effects of saquinavir on imatinib-resistant chronic myelogenous leukemia cell lines.
Journal: Haematologica 20060501
Title: Prevalence of the HIV-1 protease mutation I47A in clinical practice and association with lopinavir resistance.
Journal: AIDS (London, England) 20060424
Title: Marked intraindividual variability in antiretroviral concentrations may limit the utility of therapeutic drug monitoring.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060415
Title: Ultra-potent P1 modified arylsulfonamide HIV protease inhibitors: the discovery of GW0385.
Journal: Bioorganic & medicinal chemistry letters 20060401
Title: Susceptibility to protease inhibitors in HIV-2 primary isolates from patients failing antiretroviral therapy.
Journal: The Journal of antimicrobial chemotherapy 20060401
Title: Design and synthesis of novel HIV-1 protease inhibitors incorporating oxyindoles as the P2'-ligands.
Journal: Bioorganic & medicinal chemistry letters 20060401
Title: Lack of sex-related differences in saquinavir pharmacokinetics in an HIV-seronegative cohort.
Journal: British journal of clinical pharmacology 20060401
Title: Pharmacologic optimization of protease inhibitors and nonnucleoside reverse transcriptase inhibitors (POPIN)--a randomized controlled trial of therapeutic drug monitoring and adherence support.
Journal: Journal of acquired immune deficiency syndromes (1999) 20060401
Title: MDR- and CYP3A4-mediated drug-herbal interactions.
Journal: Life sciences 20060327
Title: 96-week comparison of once-daily atazanavir/ritonavir and twice-daily lopinavir/ritonavir in patients with multiple virologic failures.
Journal: AIDS (London, England) 20060321
Title: Analysis of genotypic and phenotypic clinical cut-off levels for ritonavir-boosted saquinavir.
Journal: HIV medicine 20060301
Title: Characterization of nelfinavir binding to plasma proteins and the lack of drug displacement interactions.
Journal: HIV medicine 20060301
Title: In vitro development of resistance to human immunodeficiency virus protease inhibitor GW640385.
Journal: Antimicrobial agents and chemotherapy 20060301
Title: [Screening of new HIV inhibitors based on the database of traditional Chinese medicine].
Journal: Yao xue xue bao = Acta pharmaceutica Sinica 20060301
Title: API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
Journal: The Journal of the Association of Physicians of India 20060301
Title: Determination of the novel non-peptidic HIV-protease inhibitor tipranavir by HPLC-UV after solid-phase extraction.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060217
Title: Simultaneous determination of 16 anti-HIV drugs in human plasma by high-performance liquid chromatography.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060202
Title: HIV-1 protease inhibitors and cytomegalovirus vMIA induce mitochondrial fragmentation without triggering apoptosis.
Journal: Cell death and differentiation 20060201
Title: HIV drug-resistant strains as epidemiologic sentinels.
Journal: Emerging infectious diseases 20060201
Title: HIV integrase inhibitors with nucleobase scaffolds: discovery of a highly potent anti-HIV agent.
Journal: Journal of medicinal chemistry 20060126
Title: Ritonavir/saquinavir safety concerns curtail antiretroviral therapy options for tuberculosis-HIV-co-infected patients in resource-constrained settings.
Journal: AIDS (London, England) 20060109
Title: Economic impact of antiretroviral therapy prescription decisions in the context of rapid scaling-up of access to treatment: lessons from Mexico.
Journal: AIDS (London, England) 20060102
Title: High rate of proV47A selection in HIV-2 patients failing lopinavir-based HAART.
Journal: AIDS (London, England) 20060102
Title: Simultaneous determination of six HIV protease inhibitors (amprenavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir), the active metabolite of nelfinavir (M8) and non-nucleoside reverse transcriptase inhibitor (efavirenz) in human plasma by high-performance liquid chromatography.
Journal: Biomedical chromatography : BMC 20060101
Title: Saquinavir does not affect adipose tissue development or metabolic parameters in mice on high fat diet.
Journal: Thrombosis research 20060101
Title: Hypertriglyceridemia and hypercholesterolemia in human immunodeficiency virus-1-infected children treated with protease inhibitors.
Journal: Archives of medical research 20060101
Title: Antiviral hepatitis and antiretroviral drug interactions.
Journal: Journal of hepatology 20060101
Title: Saquinavir/Ritonavir: its evolution and current treatment role.
Journal: The AIDS reader 20060101
Title: Differential inhibition of cytochrome P450 3A4, 3A5 and 3A7 by five human immunodeficiency virus (HIV) protease inhibitors in vitro.
Journal: Basic & clinical pharmacology & toxicology 20060101
Title: Direct and fast determination of antiretroviral drugs by automated online solid-phase extraction-liquid chromatography-tandem mass spectrometry in human plasma.
Journal: Clinical chemistry and laboratory medicine 20060101
Title: DR_SEQAN: a PC/Windows-based software to evaluate drug resistance using human immunodeficiency virus type 1 genotypes.
Journal: BMC infectious diseases 20060101
Title: Cerebrospinal fluid HIV-1 RNA, intrathecal immunoactivation, and drug concentrations after treatment with a combination of saquinavir, nelfinavir, and two nucleoside analogues: the M61022 study.
Journal: BMC infectious diseases 20060101
Title: Lung cancer as an immune reconstitution disease in an HIV-1 positive man receiving HAART.
Journal: Postepy higieny i medycyny doswiadczalnej (Online) 20060101
Title: Novel multi-component nanopharmaceuticals derived from poly(ethylene) glycol, retro-inverso-Tat nonapeptide and saquinavir demonstrate combined anti-HIV effects.
Journal: AIDS research and therapy 20060101
Title: Distinguishing HIV-1 drug resistance, accessory, and viral fitness mutations using conditional selection pressure analysis of treated versus untreated patient samples.
Journal: Biology direct 20060101
Title: Functional characterization of sodium-dependent multivitamin transporter in MDCK-MDR1 cells and its utilization as a target for drug delivery.
Journal: Molecular pharmaceutics 20060101
Title: A novel approach for in-process monitoring and managing cross-contamination in a high-throughput high-performance liquid chromatography assay with tandem mass spectrometric detection.
Journal: Rapid communications in mass spectrometry : RCM 20060101
Title: Concentration of circulating oxidized LDL in HIV-infected patients treated with antiretroviral agents: relation to HIV-related lipodystrophy.
Journal: HIV clinical trials 20060101
Title: Prevalence and impact of HIV-1 protease codon 33 mutations and polymorphisms in treatment-naive and treatment-experienced patients.
Journal: Antiviral therapy 20060101
Title: Differential susceptibility of naïve, central memory and effector memory T cells to dendritic cell-mediated HIV-1 transmission.
Journal: Retrovirology 20060101
Title: Local tumor control and toxicity in HIV-associated anal carcinoma treated with radiotherapy in the era of antiretroviral therapy.
Journal: Radiation oncology (London, England) 20060101
Title: Efficacy, safety and pharmacokinetics of once-daily saquinavir soft-gelatin capsule/ritonavir in antiretroviral-naive, HIV-infected patients.
Journal: MedGenMed : Medscape general medicine 20060101
Title: HIV-2 Protease resistance defined in yeast cells.
Journal: Retrovirology 20060101
Title: Short communication metabolic and mitochondrial effects of switching antiretroviral-experienced patients to enfuvirtide, tenofovir and saquinavir/ritonavir.
Journal: Antiviral therapy 20060101
Title: Absence of resistance mutations in antiretroviral-naive patients treated with ritonavir-boosted saquinavir.
Journal: Antiviral therapy 20060101
Title: Gender: a possible determinant in dosing of dermatologic drugs--an overview.
Journal: Cutaneous and ocular toxicology 20060101
Title: Quantitative SNP-detection method for estimating HIV-1 replicative fitness: application to protease inhibitor-resistant viruses.
Journal: Microbiology and immunology 20060101
Title: Performance of six different ritonavir-boosted protease inhibitor-based regimens in heavily antiretroviral-experienced HIV-infected patients.
Journal: HIV clinical trials 20060101
Title: Dendritic cell-mediated HIV-1 transmission to T cells of LAD-1 patients is impaired due to the defect in LFA-1.
Journal: Retrovirology 20060101
Title: Cardiovascular risk in patients with HIV Infection: impact of antiretroviral therapy.
Journal: Drugs 20060101
Title: Synthesis and in vitro biological evaluation of mannose-containing prodrugs derived from clinically used HIV-protease inhibitors with improved transepithelial transport.
Journal: Bioconjugate chemistry 20060101
Title: Second site escape of a T20-dependent HIV-1 variant by a single amino acid change in the CD4 binding region of the envelope glycoprotein.
Journal: Retrovirology 20060101
Title: Safety, efficacy and pharmacokinetics of ritonavir 400mg/saquinavir 400mg twice daily plus rifampicin combined therapy in HIV patients with tuberculosis.
Journal: Clinical drug investigation 20060101
Title: Drug-herb interactions: eliminating toxicity with hard drug design.
Journal: Current pharmaceutical design 20060101
Title: Detection of HIV protease inhibitors in alveolar epithelial lining fluid: relevance for modulation of pneumocystis infection in the course of HAART.
Journal: The Journal of eukaryotic microbiology 20060101
Title: Clinical outcome of HIV-infected patients with sustained virologic response to antiretroviral therapy: long-term follow-up of a multicenter cohort.
Journal: PloS one 20060101
Title: Using cost-effectiveness analyses to inform policy: the case of antiretroviral therapy in Thailand.
Journal: Cost effectiveness and resource allocation : C/E 20060101
Title: No virological failure in semen during properly suppressive antiretroviral therapy despite subtherapeutic local drug concentrations.
Journal: HIV clinical trials 20060101
Title: Fosamprenavir clinical study meta-analysis in ART-naïve subjects: rare occurrence of virologic failure and selection of protease-associated mutations.
Journal: HIV clinical trials 20060101
Title: Drug interactions. Coming soon--a new formulation of saquinavir (Invirase).
Journal: TreatmentUpdate 20060101
Title: [Development and validation of laboratory methods for antiretroviral quantitation using HPLC].
Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20060101
Title: Specific HIV protease inhibitors inhibit the ability of HPV16 E6 to degrade p53 and selectively kill E6-dependent cervical carcinoma cells in vitro.
Journal: Antiviral therapy 20060101
Title: Structure-Activity Relationships of Synthetic Coumarins as HIV-1 Inhibitors.
Journal: Bioinorganic chemistry and applications 20060101
Title: Disease Management - Constructing Optimal NRTI-Based Combinations: Past, Present, and Future.
Journal: Journal of the International AIDS Society 20060101
Title: Simultaneous determination of HIV protease inhibitors amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir in human plasma by high-performance liquid chromatography-tandem mass spectrometry.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20051227
Title: Efficacy of cerebrospinal fluid (CSF)-penetrating antiretroviral drugs against HIV in the neurological compartment: different patterns of phenotypic resistance in CSF and plasma.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20051215
Title: Spontaneous hepatic decompensation in patients coinfected with HIV and hepatitis C virus during interferon-ribavirin combination treatment.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20051215
Title: The anti-HIV activity of ADS-J1 targets the HIV-1 gp120.
Journal: Virology 20051205
Title: Modulation of the intracellular accumulation of saquinavir in peripheral blood mononuclear cells by inhibitors of MRP1, MRP2, P-gp and BCRP.
Journal: AIDS (London, England) 20051202
Title: Predictive value of drug levels, HIV genotyping, and the genotypic inhibitory quotient (GIQ) on response to saquinavir/ritonavir in antiretroviral-experienced HIV-infected patients.
Journal: Journal of medical virology 20051201
Title: No significant influence of saquinavir hard-gel capsule administration on pharmacokinetics of lopinavir in combination with ritonavir: a population approach.
Journal: Therapeutic drug monitoring 20051201
Title: Allosteric modulation of anti-HIV drug and ferric heme binding to human serum albumin.
Journal: The FEBS journal 20051201
Title: Quadruple-2 protease inhibitors (PI)-therapy does not accelerate viral decay and suppression in PI-naive HIV-1 infected patients with severe immunosuppression and high viral load as compared with standard triple therapy.
Journal: International journal of STD & AIDS 20051201
Title: Variation in oral clearance of saquinavir is predicted by CYP3A5*1 genotype but not by enterocyte content of cytochrome P450 3A5.
Journal: Clinical pharmacology and therapeutics 20051201
Title: Anti-retroviral therapy in HIV-infected patients: in vitro effects of AZT and saquinavir on the response of CD4 and CD8 lymphocytes to interleukin-7.
Journal: European cytokine network 20051201
Title: Safety and tolerability of oral antifungal agents in the treatment of fungal nail disease: a proven reality.
Journal: Therapeutics and clinical risk management 20051201
Title: In vitro inhibition of UDP glucuronosyltransferases by atazanavir and other HIV protease inhibitors and the relationship of this property to in vivo bilirubin glucuronidation.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20051101
Title: Interindividual variability of once-daily ritonavir boosted saquinavir pharmacokinetics in Thai and UK patients.
Journal: The Journal of antimicrobial chemotherapy 20051101
Title: Four measures of antiretroviral medication adherence and virologic response in AIDS clinical trials group study 359.
Journal: Journal of acquired immune deficiency syndromes (1999) 20051101
Title: Once-daily regimen of saquinavir, ritonavir, didanosine, and lamivudine in HIV-infected patients with standard tuberculosis therapy (TBQD Study).
Journal: Journal of acquired immune deficiency syndromes (1999) 20051101
Title: A direct comparison of drug susceptibility to HIV type 1 from antiretroviral experienced subjects as assessed by the antivirogram and PhenoSense assays and by seven resistance algorithms.
Journal: AIDS research and human retroviruses 20051101
Title: Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia.
Journal: The Journal of infectious diseases 20051015
Title: MDR1 G1199A polymorphism alters permeability of HIV protease inhibitors across P-glycoprotein-expressing epithelial cells.
Journal: AIDS (London, England) 20051014
Title: Determination of antiretroviral agents in human serum by capillary electrophoresis.
Journal: Journal of chromatography. A 20051014
Title: Evasion of P-gp mediated cellular efflux and permeability enhancement of HIV-protease inhibitor saquinavir by prodrug modification.
Journal: International journal of pharmaceutics 20051013
Title: Selection and characterization of HIV-1 showing reduced susceptibility to the non-peptidic protease inhibitor tipranavir.
Journal: Antiviral research 20051001
Title: Oxadiazols: a new class of rationally designed anti-human immunodeficiency virus compounds targeting the nuclear localization signal of the viral matrix protein.
Journal: Journal of virology 20051001
Title: Pharmacokinetics and 24-week efficacy/safety of dual boosted saquinavir/lopinavir/ritonavir in nucleoside-pretreated children.
Journal: The Pediatric infectious disease journal 20051001
Title: Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.
Journal: Current drug metabolism 20051001
Title: Grape fruit juice-drug interactions.
Journal: Pakistan journal of pharmaceutical sciences 20051001
Title: Prolonged transcriptional silencing and CpG methylation induced by siRNAs targeted to the HIV-1 promoter region.
Journal: Journal of RNAi and gene silencing : an international journal of RNA and gene targeting research 20051001
Title: Modeling K(m) values using electrotopological state: substrates for cytochrome P450 3A4-mediated metabolism.
Journal: Bioorganic & medicinal chemistry letters 20050915
Title: HIV protease inhibitors block Akt signaling and radiosensitize tumor cells both in vitro and in vivo.
Journal: Cancer research 20050915
Title: The normalized inhibitory quotient of boosted protease inhibitors is predictive of viral load response in treatment-experienced HIV-1-infected individuals.
Journal: AIDS (London, England) 20050902
Title: In vitro synergy and enhanced murine brain penetration of saquinavir coadministered with mefloquine.
Journal: The Journal of pharmacology and experimental therapeutics 20050901
Title: A human immunodeficiency virus type 1 protease biosensor assay using bioluminescence resonance energy transfer.
Journal: Journal of virological methods 20050901
Title: Effects of 5 HIV protease inhibitors on vasomotor function and superoxide anion production in porcine coronary arteries.
Journal: Journal of acquired immune deficiency syndromes (1999) 20050901
Title: Steady-state pharmacokinetics of atazanavir given alone or in combination with saquinavir hard-gel capsules or amprenavir in HIV-1-infected patients.
Journal: European journal of clinical pharmacology 20050801
Title: Placental transfer of antiretroviral drugs.
Journal: Clinical pharmacology and therapeutics 20050801
Title: Functional role of P-glycoprotein in the human blood-placental barrier.
Journal: Clinical pharmacology and therapeutics 20050801
Title: Exposure to therapeutic concentrations of ritonavir, but not saquinavir, reduces secreted aspartyl proteinase of Candida parapsilosis.
Journal: Chemotherapy 20050801
Title: Comparison of HIV type 1 protease inhibitor susceptibility results in viral samples analyzed by phenotypic drug resistance assays and by six resistance algorithms: an analysis of a subpopulation of the CHORUS cohort.
Journal: AIDS research and human retroviruses 20050801
Title: Potent saquinavir get European nod.
Journal: AIDS patient care and STDs 20050801
Title: Structural analysis of an HIV-1 protease I47A mutant resistant to the protease inhibitor lopinavir.
Journal: Protein science : a publication of the Protein Society 20050701
Title: Antileishmanial activity of HIV protease inhibitors.
Journal: International journal of antimicrobial agents 20050701
Title: HIV leucoencephalopathy and TNFalpha expression in neurones.
Journal: Journal of neurology, neurosurgery, and psychiatry 20050701
Title: Conventional HPLC method used for simultaneous determination of the seven HIV protease inhibitors and nonnucleoside reverse transcription inhibitor efavirenz in human plasma.
Journal: Biological & pharmaceutical bulletin 20050701
Title: FDA notifications. Roche issues letter about saquinavir.
Journal: AIDS alert 20050701
Title: Simultaneous quantitative assay of atazanavir and 6 other HIV protease inhibitors by isocratic reversed-phase liquid chromatography in human plasma.
Journal: Therapeutic drug monitoring 20050601
Title: TMC114, a novel human immunodeficiency virus type 1 protease inhibitor active against protease inhibitor-resistant viruses, including a broad range of clinical isolates.
Journal: Antimicrobial agents and chemotherapy 20050601
Title: Inhibitory activity of human immunodeficiency virus aspartyl protease inhibitors against Encephalitozoon intestinalis evaluated by cell culture-quantitative PCR assay.
Journal: Antimicrobial agents and chemotherapy 20050601
Title: Prediction of genotoxicity of chemical compounds by statistical learning methods.
Journal: Chemical research in toxicology 20050601
Title: Intracellular measurements of anti-HIV drugs indinavir, amprenavir, saquinavir, ritonavir, nelfinavir, lopinavir, atazanavir, efavirenz and nevirapine in peripheral blood mononuclear cells by liquid chromatography coupled to tandem mass spectrometry.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050525
Title: Evolution of resistance mutations pattern in HIV-1-infected patients during intensification therapy with a boosted protease inhibitor.
Journal: AIDS (London, England) 20050520
Title: Structure-based design: synthesis and biological evaluation of a series of novel cycloamide-derived HIV-1 protease inhibitors.
Journal: Journal of medicinal chemistry 20050519
Title: Establishment of a biological assay system for human retroviral protease activity.
Journal: Microbes and infection 20050501
Title: Emerging anti-HIV drugs.
Journal: Expert opinion on emerging drugs 20050501
Title: [Current status of HIV protease inhibitors].
Journal: Yao xue xue bao = Acta pharmaceutica Sinica 20050501
Title: Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failures.
Journal: AIDS (London, England) 20050429
Title: [A further option in PI therapy. Approval of a new protease inhibitor in the USA].
Journal: MMW Fortschritte der Medizin 20050425
Title: Boosted saquinavir hard gel formulation exposure in HIV-infected subjects: ritonavir 100 mg once daily versus twice daily.
Journal: The Journal of antimicrobial chemotherapy 20050401
Title: Involvement of HIV-1 protease in virus-induced cell killing.
Journal: Antiviral research 20050401
Title: Simple and simultaneous determination of the hiv-protease inhibitors amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir plus M8 nelfinavir metabolite and the nonnucleoside reverse transcriptase inhibitors efavirenz and nevirapine in human plasma by reversed-phase liquid chromatography.
Journal: Therapeutic drug monitoring 20050401
Title: Roche issues drug interaction warning.
Journal: AIDS alert 20050401
Title: Atazanavir affects saquinavir.
Journal: AIDS patient care and STDs 20050401
Title: Design of HIV-1 protease inhibitors active on multidrug-resistant virus.
Journal: Journal of medicinal chemistry 20050324
Title: P-glycoprotein and mutlidrug resistance-associated proteins limit the brain uptake of saquinavir in mice.
Journal: The Journal of pharmacology and experimental therapeutics 20050301
Title: Lysine derivatives as potent HIV protease inhibitors. Discovery, synthesis and structure-activity relationship studies.
Journal: Bioorganic & medicinal chemistry letters 20050301
Title: The 48-week efficacy of once-daily saquinavir/ritonavir in patients with undetectable viral load after 3 years of antiretroviral therapy.
Journal: HIV medicine 20050301
Title: Clinical outcomes and management of mechanism-based inhibition of cytochrome P450 3A4.
Journal: Therapeutics and clinical risk management 20050301
Title: Mechanism-based inactivation of CYP3A by HIV protease inhibitors.
Journal: The Journal of pharmacology and experimental therapeutics 20050201
Title: Insights into saquinavir resistance in the G48V HIV-1 protease: quantum calculations and molecular dynamic simulations.
Journal: Biophysical journal 20050201
Title: Potent anti-R5 human immunodeficiency virus type 1 effects of a CCR5 antagonist, AK602/ONO4128/GW873140, in a novel human peripheral blood mononuclear cell nonobese diabetic-SCID, interleukin-2 receptor gamma-chain-knocked-out AIDS mouse model.
Journal: Journal of virology 20050201
Title: New drugs and dosage forms.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20050201
Title: Blockade of HERG channels by HIV protease inhibitors.
Journal: Lancet (London, England) 20050201
Title: Pill burden reduced for saquinavir.
Journal: AIDS patient care and STDs 20050201
Title: Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failures.
Journal: AIDS (London, England) 20050128
Title: Short-course induction with boosted saquinavir monotherapy for naive patients with late-stage infection.
Journal: AIDS (London, England) 20050128
Title: Human immunodeficiency virus protease inhibitors accumulate into cultured human adipocytes and alter expression of adipocytokines.
Journal: The Journal of biological chemistry 20050121
Title: Pharmacokinetics of saquinavir hard gel/ritonavir (1000/100 mg twice daily) when administered with tenofovir diproxil fumarate in HIV-1-infected subjects.
Journal: British journal of clinical pharmacology 20050101
Title: Antiretroviral drug pharmacokinetics in hepatitis with hepatic dysfunction.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050101
Title: No influence of the P-glycoprotein polymorphisms MDR1 G2677T/A and C3435T on the virological and immunological response in treatment naïve HIV-positive patients.
Journal: Annals of clinical microbiology and antimicrobials 20050101
Title: Drug monitoring and viral response to lopinavir/ritonavir or saquinavir/ritonavir containing regimens in individuals infected with the human immunodeficiency virus type 1.
Journal: International journal of immunopathology and pharmacology 20050101
Title: Changes in lipids over twelve months after initiating protease inhibitor therapy among persons treated for HIV/AIDS.
Journal: Lipids in health and disease 20050101
Title: Molecular strategies to inhibit HIV-1 replication.
Journal: Retrovirology 20050101
Title: Structure, dynamics and solvation of HIV-1 protease/saquinavir complex in aqueous solution and their contributions to drug resistance: molecular dynamic simulations.
Journal: Journal of chemical information and modeling 20050101
Title: Altered adipokine response in murine 3T3-F442A adipocytes treated with protease inhibitors and nucleoside reverse transcriptase inhibitors.
Journal: Antiviral therapy 20050101
Title: The HIV protease inhibitors nelfinavir and saquinavir, but not a variety of HIV reverse transcriptase inhibitors, adversely affect human proteasome function.
Journal: Antiviral therapy 20050101
Title: Herb-drug interactions: a literature review.
Journal: Drugs 20050101
Title: Virologic and immunologic response to a boosted double-protease inhibitor-based therapy in highly pretreated HIV-1-infected patients.
Journal: HIV clinical trials 20050101
Title: Pilot study of saquinavir and lopinavir/ritonavir twice daily in protease inhibitor-naive HIV-positive patients.
Journal: HIV clinical trials 20050101
Title: Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort.
Journal: BMC infectious diseases 20050101
Title: Drug-drug interactions and the pharmacotherapy of HIV infection.
Journal: Topics in HIV medicine : a publication of the International AIDS Society, USA 20050101
Title: The HIV protease inhibitors saquinavir, ritonavir, and nelfinavir induce apoptosis and decrease barrier function in human intestinal epithelial cells.
Journal: Antiviral therapy 20050101
Title: Quantification of antiretroviral drugs in dried blood spot samples by means of liquid chromatography/tandem mass spectrometry.
Journal: Rapid communications in mass spectrometry : RCM 20050101
Title: A randomized trial to evaluate lopinavir/ritonavir versus saquinavir/ritonavir in HIV-1-infected patients: the MaxCmin2 trial.
Journal: Antiviral therapy 20050101
Title: A prospective study of efficacy and safety of once-daily saquinavir/ritonavir plus two nucleoside reverse transcriptase inhibitors in treatment-naive Thai patients.
Journal: Antiviral therapy 20050101
Title: Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment.
Journal: BMC infectious diseases 20050101
Title: Comparison of two once-daily regimens with a regimen consisting of nelfinavir, didanosine, and stavudine in antiretroviral therapy-naïve adults: 48-week results from the Antiretroviral Regimen Evaluation Study (ARES).
Journal: HIV clinical trials 20050101
Title: Saquinavir 500 mg film-coated tablets demonstrate bioequivalence to saquinavir 200 mg hard capsules when boosted with twice-daily ritonavir in healthy volunteers.
Journal: Antiviral therapy 20050101
Title: Different kinetics of immunologic recovery using nelfinavir or lopinavir/ritonavir-based regimens in children with perinatal HIV-1 infection.
Journal: International journal of immunopathology and pharmacology 20050101
Title: [New formulation--fewer tablets--optimal effect].
Journal: Krankenpflege Journal 20050101
Title: Antiretroviral Therapy in the Real World : Population-Based Pharmacoeconomic Analysis of Administration of Anti-HIV Regimens to 990 Patients.
Journal: Clinical drug investigation 20050101
Title: Simultaneous determination of the antiretroviral agents: amprenavir, lopinavir, ritonavir, saquinavir and efavirenz in human peripheral blood mononuclear cells by high-performance liquid chromatography-mass spectrometry.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20041225
Title: Determination of atazanavir and other antiretroviral drugs (indinavir, amprenavir, nelfinavir and its active metabolite M8, saquinavir, ritonavir, lopinavir, nevirapine and efavirenz) plasma levels by high performance liquid chromatography with UV detection.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20041225
Title: Interaction between saquinavir and antimycotic drugs on C. albicans and C. neoformans strains.
Journal: Pharmacological research 20041201
Title: Effects of grapefruit juice and orange juice components on P-glycoprotein- and MRP2-mediated drug efflux.
Journal: British journal of pharmacology 20041201
Title: Antiretrovirals as antimalarial agents.
Journal: The Journal of infectious diseases 20041201
Title: Lovastatin potentiates antitumor effects of saquinavir against human lymphoma cells.
Journal: Oncology reports 20041201
Title: Effect of highly active antiretroviral therapy (HAART) on pharmacokinetics and pharmacodynamics of doxorubicin in patients with HIV-associated non-Hodgkin's lymphoma.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20041201
Title: Long-term effects of HIV-1 protease inhibitors on insulin secretion and insulin signaling in INS-1 beta cells.
Journal: The Journal of endocrinology 20041201
Title: The use of saquinavir/ritonavir 1000/100 mg twice daily in patients with tuberculosis receiving rifampin.
Journal: Antiviral therapy 20041201
Title: Saquinavir trough concentration before and after switching NRTI to tenofovir in patients treated with once-daily saquinavir hard gel capsule/ritonavir 1600 mg/100 mg.
Journal: Antiviral therapy 20041201
Title: Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in antiretroviral-naive HIV patients in Campania, Italy.
Journal: Journal of chemotherapy (Florence, Italy) 20041201
Title: Inhibition of human organic anion transporting polypeptide OATP 1B1 as a mechanism of drug-induced hyperbilirubinemia.
Journal: Chemico-biological interactions 20041120
Title: Determination of saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatography and the analytical error function.
Journal: Journal of pharmaceutical and biomedical analysis 20041119
Title: International AIDS Conference: compliance issues.
Journal: AIDS (London, England) 20041119
Title: Hepatotoxicity associated with protease inhibitor-based antiretroviral regimens with or without concurrent ritonavir.
Journal: AIDS (London, England) 20041119
Title: Improved structure-activity relationship analysis of HIV-1 protease inhibitors using interaction kinetic data.
Journal: Journal of medicinal chemistry 20041118
Title: Inhibition of wild-type and mutant human immunodeficiency virus type 1 proteases by GW0385 and other arylsulfonamides.
Journal: Biochemistry 20041116
Title: CADA, a novel CD4-targeted HIV inhibitor, is synergistic with various anti-HIV drugs in vitro.
Journal: AIDS (London, England) 20041105
Title: Efficiency of a second-generation HIV-1 protease inhibitor studied by molecular dynamics and absolute binding free energy calculations.
Journal: Proteins 20041101
Title: Impact of frequent natural polymorphisms at the protease gene on the in vitro susceptibility to protease inhibitors in HIV-1 non-B subtypes.
Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20041101
Title: Steady-State pharmacokinetics of saquinavir hard-gel/ritonavir/fosamprenavir in HIV-1-infected patients.
Journal: Journal of acquired immune deficiency syndromes (1999) 20041101
Title: Atazanavir: A novel once-daily protease inhibitor.
Journal: Drugs of today (Barcelona, Spain : 1998) 20041101
Title: Pharmacokinetics of Telzir (fosamprenavir).
Journal: Journal of HIV therapy 20041101
Title: [Therapeutic strategies for HIV infection: clinical approach with boost antiproteases in adults].
Journal: Medecine et maladies infectieuses 20041101
Title: The effectiveness of highly active antiretroviral therapy in HIV-infected patients.
Journal: Danish medical bulletin 20041101
Title: Determination of the new HIV-protease inhibitor atazanavir by liquid chromatography after solid-phase extraction.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20041015
Title: HIV-1 protease inhibitor, ritonavir: a potent inhibitor of CYP3A4, enhanced the anticancer effects of docetaxel in androgen-independent prostate cancer cells in vitro and in vivo.
Journal: Cancer research 20041015
Title: Pharmacokinetic study of saquinavir hard gel caps/ritonavir in HIV-1-infected patients: 1600/100 mg once-daily compared with 2000/100 mg once-daily and 1000/100 mg twice-daily.
Journal: The Journal of antimicrobial chemotherapy 20041001
Title: Association of the CYP3A5 A6986G (CYP3A5*3) polymorphism with saquinavir pharmacokinetics.
Journal: British journal of clinical pharmacology 20041001
Title: Automated, fast, and sensitive quantification of drugs in human plasma by LC/LC-MS: quantification of 6 protease inhibitors and 3 nonnucleoside transcriptase inhibitors.
Journal: Therapeutic drug monitoring 20041001
Title: Human immunodeficiency virus type 1 protease inhibitors block toll-like receptor 2 (TLR2)- and TLR4-Induced NF-kappaB activation.
Journal: Antimicrobial agents and chemotherapy 20041001
Title: Miniature device for aqueous and non-aqueous solubility measurements during drug discovery.
Journal: Pharmaceutical research 20041001
Title: Comparative effects on intestinal absorption in situ by P-glycoprotein-modifying HIV protease inhibitors.
Journal: Pharmaceutical research 20041001
Title: Binding of anti-HIV drugs to human serum albumin.
Journal: IUBMB life 20041001
Title: Penetration of enfuvirtide, tenofovir, efavirenz, and protease inhibitors in the genital tract of HIV-1-infected men.
Journal: AIDS (London, England) 20040924
Title: Resistance profiles and adherence at primary virological failure in three different highly active antiretroviral therapy regimens: analysis of failure rates in a randomized study.
Journal: HIV medicine 20040901
Title: The pharmacokinetics, safety, and initial virologic response of a triple-protease inhibitor salvage regimen containing amprenavir, saquinavir, and ritonavir.
Journal: Journal of acquired immune deficiency syndromes (1999) 20040801
Title: Spirodiketopiperazine-based CCR5 inhibitor which preserves CC-chemokine/CCR5 interactions and exerts potent activity against R5 human immunodeficiency virus type 1 in vitro.
Journal: Journal of virology 20040801
Title: Resistance to HIV protease inhibitors: mechanisms and clinical consequences.
Journal: Current drug metabolism 20040801
Title: Maternal-fetal transfer and amniotic fluid accumulation of protease inhibitors in pregnant women who are infected with human immunodeficiency virus.
Journal: American journal of obstetrics and gynecology 20040801
Title: Electronic transduction of HIV-1 drug resistance in AIDS patients.
Journal: Chembiochem : a European journal of chemical biology 20040705
Title: Differentiation of gut and hepatic first pass metabolism and secretion of saquinavir in ported rabbits.
Journal: The Journal of pharmacology and experimental therapeutics 20040701
Title: HIV protease inhibitors are inhibitors but not substrates of the human breast cancer resistance protein (BCRP/ABCG2).
Journal: The Journal of pharmacology and experimental therapeutics 20040701
Title: Lack of interaction between enfuvirtide and ritonavir or ritonavir-boosted saquinavir in HIV-1-infected patients.
Journal: Journal of clinical pharmacology 20040701
Title: Utility of 96 well Caco-2 cell system for increased throughput of P-gp screening in drug discovery.
Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20040701
Title: Atazanavir: a new protease inhibitor to treat HIV infection.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20040701
Title: Atazanavir enhances saquinavir hard-gel concentrations in a ritonavir-boosted once-daily regimen.
Journal: AIDS (London, England) 20040618
Title: High-performance liquid chromatography assay for the quantification of HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in human plasma.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20040615
Title: Antiviral drugs in current clinical use.
Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20040601
Title: The influence of protease inhibitor resistance profiles on selection of HIV therapy in treatment-naive patients.
Journal: Antiviral therapy 20040601
Title: Pharmacokinetics of once-daily saquinavir/ritonavir in HIV-infected subjects: comparison with the standard twice-daily regimen.
Journal: Antiviral therapy 20040601
Title: Multidrug resistance protein 1-mediated transport of saquinavir by microglia.
Journal: Neuroreport 20040519
Title: Drug monitoring of pyrimethamine during maintenance therapy of toxoplasmic encephalitis in patients with advanced HIV infection during HAART.
Journal: Medical science monitor : international medical journal of experimental and clinical research 20040501
Title: Sex-related differences in the pharmacokinetics of once-daily saquinavir soft-gelatin capsules boosted with low-dose ritonavir in patients infected with human immunodeficiency virus type 1.
Journal: Pharmacotherapy 20040501
Title: Involvement of P-glycoprotein in the transport of saquinavir and indinavir in rat brain microvessel endothelial and microglia cell lines.
Journal: Pharmaceutical research 20040501
Title: Practical aspects of transporter model systems: a case study involving SQV.
Journal: Drug metabolism reviews 20040501
Title: [Good experiences with saquinavir. Double boosting of protease inhibitors gains significance].
Journal: MMW Fortschritte der Medizin 20040426
Title: [FPV plus SQV plus a mini-dose ritonavir. 'Double boosting with compatible partners].
Journal: MMW Fortschritte der Medizin 20040426
Title: Indium-mediated atom-transfer and reductive radical cyclizations of iodoalkynes: synthesis and biological evaluation of HIV-protease inhibitors.
Journal: The Journal of organic chemistry 20040402
Title: Sex-based differences in saquinavir pharmacology and virologic response in AIDS Clinical Trials Group Study 359.
Journal: The Journal of infectious diseases 20040401
Title: HIV-1 protease inhibitor induces growth arrest and apoptosis of human multiple myeloma cells via inactivation of signal transducer and activator of transcription 3 and extracellular signal-regulated kinase 1/2.
Journal: Molecular cancer therapeutics 20040401
Title: Comparison of drug resistance mutations and their interpretation in patients infected with non-B HIV-1 variants and matched patients infected with HIV-1 subtype B.
Journal: Journal of acquired immune deficiency syndromes (1999) 20040401
Title: Once-daily dosing of saquinavir soft-gel capsules and ritonavir combination in HIV-1-infected patients (IMEA015 study).
Journal: Antiviral therapy 20040401
Title: Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs.
Journal: Emerging infectious diseases 20040401
Title: P-glycoprotein expression affects the intracellular concentration and antiviral activity of the protease inhibitor saquinavir in a T cell line.
Journal: The new microbiologica 20040401
Title: Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?
Journal: The Journal of infectious diseases 20040315
Title: Optimizing dosing strategies for the combination of atazanavir plus saquinavir.
Journal: AIDS (London, England) 20040305
Title: Contributions of CYP3A4, P-glycoprotein, and serum protein binding to the intestinal first-pass extraction of saquinavir.
Journal: The Journal of pharmacology and experimental therapeutics 20040301
Title: Protease inhibitors modulate apoptosis in mesangial cells derived from a mouse model of HIVAN.
Journal: Kidney international 20040301
Title: The effects of once-daily saquinavir/minidose ritonavir on the pharmacokinetics of methadone.
Journal: Journal of clinical pharmacology 20040301
Title: Oral contraception does not alter single dose saquinavir pharmacokinetics in women.
Journal: British journal of clinical pharmacology 20040301
Title: Combo approved for HIV treatment.
Journal: The Nurse practitioner 20040301
Title: In vitro studies of the effects of HAART drugs and excipients on activity of digestive enzymes.
Journal: Pharmaceutical research 20040301
Title: Factors responsible for the variability of saquinavir absorption: studies using an instrumented dog model.
Journal: Pharmaceutical research 20040301
Title: Anti-HIV effects of chloroquine: inhibition of viral particle glycosylation and synergism with protease inhibitors.
Journal: Journal of acquired immune deficiency syndromes (1999) 20040301
Title: Boosted saquinavir approved.
Journal: AIDS patient care and STDs 20040301
Title: Simultaneous determination of indinavir, ritonavir and saquinavir in plasma by high-performance liquid chromatography.
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi 20040301
Title: Efficacy of two modalities of triple HIV therapy: probable superiority of indinavir.
Journal: International journal of antimicrobial agents 20040301
Title: Prediction of in vivo drug interactions with eplerenone in man from in vitro metabolic inhibition data.
Journal: Xenobiotica; the fate of foreign compounds in biological systems 20040301
Title: Saquinavir drug exposure is not impaired by the boosted double protease inhibitor combination of lopinavir/ritonavir.
Journal: AIDS (London, England) 20040220
Title: Prodrugs of HIV protease inhibitors-saquinavir, indinavir and nelfinavir-derived from diglycerides or amino acids: synthesis, stability and anti-HIV activity.
Journal: Organic & biomolecular chemistry 20040207
Title: Toward the development of a structurally novel class of chiral auxiliaries. Conformational properties of the aldol adducts of oxadiazinones: observation of unusual shielding effects.
Journal: The Journal of organic chemistry 20040206
Title: Pharmacokinetics of saquinavir plus low-dose ritonavir in human immunodeficiency virus-infected pregnant women.
Journal: Antimicrobial agents and chemotherapy 20040201
Title: Evaluation of factors to decrease plasma concentration of an HIV protease inhibitor, saquinavir in ethanol-treated rats.
Journal: Biological & pharmaceutical bulletin 20040201
Title: Effect of polymorphisms on the replicative capacity of protease inhibitor-resistant HIV-1 variants under drug pressure.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20040201
Title: Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: implications for treatment and postexposure prophylaxis.
Journal: Antiviral therapy 20040201
Title: Intracellular and plasma pharmacokinetics of nelfinavir and M8 in HIV-infected patients: relationship with P-glycoprotein expression.
Journal: Antiviral therapy 20040201
Title: Human organic anion-transporting polypeptide OATP-A (SLC21A3) acts in concert with P-glycoprotein and multidrug resistance protein 2 in the vectorial transport of Saquinavir in Hep G2 cells.
Journal: Molecular pharmaceutics 20040112
Title: Determinants of long-term highly active antiretroviral treatment efficacy.
Journal: HIV medicine 20040101
Title: Once-daily saquinavir and ritonavir in treatment-experienced HIV-1-infected individuals.
Journal: The new microbiologica 20040101
Title: A Mathematical simulation to explain the coordinated functions of efflux and metabolism limiting the transport of anti-HIV agents across Caco-2 cells.
Journal: American journal of therapeutics 20040101
Title: A randomized clinical trial comparing nelfinavir and ritonavir in patients with advanced HIV disease (CPCRA 042/CTN 102).
Journal: HIV clinical trials 20040101
Title: Kinetic and thermodynamic characterization of HIV-1 protease inhibitors.
Journal: Journal of molecular recognition : JMR 20040101
Title: Synthesis and evaluation of a novel synthetic phosphocholine lipid-AZT conjugate that double-targets wild-type and drug resistant variants of HIV.
Journal: Nucleosides, nucleotides & nucleic acids 20040101
Title: Pharmacokinetic enhancement of protease inhibitor therapy.
Journal: Clinical pharmacokinetics 20040101
Title: FDA approves SQV/r.
Journal: IAPAC monthly 20040101
Title: Membrane transport of camptothecin: facilitation by human P-glycoprotein (ABCB1) and multidrug resistance protein 2 (ABCC2).
Journal: BMC medicine 20040101
Title: Peptidomimetic inhibitors of HIV protease.
Journal: Current topics in medicinal chemistry 20040101
Title: HIV-1 gene expression: lessons from provirus and non-integrated DNA.
Journal: Retrovirology 20040101
Title: Efficacy of quality criteria to identify potentially harmful information: a cross-sectional survey of complementary and alternative medicine web sites.
Journal: Journal of medical Internet research 20040101
Title: Vascular endothelial toxicity induced by HIV protease inhibitor: evidence of oxidant-related dysfunction and apoptosis.
Journal: Cardiovascular toxicology 20040101
Title: Practical guidelines to interpret plasma concentrations of antiretroviral drugs.
Journal: Clinical pharmacokinetics 20040101
Title: Reduction of saquinavir exposure by coadministration of loperamide: a two-way pharmacokinetic interaction.
Journal: Clinical pharmacokinetics 20040101
Title: Synthesis of poly(ethylene glycol)-based saquinavir prodrug conjugates and assessment of release and anti-HIV-1 bioactivity using a novel protease inhibition assay.
Journal: Bioconjugate chemistry 20040101
Title: Assessment of FIV-C infection of cats as a function of treatment with the protease inhibitor, TL-3.
Journal: Retrovirology 20040101
Title: Pharmacokinetics of antiretrovirals in pregnant women.
Journal: Clinical pharmacokinetics 20040101
Title: Anti-HIV agents. A protease-only regimen--Kaletra and saquinavir.
Journal: TreatmentUpdate 20040101
Title: Anti-HIV agents. No interaction between tenofovir and saquinavir.
Journal: TreatmentUpdate 20040101
Title: Anti-HIV agents. Saquinavir--switching from Fortovase to Invirase.
Journal: TreatmentUpdate 20040101
Title: Anti-HIV agents. Saquinavir with fosamprenavir.
Journal: TreatmentUpdate 20040101
Title: Anti-HIV agents. Atazanavir and saquinavir.
Journal: TreatmentUpdate 20040101
Title: Clinical use of a simultaneous HPLC assay for indinavir, saquinavir, ritonavir and nelfinavir in children and adults.
Journal: Therapeutic drug monitoring 20031201
Title: Stability of extemporaneously prepared saquinavir formulations.
Journal: Journal of clinical pharmacy and therapeutics 20031201
Title: Therapeutic dose of HIV-1 protease inhibitor saquinavir does not permanently influence early insulin signaling.
Journal: Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 20031201
Title: A randomized trial comparing initial HAART regimens of nelfinavir/nevirapine and ritonavir/saquinavir in combination with two nucleoside reverse transcriptase inhibitors.
Journal: Antiviral therapy 20031201
Title: HIV envelope gp120-mediated regulation of osteoclastogenesis via receptor activator of nuclear factor kappa B ligand (RANKL) secretion and its modulation by certain HIV protease inhibitors through interferon-gamma/RANKL cross-talk.
Journal: The Journal of biological chemistry 20031128
Title: Multidrug resistance to HIV-1 protease inhibition requires cooperative coupling between distal mutations.
Journal: Biochemistry 20031125
Title: Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome p450 3A4 substrate, in patients with chronic myeloid leukaemia.
Journal: British journal of cancer 20031117
Title: Pharmacokinetic characterization of a human immunodeficiency virus protease inhibitor, saquinavir, during ethanol intake in rats.
Journal: Biopharmaceutics & drug disposition 20031101
Title: Inhibitory effect of stiripentol on carbamazepine and saquinavir metabolism in human.
Journal: British journal of clinical pharmacology 20031101
Title: [A randomized clinical trial to compare the effectiveness of indinavir, ritonavir and saquinavir].
Journal: Medicina clinica 20031025
Title: Differential effect of HIV protease inhibitors on adipogenesis: intracellular ritonavir is not sufficient to inhibit differentiation.
Journal: AIDS (London, England) 20031017
Title: Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial.
Journal: AIDS (London, England) 20031017
Title: Modulation of the LDL receptor and LRP levels by HIV protease inhibitors.
Journal: Journal of lipid research 20031001
Title: The effect of cell culture conditions on saquinavir transport through, and interactions with, MDCKII cells overexpressing hMDR1.
Journal: Journal of pharmaceutical sciences 20031001
Title: Novel bis-tetrahydrofuranylurethane-containing nonpeptidic protease inhibitor (PI) UIC-94017 (TMC114) with potent activity against multi-PI-resistant human immunodeficiency virus in vitro.
Journal: Antimicrobial agents and chemotherapy 20031001
Title: Clinical use of a simultaneous HPLC assay for indinavir, saquinavir, ritonavir, and nelfinavir in children and adults.
Journal: Therapeutic drug monitoring 20031001
Title: Saquinavir induces stable and functional expression of the multidrug transporter P-glycoprotein in human CD4 T-lymphoblastoid CEMrev cells.
Journal: HIV medicine 20031001
Title: Low efficacy and high frequency of adverse events in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosine.
Journal: AIDS (London, England) 20030926
Title: Effect of antiretroviral protease inhibitors alone, and in combination with paromomycin, on the excystation, invasion and in vitro development of Cryptosporidium parvum.
Journal: The Journal of antimicrobial chemotherapy 20030901
Title: Effect of protease inhibitor-containing regimens on lymphocyte multidrug resistance transporter expression.
Journal: The Journal of antimicrobial chemotherapy 20030901
Title: Randomized trial to evaluate indinavir/ritonavir versus saquinavir/ritonavir in human immunodeficiency virus type 1-infected patients: the MaxCmin1 Trial.
Journal: The Journal of infectious diseases 20030901
Title: In vitro hypersusceptibility of human immunodeficiency virus type 1 subtype C protease to lopinavir.
Journal: Antimicrobial agents and chemotherapy 20030901
Title: Use of HIV protease inhibitors to block Kaposi's sarcoma and tumour growth.
Journal: The Lancet. Oncology 20030901
Title: The long-term effects of anti-retroviral protease inhibitors on sugar transport in L6 cells.
Journal: The Journal of endocrinology 20030901
Title: The binding of HIV-1 protease inhibitors to human serum proteins.
Journal: Biophysical chemistry 20030901
Title: Contraindicated antiretroviral drug combinations.
Journal: New Jersey medicine : the journal of the Medical Society of New Jersey 20030901
Title: Mitochondrial toxicity in the era of HAART: evaluating venous lactate and peripheral blood mitochondrial DNA in HIV-infected patients taking antiretroviral therapy.
Journal: Journal of acquired immune deficiency syndromes (1999) 20030901
Title: Rapidly progressive human herpesvirus 8-associated solid anaplastic lymphoma in a patient with AIDS--associated Kaposi sarcoma.
Journal: Leukemia & lymphoma 20030901
Title: Boosted PIs: competition hots up.
Journal: The AIDS reader 20030901
Title: Virological rebound after suppression on highly active antiretroviral therapy.
Journal: AIDS (London, England) 20030815
Title: The effects of protease inhibitors and nonnucleoside reverse transcriptase inhibitors on p-glycoprotein expression in peripheral blood mononuclear cells in vitro.
Journal: Journal of acquired immune deficiency syndromes (1999) 20030815
Title: Viral dynamics and their relations to baseline factors and longer term virologic responses in treatment-naive HIV-1-infected patients receiving abacavir in combination with HIV-1 protease inhibitors.
Journal: Journal of acquired immune deficiency syndromes (1999) 20030815
Title: HIV protease inhibitors as new treatment options for Kaposi's sarcoma.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 20030801
Title: Lopinavir/ritonavir plus saquinavir in salvage therapy; pharmacokinetics, tolerability and efficacy.
Journal: AIDS (London, England) 20030725
Title: Indinavir reduces Cryptosporidium parvum infection in both in vitro and in vivo models.
Journal: International journal for parasitology 20030701
Title: Rapid enzymatic test for phenotypic HIV protease drug resistance.
Journal: Biological chemistry 20030701
Title: Evidence for two interacting ligand binding sites in human multidrug resistance protein 2 (ATP binding cassette C2).
Journal: The Journal of biological chemistry 20030627
Title: Mitochondrial:nuclear DNA ratios in peripheral blood cells from human immunodeficiency virus (HIV)-infected patients who received selected HIV antiretroviral drug regimens.
Journal: The Journal of infectious diseases 20030615
Title: Mitochondrial membrane hyperpolarization hijacks activated T lymphocytes toward the apoptotic-prone phenotype: homeostatic mechanisms of HIV protease inhibitors.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20030615
Title: A review of low-dose ritonavir in protease inhibitor combination therapy.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20030615
Title: Therapy with atazanavir plus saquinavir in patients failing highly active antiretroviral therapy: a randomized comparative pilot trial.
Journal: AIDS (London, England) 20030613
Title: Reverse phase high-performance liquid chromatography method for the analysis of amprenavir, efavirenz, indinavir, lopinavir, nelfinavir and its active metabolite (M8), ritonavir, and saquinavir in heparinized human plasma.
Journal: Therapeutic drug monitoring 20030601
Title: Simultaneous determination of the HIV drugs indinavir, amprenavir, saquinavir, ritonavir, lopinavir, nelfinavir, the nelfinavir hydroxymetabolite M8, and nevirapine in human plasma by reversed-phase high-performance liquid chromatography.
Journal: Therapeutic drug monitoring 20030601
Title: [Comparison of pharmacokinetics of saquinavir soft-gel capsule (SQV-SGC) combined with ritonavir (RTV), SQV hard-gel capsule with RTV, and SQV-SGC alone].
Journal: Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases 20030601
Title: Comparison of nine resistance interpretation systems for HIV-1 genotyping.
Journal: Antiviral therapy 20030601
Title: Pharmacokinetics of lower doses of saquinavir soft-gel caps (800 and 1200 mg twice daily) boosted with itraconazole in HIV-1-positive patients.
Journal: Antiviral therapy 20030601
Title: Sensitive and specific determination of eight antiretroviral agents in plasma by high-performance liquid chromatography-mass spectrometry.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030525
Title: Differential effect of HIV-1 protease inhibitors on P-glycoprotein function in multidrug-resistant variants of the human CD4+ T lymphoblastoid CEM cell line.
Journal: Chemotherapy 20030501
Title: Effect of simultaneous versus staggered dosing on pharmacokinetic interactions of protease inhibitors.
Journal: Clinical pharmacology and therapeutics 20030501
Title: Elucidation of HIV-1 protease resistance by characterization of interaction kinetics between inhibitors and enzyme variants.
Journal: Antiviral research 20030501
Title: Hepatotoxicity associated with antiretroviral therapy containing HIV-1 protease inhibitors.
Journal: Seminars in liver disease 20030501
Title: Factors associated with accelerated atherosclerosis in HIV-1-infected persons treated with protease inhibitors.
Journal: AIDS patient care and STDs 20030501
Title: ['Double boosting' passes the test. LPV/r plus SQV in complicated salvage situation].
Journal: MMW Fortschritte der Medizin 20030428
Title: Determination of protease inhibitors using liquid chromatography-tandem mass spectrometry.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030425
Title: Comparison of in vitro P-glycoprotein screening assays: recommendations for their use in drug discovery.
Journal: Journal of medicinal chemistry 20030424
Title: Reduction of peptide character of HIV protease inhibitors that exhibit nanomolar potency against multidrug resistant HIV-1 strains.
Journal: Journal of medicinal chemistry 20030424
Title: Brief report: efficacy and treatment-limiting toxicity with the concurrent use of lopinavir/ritonavir and a third protease inhibitor in treatment-experienced HIV-infected patients.
Journal: Journal of acquired immune deficiency syndromes (1999) 20030415
Title: Pharmacokinetics of once-daily saquinavir hard-gelatin capsules and saquinavir soft-gelatin capsules boosted with ritonavir in HIV-1-infected subjects.
Journal: Journal of acquired immune deficiency syndromes (1999) 20030401
Title: Sildenafil does not alter nelfinavir pharmacokinetics.
Journal: Therapeutic drug monitoring 20030401
Title: Pharmacokinetic and tolerability profile of twice-daily saquinavir hard gelatin capsules and saquinavir soft gelatin capsules boosted with ritonavir in healthy volunteers.
Journal: HIV medicine 20030401
Title: Effect of ritonavir and saquinavir on Candida albicans growth rate and in vitro activity of aspartyl proteinases.
Journal: Medical mycology 20030401
Title: Control of human immunodeficiency virus type-1 protease activity in insect cells expressing Gag-Pol rescues assembly of immature but not mature virus-like particles.
Journal: Virology 20030330
Title: New anti-human immunodeficiency virus type 1 6-aminoquinolones: mechanism of action.
Journal: Antimicrobial agents and chemotherapy 20030301
Title: Effect of antimycotic agents on the activity of aspartyl proteinases secreted by Candida albicans.
Journal: Journal of medical microbiology 20030301
Title: Molecular dynamics study of the connection between flap closing and binding of fullerene-based inhibitors of the HIV-1 protease.
Journal: Biochemistry 20030211
Title: Highly sensitive determination of saquinavir in biological samples using liquid chromatography-tandem mass spectrometry.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030205
Title: Simultaneous determination of nine antiretroviral compounds in human plasma using liquid chromatography.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030205
Title: Assessing safety and efficacy of directed P-glycoprotein inhibition to improve the pharmacokinetic properties of saquinavir coadministered with ritonavir.
Journal: The Journal of pharmacology and experimental therapeutics 20030201
Title: Once-daily saquinavir-sgc plus low-dose ritonavir (1200/100 mg) in combination with efavirenz: pharmacokinetics and efficacy in HIV-infected patients with prior antiretroviral therapy.
Journal: Journal of acquired immune deficiency syndromes (1999) 20030201
Title: Effect of indinavir on the intestinal exsorption of amprenavir, saquinavir and nelfinavir after intravenous administration in rats.
Journal: Biological & pharmaceutical bulletin 20030201
Title: Rapid quantification of HIV protease inhibitors in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry.
Journal: Journal of mass spectrometry : JMS 20030201
Title: Long-term efficacy and safety of twice-daily saquinavir soft gelatin capsules (SGC), with or without nelfinavir, and three times daily saquinavir-SGC, in triple combination therapy for HIV infection: 100-week follow-up.
Journal: Antiviral therapy 20030201
Title: [HIV protease inhibitors for the treatment of Kaposi's sarcoma].
Journal: Recenti progressi in medicina 20030201
Title: A major role for a set of non-active site mutations in the development of HIV-1 protease drug resistance.
Journal: Biochemistry 20030128
Title: Inhibition of TNF-alpha mediated cell death by HIV-1 specific protease inhibitors.
Journal: European journal of medical research 20030128
Title: Simultaneous quantitative determination of the HIV protease inhibitors indinavir, amprenavir, ritonavir, lopinavir, saquinavir, nelfinavir and the nelfinavir active metabolite M8 in plasma by liquid chromatography.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030115
Title: Agent and cell-type specificity in the induction of insulin resistance by HIV protease inhibitors.
Journal: AIDS (London, England) 20030103
Title: Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation.
Journal: The Journal of pharmacology and experimental therapeutics 20030101
Title: Predicting HIV drug resistance with neural networks.
Journal: Bioinformatics (Oxford, England) 20030101
Title: The effects of protease inhibitors on basal and insulin-stimulated lipid metabolism, insulin binding, and signaling.
Journal: Journal of lipid research 20030101
Title: Quantitative determination of saquinavir from Caco-2 cell monolayers by HPLC-UV. High performance liquid chromatography.
Journal: Biomedical chromatography : BMC 20030101
Title: In vitro activity of potential anti-poxvirus agents.
Journal: Antiviral research 20030101
Title: Lopinavir/ritonavir: a review of its use in the management of HIV infection.
Journal: Drugs 20030101
Title: Saquinavir: a review of its use in boosted regimens for treating HIV infection.
Journal: Drugs 20030101
Title: Once-daily saquinavir-hgc plus low-dose ritonavir (1200/100 mg) in HIV-infected pregnant women: pharmacokinetics and efficacy.
Journal: HIV clinical trials 20030101
Title: Saquinavir/low-dose ritonavir: its use in HIV infection.
Journal: AIDS reviews 20030101
Title: Pharmacokinetic interactions with rifampicin : clinical relevance.
Journal: Clinical pharmacokinetics 20030101
Title: Commentary on using the SF-36 or MOS-HIV in studies of persons with HIV disease.
Journal: Health and quality of life outcomes 20030101
Title: Inhibition of cytochrome P450 3A: relevant drug interactions in gastroenterology.
Journal: Digestion 20030101
Title: The effect of human immunodeficiency virus-1 protease inhibitors on the toxicity of a variety of cells.
Journal: In vitro cellular & developmental biology. Animal 20030101
Title: Use of the protease inhibitor saquinavir hard gel in human immunodeficiency virus-infected patients in the early period of highly active antiretroviral therapy: does it affect long-term treatment outcome?
Journal: Scandinavian journal of infectious diseases 20030101
Title: Unusual binding mode of an HIV-1 protease inhibitor explains its potency against multi-drug-resistant virus strains.
Journal: Journal of molecular biology 20021206
Title: Diurnal variation of plasma protease inhibitor concentrations.
Journal: AIDS (London, England) 20021206
Title: Relationships between structure and interaction kinetics for HIV-1 protease inhibitors.
Journal: Journal of medicinal chemistry 20021205
Title: Persistence of earlier HIV-1 drug resistance mutations at new treatment failure.
Journal: Journal of medical virology 20021201
Title: Model-based analysis of the pharmacokinetic interactions between ritonavir, nelfinavir, and saquinavir after simultaneous and staggered oral administration.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20021201
Title: Comparison of the efficacy, safety and predictive value of HIV genotyping using distinct ritonavir-boosted protease inhibitors.
Journal: International journal of antimicrobial agents 20021201
Title: Pharmacokinetics of saquinavir co-administered with cimetidine.
Journal: The Journal of antimicrobial chemotherapy 20021201
Title: Transient rebounds of low-level viraemia among HIV-infected patients under HAART are not associated with virological or immunological failure.
Journal: Antiviral therapy 20021201
Title: Multidrug resistance protein 2 (MRP2) transports HIV protease inhibitors, and transport can be enhanced by other drugs.
Journal: AIDS (London, England) 20021122
Title: Simple and rapid high-performance liquid chromatographic method for nelfinavir, M8 nelfinavir metabolite, ritonavir and saquinavir assay in plasma.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20021115
Title: New anti-HIV agents and targets.
Journal: Medicinal research reviews 20021101
Title: Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophy.
Journal: Diabetes 20021101
Title: Rapid assessment of phenotypic resistance to protease inhibitors in human immunodeficiency virus type 1 group O.
Journal: Journal of clinical microbiology 20021101
Title: Transport of HIV-protease inhibitors across 1 alpha,25di-hydroxy vitamin D3-treated Calu-3 cell monolayers: modulation of P-glycoprotein activity.
Journal: Pharmaceutical research 20021101
Title: Transepithelial transport of prodrugs of the HIV protease inhibitors saquinavir, indinavir, and nelfinavir across Caco-2 cell monolayers.
Journal: Pharmaceutical research 20021101
Title: Simultaneous determination of five HIV protease inhibitors nelfinavir, indinavir, ritonavir, saquinavir and amprenavir in human plasma by LC/MS/MS.
Journal: Journal of pharmaceutical and biomedical analysis 20021015
Title: The secreted aspartic proteinases as a new target in the therapy of candidiasis.
Journal: Current drug targets 20021001
Title: Therapeutic drug monitoring of HIV-protease inhibitors to assess noncompliance.
Journal: Therapeutic drug monitoring 20021001
Title: P-glycoprotein and MRP1 expression and reduced ritonavir and saquinavir accumulation in HIV-infected individuals.
Journal: The Journal of antimicrobial chemotherapy 20021001
Title: Rheumatoid arthritis after 9 years of human immunodeficiency virus infection: possible contribution of tritherapy.
Journal: The Journal of rheumatology 20021001
Title: Clinical lipoatrophy in HIV-1 patients on HAART is not associated with increased abdominal girth, hyperlipidaemia or glucose intolerance.
Journal: HIV medicine 20021001
Title: Ritonavir plus saquinavir versus single protease inhibitor therapy in protease inhibitor-naive HIV-infected patients: the Swiss HIV Cohort Study.
Journal: HIV medicine 20021001
Title: Low increase in serum lipids in patients receiving a combination of ritonavir, saquinavir and efavirenz.
Journal: HIV medicine 20021001
Title: In vitro evidence of inhibition of mitochondrial protease processing by HIV-1 protease inhibitors in yeast: a possible contribution to lipodystrophy syndrome.
Journal: Mitochondrion 20021001
Title: Impact of HIV genotyping and drug levels on the response to salvage therapy with saquinavir/ritonavir.
Journal: AIDS (London, England) 20020927
Title: Genotypic and phenotypic cross-resistance patterns to lopinavir and amprenavir in protease inhibitor-experienced patients with HIV viremia.
Journal: AIDS research and human retroviruses 20020920
Title: The human immunodeficiency virus (HIV)-1 protease inhibitor saquinavir inhibits proteasome function and causes apoptosis and radiosensitization in non-HIV-associated human cancer cells.
Journal: Cancer research 20020915
Title: Durability of response to treatment among antiretroviral-experienced subjects: 48-week results from AIDS Clinical Trials Group Protocol 359.
Journal: The Journal of infectious diseases 20020901
Title: [Cytomegalovirus retinitis after highly active antiretroviral therapy: a case report].
Journal: Archivos de la Sociedad Espanola de Oftalmologia 20020901
Title: The unbound percentage of saquinavir and indinavir remains constant throughout the dosing interval in HIV positive subjects.
Journal: British journal of clinical pharmacology 20020901
Title: Concentrations of protease inhibitors in cord blood after in utero exposure.
Journal: The Pediatric infectious disease journal 20020901
Title: Efficacy and safety of twice-daily versus three-times daily saquinavir soft gelatin capsules as part of triple combination therapy for HIV-1 infection.
Journal: Antiviral therapy 20020901
Title: Predictors of treatment failure during highly active antiretroviral therapy (racing trial).
Journal: European journal of medical research 20020830
Title: Novel cyclourethane-derived HIV protease inhibitors: a ring-closing olefin metathesis based strategy.
Journal: Bioorganic & medicinal chemistry letters 20020805
Title: Garlic supplements and saquinavir.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20020801
Title: Effect of interleukin-2 on intestinal P-glycoprotein expression and functionality in mice.
Journal: The Journal of pharmacology and experimental therapeutics 20020801
Title: Safety and efficacy of saquinavir soft-gelatin capsules + zidovudine + optional lamivudine in pregnancy and prevention of vertical HIV transmission.
Journal: Journal of acquired immune deficiency syndromes (1999) 20020801
Title: Simultaneous quantitative assay of six HIV protease inhibitors, one metabolite, and two non-nucleoside reverse transcriptase inhibitors in human plasma by isocratic reversed-phase liquid chromatography.
Journal: Therapeutic drug monitoring 20020801
Title: Effect of coadministration of nelfinavir, indinavir, and saquinavir on the pharmacokinetics of amprenavir.
Journal: Clinical pharmacology and therapeutics 20020801
Title: Interaction between saquinavir soft-gel and rifabutin in patients infected with HIV.
Journal: British journal of clinical pharmacology 20020801
Title: Effects of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication and proviral DNA (COSMIC trial).
Journal: AIDS (London, England) 20020726
Title: New developments in anti-HIV chemotherapy.
Journal: Biochimica et biophysica acta 20020718
Title: Determination of lopinavir and nevirapine by high-performance liquid chromatography after solid-phase extraction: application for the assessment of their transplacental passage at delivery.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20020715
Title: Dual vs single protease inhibitor therapy following antiretroviral treatment failure: a randomized trial.
Journal: JAMA 20020710
Title: Amplification of the effects of drug resistance mutations by background polymorphisms in HIV-1 protease from African subtypes.
Journal: Biochemistry 20020709
Title: Structure-based design and synthesis of HIV-1 protease inhibitors employing beta-D-mannopyranoside scaffolds.
Journal: Bioorganic & medicinal chemistry letters 20020708
Title: Evolutionary analysis of HIV-1 protease inhibitors: Methods for design of inhibitors that evade resistance.
Journal: Proteins 20020701
Title: In vitro antiviral interaction of lopinavir with other protease inhibitors.
Journal: Antimicrobial agents and chemotherapy 20020701
Title: Longitudinal use of phenotypic resistance testing to HIV-1 protease inhibitors in patients developing HAART failure.
Journal: Journal of medical virology 20020701
Title: Pharmacokinetics of saquinavir in children during long term treatment.
Journal: The Pediatric infectious disease journal 20020701
Title: Garlic supplements can impede HIV medication.
Journal: AIDS (London, England) 20020614
Title: Sensitive and simultaneous determination of HIV protease inhibitors in rat biological samples by liquid chromatography-mass spectrometry.
Journal: Biomedical chromatography : BMC 20020601
Title: High-performance liquid chromatographic method for the simultaneous determination of the six HIV-protease inhibitors and two non-nucleoside reverse transcriptase inhibitors in human plasma.
Journal: Therapeutic drug monitoring 20020601
Title: Dose-dependent increase of saquinavir bioavailability by the pharmaceutic aid cremophor EL.
Journal: British journal of clinical pharmacology 20020601
Title: Functional expression and localization of P-glycoprotein at the blood brain barrier.
Journal: Microscopy research and technique 20020601
Title: Effects of grapefruit juice and orange juice on the intestinal efflux of P-glycoprotein substrates.
Journal: Pharmaceutical research 20020601
Title: Saquinavir soft-gel capsules (Fortovase) give lower exposure than expected, even after a high-fat breakfast.
Journal: Pharmacy world & science : PWS 20020601
Title: Select HIV protease inhibitors alter bone and fat metabolism ex vivo.
Journal: The Journal of biological chemistry 20020531
Title: A neutravidin-based assay for reverse transcriptase suitable for high throughput screening of retroviral activity.
Journal: Journal of biochemistry and molecular biology 20020531
Title: [When nucleoside analogs cannot be tolerated. HIV therapy with booster].
Journal: MMW Fortschritte der Medizin 20020509
Title: Inhibition of morphine-potentiated HIV-1 replication in peripheral blood mononuclear cells with the nuclease-resistant 2-5A agonist analog, 2-5A(N6B).
Journal: Journal of acquired immune deficiency syndromes (1999) 20020501
Title: Male sexual dysfunction associated with antiretroviral therapy.
Journal: Journal of acquired immune deficiency syndromes (1999) 20020501
Title: A randomized, open-label, comparative trial of BID and TID dosing of saquinavir enhanced oral formulation as part of a triple therapy for advanced AIDS patients.
Journal: Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20020501
Title: Simplifying protease inhibitor therapy with once-daily dosing of saquinavir soft-gelatin capsules/ritonavir (1600/100 mg): HIVNAT 001.3 study.
Journal: Journal of acquired immune deficiency syndromes (1999) 20020415
Title: Transplacental passage of protease inhibitors at delivery.
Journal: AIDS (London, England) 20020412
Title: [More transparency facilities drug choice in general practice. Booster regimens in direct comparison].
Journal: MMW Fortschritte der Medizin 20020409
Title: Antiviral activity of UIC-PI, a novel inhibitor of the human immunodeficiency virus type 1 protease.
Journal: Antiviral research 20020401
Title: Simultaneous determination of the six HIV protease inhibitors (amprenavir, indinavir, lopinavir, nelfinavir, ritonavir, and saquinavir) plus M8 nelfinavir metabolite and the nonnucleoside reverse transcription inhibitor efavirenz in human plasma by solid-phase extraction and column liquid chromatography.
Journal: Therapeutic drug monitoring 20020401
Title: The effect of ritonavir on saquinavir plasma concentration is independent of ritonavir dosage: combined analysis of pharmacokinetic data from 97 subjects.
Journal: HIV medicine 20020401
Title: Long-term maintenance antiretroviral therapy with saquinavir hard gel, after voluntary abandonment of successful induction HAART.
Journal: Journal of chemotherapy (Florence, Italy) 20020401
Title: The utility of inhibitory quotients in determining the relative potency of protease inhibitors.
Journal: AIDS (London, England) 20020329
Title: Eruptive angiolipomas associated with antiretroviral therapy.
Journal: AIDS (London, England) 20020329
Title: Garlic supplements and HIV medication.
Journal: American family physician 20020315
Title: Inter-retroviral fusion mediated by human immunodeficiency virus or murine leukemia virus glycoproteins: independence of cellular membranes and membrane vesicles.
Journal: Virology 20020315
Title: Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047.
Journal: AIDS (London, England) 20020308
Title: Poor solubility limiting significance of in-vitro studies with HIV protease inhibitors.
Journal: AIDS (London, England) 20020308
Title: [Acute coronary syndromes in patients treated with HIV protease inhibitors].
Journal: Presse medicale (Paris, France : 1983) 20020302
Title: HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma.
Journal: Nature medicine 20020301
Title: Pharmacokinetics and pharmacodynamics of saquinavir in pediatric patients with human immunodeficiency virus infection.
Journal: Clinical pharmacology and therapeutics 20020301
Title: Drug interactions between HIV protease inhibitors based on physiologically-based pharmacokinetic model.
Journal: Journal of pharmaceutical sciences 20020301
Title: [Comparison between HIV-1-infected hemophiliacs and non-hemophiliacs on survival and clinical courses after starting highly active antiretroviral therapy].
Journal: Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases 20020301
Title: Resistance testing in children changing human immunodeficiency virus type 1 protease inhibitor.
Journal: The Pediatric infectious disease journal 20020301
Title: A potent human immunodeficiency virus type 1 protease inhibitor, UIC-94003 (TMC-126), and selection of a novel (A28S) mutation in the protease active site.
Journal: Journal of virology 20020201
Title: Development and significance of resistance to protease inhibitors in HIV-1-infected adults under triple-drug therapy in clinical practice.
Journal: Journal of medical virology 20020201
Title: Development of a chromatographic method for the determination of saquinavir in plasma samples of HIV patients.
Journal: Biomedical chromatography : BMC 20020201
Title: In-vitro and in-vivo pharmacokinetic interactions of amprenavir, an HIV protease inhibitor, with other current HIV protease inhibitors in rats.
Journal: The Journal of pharmacy and pharmacology 20020201
Title: Garlic supplements can impede HIV medication.
Journal: Journal of the American College of Surgeons 20020201
Title: Long-term suppression of viral replication despite low plasma saquinavir concentrations in the CHEESE Study.
Journal: British journal of clinical pharmacology 20020201
Title: NIH studies link between saquinavir and garlic pills.
Journal: AIDS alert 20020201
Title: Efficacy of highly active antiretroviral therapy in HIV-1 infected children.
Journal: The Lancet. Infectious diseases 20020201
Title: Lymphocytes proliferate in blood and lymph nodes following interleukin-2 therapy in addition to highly active antiretroviral therapy.
Journal: AIDS (London, England) 20020125
Title: Duration and predictors of CD4 T-cell gains in patients who continue combination therapy despite detectable plasma viremia.
Journal: AIDS (London, England) 20020125
Title: The effect of garlic supplements on the pharmacokinetics of saquinavir.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20020115
Title: Impact of discontinuation of initial protease inhibitor therapy on further virological response in a cohort of human immunodeficiency virus-infected patients.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20020115
Title: Effects of antiretroviral drug combinations on the differentiation of adipocytes.
Journal: AIDS (London, England) 20020104
Title: Plasma drug levels, genotypic resistance, and virological response to a nelfinavir plus saquinavir-containing regimen.
Journal: AIDS (London, England) 20020104
Title: The HIV protease inhibitor saquinavir impairs lipid metabolism and glucose transport in cultured adipocytes.
Journal: The Journal of endocrinology 20020101
Title: CYP3A4-mediated hepatic metabolism of the HIV-1 protease inhibitor saquinavir in vitro.
Journal: Xenobiotica; the fate of foreign compounds in biological systems 20020101
Title: Viral and immunologic follow up of 4 to 9 years of AIDS treatments by quadruple combinations of virostatics including integrase inhibitors applied in short sequences differing by drug rotation.
Journal: Acta pharmacologica Sinica 20020101
Title: Response to two consecutive protease inhibitor combination therapy regimens in a cohort of HIV-1-infected children.
Journal: Scandinavian journal of infectious diseases 20020101
Title: A SOFM approach to predicting HIV drug resistance.
Journal: Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing 20020101
Title: Interaction potential of lercanidipine, a new vasoselective dihydropyridine calcium antagonist.
Journal: Arzneimittel-Forschung 20020101
Title: Retroviral proteases.
Journal: Genome biology 20020101
Title: The effect of HAART on humoral immune response in primary HIV-1 infected patients.
Journal: Journal of biological regulators and homeostatic agents 20020101
Title: Saquinavir with low-dose ritonavir twice daily.
Journal: TreatmentUpdate 20020101
Title: Invirase vs. Fortovase: unexpected results?
Journal: TreatmentUpdate 20020101
Title: Saquinavir once daily.
Journal: TreatmentUpdate 20020101
Title: Could cimetidine be used as a booster?
Journal: TreatmentUpdate 20020101
Title: Food-drug interactions.
Journal: Drugs 20020101
Title: Hepatic and intestinal contributions to pharmacokinetic interaction of indinavir with amprenavir, nelfinavir and saquinavir in rats.
Journal: Antiviral chemistry & chemotherapy 20020101
Title: Resistance profiles of cyclic and linear inhibitors of HIV-1 protease.
Journal: Antiviral chemistry & chemotherapy 20020101
Title: [Plasmatic dosage of antiretroviral drugs by high performance liquid chromathography ].
Journal: Therapie 20020101
Title: Fast relapse and high drop out rate of 48 weeks daily interferon monotherapy in HIV-infected patients with chronic hepatitis C.
Journal: BMC infectious diseases 20020101
Title: Highlights of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).
Journal: The Body positive 20020101
Title: Aphtous stomatitis in a patient with Behçet's disease and HIV was associated with an increased HIV load.
Journal: Clinical and experimental rheumatology 20020101
Title: Interactions between antiretroviral drugs and drugs used for the therapy of the metabolic complications encountered during HIV infection.
Journal: Clinical pharmacokinetics 20020101
Title: Hepatic adverse events during highly active antiretroviral therapy containing nevirapine: a case report.
Journal: Annals of clinical microbiology and antimicrobials 20020101
Title: Intracellular concentration of protease inhibitors in HIV-1-infected patients: correlation with MDR-1 gene expression and low dose of ritonavir.
Journal: HIV clinical trials 20020101
Title: Modulation of the multidrug resistance (MDR) phenotype in CEM MDR cells simultaneously exposed to anti HIV-1 protease inhibitors (PI's) and cytotoxic drugs.
Journal: Annali dell'Istituto superiore di sanita 20020101
Title: Management of protease inhibitor-associated hyperlipidemia.
Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions 20020101
Title: Differential effects of HIV-1 protease inhibitors on dendritic cell immunophenotype and function.
Journal: The Journal of biological chemistry 20011221
Title: Garlic reduces saquinavir blood levels 50%; may affect other drugs.
Journal: AIDS treatment news 20011221
Title: Has there been a decrease in the prevalence of mood disorders in HIV-seropositive individuals since the introduction of combination therapy?
Journal: European psychiatry : the journal of the Association of European Psychiatrists 20011201
Title: Therapeutic drug monitoring of HIV protease inhibitors using high-performance liquid chromatography with ultraviolet or photodiode array detection.
Journal: Therapeutic drug monitoring 20011201
Title: Combination of protease inhibitors for the treatment of HIV-1-infected patients: a review of pharmacokinetics and clinical experience.
Journal: Antiviral therapy 20011201
Title: Genotypic correlates of resistance to HIV-1 protease inhibitors on longitudinal data: the role of secondary mutations.
Journal: Antiviral therapy 20011201
Title: Ritonavir/saquinavir plus one nucleoside reverse transcriptase inhibitor (NRTI) versus indinavir plus two NRTIs in protease inhibitor-naive HIV-1-infected adults (IRIS study).
Journal: Antiviral therapy 20011201
Title: [Therapeutic aspects of HIV/AIDS infected patients and evaluation of therapeutic protocols].
Journal: Acta pharmaceutica Hungarica 20011201
Title: Drugs for HIV infection.
Journal: The Medical letter on drugs and therapeutics 20011126
Title: HIV protease inhibitors reduce IL-2 release from normal human phytohaemagglutinin-activated T cells.
Journal: AIDS (London, England) 20011123
Title: The biological effects of structural variation at the meta position of the aromatic rings and at the end of the alkenyl chain in the alkenyldiarylmethane series of non-nucleoside reverse transcriptase inhibitors.
Journal: Journal of medicinal chemistry 20011122
Title: Synthesis and anti-HIV activity of glucose-containing prodrugs derived from saquinavir, indinavir and nelfinavir.
Journal: Carbohydrate research 20011121
Title: Anti-human immunodeficiency virus drugs are ineffective against Pneumocystis carinii in vitro and in vivo.
Journal: The Journal of infectious diseases 20011115
Title: Replacing ritonavir by nelfinavir or nelfinavir/saquinavir as part of highly active antiretroviral therapy leads to an improvement of triglyceride levels.
Journal: AIDS (London, England) 20011109
Title: New developments in anti-HIV chemotherapy.
Journal: Current medicinal chemistry 20011101
Title: DPC 681 and DPC 684: potent, selective inhibitors of human immunodeficiency virus protease active against clinically relevant mutant variants.
Journal: Antimicrobial agents and chemotherapy 20011101
Title: Decrease of elevated N,N-dimethylglycine and N-methylglycine in human immunodeficiency virus infection during short-term highly active antiretroviral therapy.
Journal: Metabolism: clinical and experimental 20011101
Title: Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study.
Journal: Lancet (London, England) 20011020
Title: Effects of the membrane dipole potential on the interaction of saquinavir with phospholipid membranes and plasma membrane receptors of Caco-2 cells.
Journal: The Journal of biological chemistry 20011019
Title: HIV-protease inhibitors alter retinoic acid synthesis.
Journal: AIDS (London, England) 20011019
Title: Penetration of the nucleoside analogue abacavir into the genital tract of men infected with human immunodeficiency virus type 1.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20011015
Title: Functional expression of P-glycoprotein in rat brain microglia.
Journal: The Journal of pharmacology and experimental therapeutics 20011001
Title: HIV-1 induction-maintenance at the lymph node level: the 'Apollo-97' Study.
Journal: Journal of acquired immune deficiency syndromes (1999) 20011001
Title: Potential adverse effects of structured therapeutic interruptions on the pool of HIV-infected cells.
Journal: Journal of acquired immune deficiency syndromes (1999) 20011001
Title: [Value of saquinavir in antiretroviral treatment of adult HIV-1 infection in 2001].
Journal: Presse medicale (Paris, France : 1983) 20010922
Title: Novel low molecular weight spirodiketopiperazine derivatives potently inhibit R5 HIV-1 infection through their antagonistic effects on CCR5.
Journal: The Journal of biological chemistry 20010914
Title: Design and synthesis of potent C(2)-symmetric diol-based HIV-1 protease inhibitors: effects of fluoro substitution.
Journal: Journal of medicinal chemistry 20010913
Title: Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study.
Journal: Archives of internal medicine 20010910
Title: Peptide mimetic HIV protease inhibitors are ligands for the orphan receptor SXR.
Journal: The Journal of biological chemistry 20010907
Title: Comparison of initial combination antiretroviral therapy with a single protease inhibitor, ritonavir and saquinavir, or efavirenz.
Journal: AIDS (London, England) 20010907
Title: Mismatched double-stranded RNA (polyI-polyC(12)U) is synergistic with multiple anti-HIV drugs and is active against drug-sensitive and drug-resistant HIV-1 in vitro.
Journal: Antiviral research 20010901
Title: Antiretroviral drug concentrations in semen of HIV-infected men: differential penetration of indinavir, ritonavir and saquinavir.
Journal: The Journal of antimicrobial chemotherapy 20010901
Title: Novel deletion of HIV type 1 reverse transcriptase residue 69 conferring selective high-level resistance to nevirapine.
Journal: AIDS research and human retroviruses 20010901
Title: Saquinavir and ritonavir pharmacokinetics following combined ritonavir and saquinavir (soft gelatin capsules) administration.
Journal: British journal of clinical pharmacology 20010901
Title: Searching for the right dose of ritonavir-saquinavir.
Journal: TreatmentUpdate 20010901
Title: Protection against experimental autoimmune encephalomyelitis by a proteasome modulator.
Journal: Journal of neuroimmunology 20010830
Title: Effect of Saquinavir on proliferation and telomerase activity of human peripheral blood mononuclear cells.
Journal: Life sciences 20010817
Title: Antiapoptotic mechanism of HIV protease inhibitors: preventing mitochondrial transmembrane potential loss.
Journal: Blood 20010815
Title: Antiviral drugs: current state of the art.
Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20010801
Title: HIV-protease inhibitors contribute to P-glycoprotein efflux function defect in peripheral blood lymphocytes from HIV-positive patients receiving HAART.
Journal: Journal of acquired immune deficiency syndromes (1999) 20010801
Title: Steady-state pharmacokinetics of twice-daily dosing of saquinavir plus ritonavir in HIV-1-infected individuals.
Journal: Journal of acquired immune deficiency syndromes (1999) 20010801
Title: Comparison of virologic, immunologic, and clinical response to five different initial protease inhibitor-containing and nevirapine-containing regimens.
Journal: Journal of acquired immune deficiency syndromes (1999) 20010801
Title: Pharmacokinetics and resistance mutations affect virologic response to ritonavir/saquinavir-containing regimens.
Journal: Therapeutic drug monitoring 20010801
Title: Antiretrovirals: simultaneous determination of five protease inhibitors and three nonnucleoside transcriptase inhibitors in human plasma by a rapid high-performance liquid chromatography--mass spectrometry assay.
Journal: Therapeutic drug monitoring 20010801
Title: A pharmacokinetic study of intermittent rifabutin dosing with a combination of ritonavir and saquinavir in patients infected with human immunodeficiency virus.
Journal: Clinical pharmacology and therapeutics 20010801
Title: Saquinavir up-regulates telomerase activity in lymphocytes activated with monoclonal antibodies against CD3/CD28.
Journal: Journal of chemotherapy (Florence, Italy) 20010801
Title: P-Glycoprotein and transporter MRP1 reduce HIV protease inhibitor uptake in CD4 cells: potential for accelerated viral drug resistance?
Journal: AIDS (London, England) 20010727
Title: Synthesis of a chiral aziridine derivative as a versatile intermediate for HIV protease inhibitors.
Journal: Organic letters 20010726
Title: High-performance liquid chromatographic assay to determine the plasma levels of HIV-protease inhibitors (amprenavir, indinavir, nelfinavir, ritonavir and saquinavir) and the non-nucleoside reverse transcriptase inhibitor (nevirapine) after liquid-liquid extraction.
Journal: Journal of chromatography. B, Biomedical sciences and applications 20010715
Title: Capillary electrophoretic separation of protease inhibitors used in human immunodeficiency virus therapy.
Journal: Journal of chromatography. A 20010713
Title: CMVR diagnoses and progression of CD4 cell counts and HIV viral load measurements in HIV patients on HAART.
Journal: The British journal of ophthalmology 20010701
Title: Combination therapy with saquinavir soft gelatin capsules in children with human immunodeficiency virus infection.
Journal: The Pediatric infectious disease journal 20010701
Title: HIV protease inhibitors attenuate adherence of Candida albicans to epithelial cells in vitro.
Journal: FEMS immunology and medical microbiology 20010701
Title: Predictors of protease inhibitor-associated adverse events.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20010701
Title: Maternal-fetal transfer of saquinavir studied in the ex vivo placental perfusion model.
Journal: American journal of obstetrics and gynecology 20010701
Title: The binding energetics of first- and second-generation HIV-1 protease inhibitors: implications for drug design.
Journal: Archives of biochemistry and biophysics 20010615
Title: Simultaneous determination of the HIV-protease inhibitors indinavir, amprenavir, ritonavir, saquinavir and nelfinavir in human plasma by reversed-phase high-performance liquid chromatography.
Journal: Journal of chromatography. B, Biomedical sciences and applications 20010615
Title: Selection by AZT and rapid replacement in the absence of drugs of HIV type 1 resistant to multiple nucleoside analogs.
Journal: AIDS research and human retroviruses 20010610
Title: Design and synthesis of a conformationally restricted trans peptide isostere based on the bioactive conformations of saquinavir and nelfinavir.
Journal: The Journal of organic chemistry 20010601
Title: The effect of nevirapine in combination with nelfinavir in heavily pretreated HIV-1-infected patients: a prospective, open-label, controlled, randomized study.
Journal: Journal of acquired immune deficiency syndromes (1999) 20010601
Title: Effect of ritonavir/saquinavir on stereoselective pharmacokinetics of methadone: results of AIDS Clinical Trials Group (ACTG) 401.
Journal: Journal of acquired immune deficiency syndromes (1999) 20010601
Title: Prognostic factors of combined viral load and CD4+ cell count responses under triple antiretroviral therapy, Aquitaine cohort, 1996-1998.
Journal: Journal of acquired immune deficiency syndromes (1999) 20010601
Title: The effect of fluconazole on ritonavir and saquinavir pharmacokinetics in HIV-1-infected individuals.
Journal: British journal of clinical pharmacology 20010601
Title: The effects of antiretroviral protease inhibitors on serum lipid levels in HIV-infected patients.
Journal: Journal of the American Dietetic Association 20010601
Title: Antiretroviral activity and safety of abacavir in combination with selected HIV-1 protease inhibitors in therapy-naive HIV-1-infected adults.
Journal: Antiviral therapy 20010601
Title: Adherence over 48 weeks in an antiretroviral clinical trial: variable within patients, affected by toxicities and independently predictive of virological response.
Journal: Antiviral therapy 20010601
Title: Clinical outcome among HIV-infected patients starting saquinavir hard gel compared to ritonavir or indinavir.
Journal: AIDS (London, England) 20010525
Title: Combined hydroxypropyl-beta-cyclodextrin and poly(alkylcyanoacrylate) nanoparticles intended for oral administration of saquinavir.
Journal: International journal of pharmaceutics 20010507
Title: Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir and nelfinavir in human plasma by high-performance liquid chromatography.
Journal: Journal of chromatography. B, Biomedical sciences and applications 20010505
Title: Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection.
Journal: AIDS (London, England) 20010504
Title: Regulation of expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue-specific induction by cytokines.
Journal: Endocrinology 20010501
Title: Secreted aspartic proteases of Candida albicans, Candida tropicalis, Candida parapsilosis and Candida lusitaniae. Inhibition with peptidomimetic inhibitors.
Journal: European journal of biochemistry 20010501
Title: Structure-activity studies of FIV and HIV protease inhibitors containing allophenylnorstatine.
Journal: Bioorganic & medicinal chemistry 20010501
Title: The interaction of saquinavir (soft gelatin capsule) with ketoconazole, erythromycin and rifampicin: comparison of the effect in healthy volunteers and in HIV-infected patients.
Journal: European journal of clinical pharmacology 20010501
Title: [HIV-HBV coinfection and the liver].
Journal: Gastroenterologie clinique et biologique 20010501
Title: A phase II trial of dual protease inhibitor therapy: amprenavir in combination with indinavir, nelfinavir, or saquinavir.
Journal: Journal of acquired immune deficiency syndromes (1999) 20010415
Title: High prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients receiving antiretroviral therapy in Abidjan, Côte d'Ivoire.
Journal: Journal of acquired immune deficiency syndromes (1999) 20010415
Title: Determination of interaction kinetic constants for HIV-1 protease inhibitors using optical biosensor technology.
Journal: Analytical biochemistry 20010415
Title: Determination of serum levels of thirteen human immunodeficiency virus-suppressing drugs by high-performance liquid chromatography.
Journal: Journal of chromatography. A 20010413
Title: Differences in the intracellular accumulation of HIV protease inhibitors in vitro and the effect of active transport.
Journal: AIDS (London, England) 20010413
Title: Impact of HIV type 1 protease, reverse transcriptase, cleavage site, and p6 mutations on the virological response to quadruple therapy with saquinavir, ritonavir, and two nucleoside analogs.
Journal: AIDS research and human retroviruses 20010410
Title: [Improving the pharmacokinetics of protease inhibitors in a more innovative manner. HIV drugs administered in a more clever way].
Journal: MMW Fortschritte der Medizin 20010402
Title: P-glycoprotein limits oral availability, brain, and fetal penetration of saquinavir even with high doses of ritonavir.
Journal: Molecular pharmacology 20010401
Title: Intracellular concentration of the HIV protease inhibitors indinavir and saquinavir in human endothelial cells.
Journal: The Journal of antimicrobial chemotherapy 20010401
Title: An open-label randomized trial to evaluate different therapeutic strategies of combination therapy in HIV-1 infection: design, rationale, and methods of the initio trial.
Journal: Controlled clinical trials 20010401
Title: Generation of a flexible cell line with regulatable, high-level expression of HIV Gag/Pol particles capable of packaging HIV-derived vectors.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy 20010401
Title: Disorders of lipid metabolism in patients with HIV disease treated with antiretroviral agents: frequency, relationship with administered drugs, and role of hypolipidaemic therapy with bezafibrate.
Journal: The Journal of infection 20010401
Title: Principles and practice of HIV-protease inhibitor pharmacoenhancement.
Journal: HIV medicine 20010401
Title: Sequencing of protease inhibitor therapy: insights from an analysis of HIV phenotypic resistance in patients failing protease inhibitors.
Journal: AIDS (London, England) 20010330
Title: Elevated alpha-1-acid glycoprotein reduces the volume of distribution and systemic clearance of saquinavir.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20010301
Title: A distinct binding mode of a hydroxyethylamine isostere inhibitor of HIV-1 protease.
Journal: Acta crystallographica. Section D, Biological crystallography 20010301
Title: The safety and antiviral effect of protease inhibitors in children.
Journal: Pharmacotherapy 20010301
Title: Challenges of antiretroviral treatment in transient and drug-using populations: the SUN study.
Journal: AIDS patient care and STDs 20010301
Title: A comprehensive account on the role of efflux transporters in the gastrointestinal absorption of 13 commonly used substrate drugs in humans.
Journal: International journal of clinical pharmacology and therapeutics 20010301
Title: Large hepatic mitochondrial DNA deletions associated with L-lactic acidosis and highly active antiretroviral therapy.
Journal: AIDS (London, England) 20010216
Title: Progressive human immunodeficiency virus-specific immune recovery with prolonged viral suppression.
Journal: The Journal of infectious diseases 20010215
Title: Ritonavir, efavirenz, and nelfinavir inhibit CYP2B6 activity in vitro: potential drug interactions with bupropion.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20010201
Title: Sensitive and rapid method for the simultaneous quantification of the HIV-protease inhibitors indinavir, nelfinavir, ritonavir, and saquinavir in human plasma by reversed-phase liquid chromatography.
Journal: Therapeutic drug monitoring 20010201
Title: Switch of protease inhibitor-containing HAART in routine clinical practice: a four-year prospective observational study.
Journal: International journal of STD & AIDS 20010201
Title: [Long-term immunologic response in HIV-infected patients with CD4 cell counts </= 50/mm3 when initiating protease inhibitor therapy].
Journal: Annales de medecine interne 20010201
Title: Pharmacokinetics of ritonavir and saquinavir in a haemodialysis patient.
Journal: Nephron 20010201
Title: Pharmacology and clinical experience with saquinavir.
Journal: Expert opinion on pharmacotherapy 20010201
Title: [Resistance to protease inhibitors].
Journal: Enfermedades infecciosas y microbiologia clinica 20010201
Title: The use of and response to second-line protease inhibitor regimens: results from the EuroSIDA study.
Journal: AIDS (London, England) 20010126
Title: Efficacy, tolerance, and pharmacokinetics of the combination of stavudine, nevirapine, nelfinavir, and saquinavir as salvage regimen after ritonavir or indinavir failure.
Journal: AIDS research and human retroviruses 20010120
Title: The ADAM study continued: maintenance therapy after 50 weeks of induction therapy.
Journal: AIDS (London, England) 20010105
Title: Effect of alpha1-acid glycoprotein on the intracellular accumulation of the HIV protease inhibitors saquinavir, ritonavir and indinavir in vitro.
Journal: British journal of clinical pharmacology 20010101
Title: Analysis of HIV-1 mutation patterns in patients failing antiretroviral therapy.
Journal: Journal of clinical laboratory analysis 20010101
Title: Patterns of resistance mutations to antiretroviral drugs in extensively treated HIV-1-infected patients with failure of highly active antiretroviral therapy.
Journal: Journal of acquired immune deficiency syndromes (1999) 20010101
Title: Pilot study of a combination of highly active antiretroviral therapy and cytokines to induce HIV-1 remission.
Journal: Journal of acquired immune deficiency syndromes (1999) 20010101
Title: Ritonavir-induced carbamazepine toxicity.
Journal: The Annals of pharmacotherapy 20010101
Title: Synergistic antiviral effect of PEG-asparaginase (ONCASPAR), with protease inhibitor alone and in combination with RT inhibitors against HIV-1 infected T-cells: a model of HIV-1-induced T-cell lymphoma.
Journal: In vivo (Athens, Greece) 20010101
Title: Comparison of P-triglyceride levels among patients with human immunodeficiency virus on randomized treatment with ritonavir, indinavir or ritonavir/saquinavir.
Journal: Scandinavian journal of infectious diseases 20010101
Title: Saquinavir soft gelatin capsule: a comparative safety review.
Journal: Drug safety 20010101
Title: Structure-based design of non-peptide HIV protease inhibitors.
Journal: Farmaco (Societa chimica italiana : 1989) 20010101
Title: New developments in anti-HIV chemotherapy.
Journal: Farmaco (Societa chimica italiana : 1989) 20010101
Title: [Drug interactions with antiretroviral agents].
Journal: Therapie 20010101
Title: Eruptive cheilitis: a new adverse effect in reactive HIV-positive patients subjected to high activity antiretroviral therapy (HAART). Presentation of six clinical cases.
Journal: Medicina oral : organo oficial de la Sociedad Espanola de Medicina Oral y de la Academia Iberoamericana de Patologia y Medicina Bucal 20010101
Title: Development of HIV protease inhibitors: a survey.
Journal: Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques 20010101
Title: A peptide inhibitor of HIV-1 protease using alpha, beta- dehydro residues: a structure based computer model.
Journal: Indian journal of biochemistry & biophysics 20010101
Title: Garlic supplements found to lower saquinavir levels.
Journal: TreatmentUpdate 20010101
Title: From grapefruit juice to ritonavir.
Journal: TreatmentUpdate 20010101
Title: A randomized trial of nelfinavir, ritonavir, or delavirdine in combination with saquinavir-SGC and stavudine in treatment-experienced HIV-1-infected patients.
Journal: HIV clinical trials 20010101
Title: The insufficient suppression of viral load by saquinavir hard gel is reversible: a retrospective cohort study.
Journal: HIV clinical trials 20010101
Title: Effect of prior nucleoside use on the two-year virological response to an initial protease inhibitor regimen in HIV-infected patients.
Journal: HIV clinical trials 20010101
Title: Simultaneous determination of the new HIV protease inhibitor lopinavir (ABT 378) and of indinavir(1), amprenavir, saquinavir, ritonavir (ABT 538)(2) and nelfinavir(3) in human plasma by gradient HPLC.
Journal: Clinical laboratory 20010101
Title: Antiviral potency of HAART regimens and clinical success are not strictly coupled in real life conditions: evidence from the MASTER-1 study.
Journal: HIV clinical trials 20010101
Title: Randomized salvage therapy with saquinavir-ritonavir versus saquinavir-nelfinavir for highly protease inhibitor-experienced HIV-infected patients.
Journal: HIV clinical trials 20010101
Title: The use of efavirenz as a part of late rescue antiretroviral treatment.
Journal: HIV clinical trials 20010101
Title: MIKADO: a multicentre, open-label pilot study to evaluate the antiretroviral activity and safety of saquinavir with stavudine and zalcitabine.
Journal: HIV medicine 20010101
Title: Combined therapy with saquinavir, ritonavir and stavudine in moderately to severely immunosuppressed HIV-infected protease inhibitor-naive patients.
Journal: HIV medicine 20010101
Title: Low body weight and type of protease inhibitor predict discontinuation and treatment-limiting adverse drug reactions among HIV-infected patients starting a protease inhibitor regimen: consistent results from a randomized trial and an observational cohort.
Journal: HIV medicine 20010101
Title: Baseline antiretroviral drug susceptibility influences treatment response in patients receiving saquinavir-enhancing therapy.
Journal: HIV clinical trials 20010101
Title: Pharmacokinetics of saquinavir-SGC in HIV-infected pregnant women.
Journal: HIV clinical trials 20010101
Title: 'In vitro' antifungal activity of protease inhibitors.
Journal: Mycopathologia 20010101
Title: Increasing cerebrospinal fluid chemokine concentrations despite undetectable cerebrospinal fluid HIV RNA in HIV-1-infected patients receiving antiretroviral therapy.
Journal: Journal of acquired immune deficiency syndromes (1999) 20001215
Title: Inhibitory effect of human immunodeficiency virus protease inhibitors on multidrug resistance transporter P-glycoproteins.
Journal: Biological & pharmaceutical bulletin 20001201
Title: Inhibition of HIV-1 protease by a boron-modified polypeptide.
Journal: Biochemical pharmacology 20001001
Title: Tipranavir inhibits broadly protease inhibitor-resistant HIV-1 clinical samples.
Journal: AIDS (London, England) 20000908
Title: Identification of MK-944a: a second clinical candidate from the hydroxylaminepentanamide isostere series of HIV protease inhibitors.
Journal: Journal of medicinal chemistry 20000907
Title: In vitro resistance profile of the human immunodeficiency virus type 1 protease inhibitor BMS-232632.
Journal: Antimicrobial agents and chemotherapy 20000901
Title: BMS-232632, a highly potent human immunodeficiency virus protease inhibitor that can be used in combination with other available antiretroviral agents.
Journal: Antimicrobial agents and chemotherapy 20000801
Title: Structural and kinetic analyses of the protease from an amprenavir-resistant human immunodeficiency virus type 1 mutant rendered resistant to saquinavir and resensitized to amprenavir.
Journal: Journal of virology 20000801
Title: Drug resistance and drug combination features of the human immunodeficiency virus inhibitor, BCH-10652 [(+/-)-2'-deoxy-3'-oxa-4'-thiocytidine, dOTC].
Journal: Antiviral chemistry & chemotherapy 20000701
Title: Novel inhibitors of HIV protease: design, synthesis and biological evaluation of picomolar inhibitors containing cyclic P1/P2 scaffolds.
Journal: Bioorganic & medicinal chemistry letters 20000605
Title: A mutation in human immunodeficiency virus type 1 protease, N88S, that causes in vitro hypersensitivity to amprenavir.
Journal: Journal of virology 20000501
Title: In vitro activity of human immunodeficiency virus protease inhibitors against Pneumocystis carinii.
Journal: The Journal of infectious diseases 20000501
Title: 2',6'-Dimethylphenoxyacetyl: a new achiral high affinity P(3)-P(2) ligand for peptidomimetic-based HIV protease inhibitors.
Journal: Journal of medicinal chemistry 20000323
Title: 5,6-Dihydropyran-2-ones possessing various sulfonyl functionalities: potent nonpeptidic inhibitors of HIV protease.
Journal: Journal of medicinal chemistry 20000309
Title: Synthesis and anti-HIV activity of prodrugs derived from saquinavir and indinavir.
Journal: Antiviral chemistry & chemotherapy 20000301
Title: Protease inhibitors: current status and future prospects.
Journal: Journal of medicinal chemistry 20000210
Title: In-vitro tipranavir susceptibility of HIV-1 isolates with reduced susceptibility to other protease inhibitors.
Journal: AIDS (London, England) 20000107
Title: Decreased methadone effect after ritonavir initiation.
Journal: Pharmacotherapy 20000101
Title: Unexplained thrombosis in HIV-infected patients receiving protease inhibitors: report of seven cases.
Journal: The American journal of medicine 19991201
Title: Cage dimeric N-acyl- and N-acyloxy-4-aryl-1,4-dihydropyridines as first representatives of a novel class of HIV-1 protease inhibitors.
Journal: Archiv der Pharmazie 19991101
Title: Renin-angiotensin system inhibition in a patient having an overdose of HIV protease inhibitor.
Journal: AIDS (London, England) 19991001
Title: Design and fast synthesis of C-terminal duplicated potent C(2)-symmetric P1/P1'-modified HIV-1 protease inhibitors.
Journal: Journal of medicinal chemistry 19990923
Title: Non-active site changes elicit broad-based cross-resistance of the HIV-1 protease to inhibitors.
Journal: The Journal of biological chemistry 19990820
Title: Hydroxyurea-induced neurotoxicity in HIV disease.
Journal: AIDS (London, England) 19990820
Title: A new class of anti-HIV agents: synthesis and activity of conjugates of HIV protease inhibitors with a reverse transcriptase inhibitor.
Journal: Bioorganic & medicinal chemistry letters 19990322
Title: The HIV type 1 protease inhibitor saquinavir can select for multiple mutations that confer increasing resistance.
Journal: AIDS research and human retroviruses 19990301
Title: Pyrido [1,2a] indole derivatives identified as novel non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1.
Journal: Antiviral chemistry & chemotherapy 19990301
Title: Genetic variation and susceptibilities to protease inhibitors among subtype B and F isolates in Brazil.
Journal: Antimicrobial agents and chemotherapy 19990201
Title: Cage dimeric 4-aryl-1,4-dihydropyridines as promising lead structures for the development of a novel class of HIV-1 protease inhibitors.
Journal: Archiv der Pharmazie 19990101
Title: Human immunodeficiency virus type 1 Vif-derived peptides inhibit the viral protease and arrest virus production.
Journal: FEBS letters 19981228
Title: Prediction of aryl hydrocarbon receptor-mediated enzyme induction of drugs and chemicals by mRNA quantification.
Journal: Chemical research in toxicology 19981201
Title: Anti-HIV activity and mechanism of action of macrocyclic diamide SRR-SB3.
Journal: The Journal of pharmacy and pharmacology 19981201
Title: Lipid lowering therapy in patients with HIV infection.
Journal: Lancet (London, England) 19981128
Title: [Nephrotoxicity of ritonavir].
Journal: Presse medicale (Paris, France : 1983) 19981114
Title: Counteracting HIV-1 protease drug resistance: structural analysis of mutant proteases complexed with XV638 and SD146, cyclic urea amides with broad specificities.
Journal: Biochemistry 19981027
Title: Human serum attenuates the activity of protease inhibitors toward wild-type and mutant human immunodeficiency virus.
Journal: Virology 19981025
Title: Multiple dideoxynucleoside analogue-resistant (MddNR) HIV-1 strains isolated from patients from different European countries.
Journal: AIDS (London, England) 19981022
Title: Genotypic and phenotypic characterization of human immunodeficiency virus type 1 variants isolated from patients treated with the protease inhibitor nelfinavir.
Journal: Antimicrobial agents and chemotherapy 19981001
Title: Design and selection of DMP 850 and DMP 851: the next generation of cyclic urea HIV protease inhibitors.
Journal: Chemistry & biology 19981001
Title: In vitro selection and characterization of human immunodeficiency virus type 1 variants with increased resistance to ABT-378, a novel protease inhibitor.
Journal: Journal of virology 19980901
Title: Renal calculi developing de novo in a patient taking saquinavir.
Journal: International journal of STD & AIDS 19980901
Title: New aza-dipeptide analogues as potent and orally absorbed HIV-1 protease inhibitors: candidates for clinical development.
Journal: Journal of medicinal chemistry 19980827
Title: Relative potency of protease inhibitors in monocytes/macrophages acutely and chronically infected with human immunodeficiency virus.
Journal: The Journal of infectious diseases 19980801
Title: Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors.
Journal: The New England journal of medicine 19980730
Title: S-1153 inhibits replication of known drug-resistant strains of human immunodeficiency virus type 1.
Journal: Antimicrobial agents and chemotherapy 19980601
Title: Human immunodeficiency virus type 1 subtype F reverse transcriptase sequence and drug susceptibility.
Journal: Journal of virology 19980501
Title: Novel HIV-protease inhibitors containing beta-hydroxyether and -thioether dipeptide isostere surrogates: modification of the P3 ligand.
Journal: Bioorganic & medicinal chemistry letters 19980421
Title: Structure based design: novel spirocyclic ethers as nonpeptidal P2-ligands for HIV protease inhibitors.
Journal: Bioorganic & medicinal chemistry letters 19980421
Title: Potent HIV protease inhibitors incorporating high-affinity P2-ligands and (R)-(hydroxyethylamino)sulfonamide isostere.
Journal: Bioorganic & medicinal chemistry letters 19980317
Title: Analysis of the S3 and S3' subsite specificities of feline immunodeficiency virus (FIV) protease: development of a broad-based protease inhibitor efficacious against FIV, SIV, and HIV in vitro and ex vivo.
Journal: Proceedings of the National Academy of Sciences of the United States of America 19980203
Title: In vitro selection and characterization of VX-478 resistant HIV-1 variants.
Journal: Advances in experimental medicine and biology 19980101
Title: Nonsymmetrically substituted cyclic urea HIV protease inhibitors.
Journal: Journal of medicinal chemistry 19971205
Title: Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analyses.
Journal: Journal of virology 19971101
Title: Human immunodeficiency virus type 1 proteinase resistance to symmetric cyclic urea inhibitor analogs.
Journal: Antimicrobial agents and chemotherapy 19971101
Title: Anti-HIV activity of adefovir (PMEA) and PMPA in combination with antiretroviral compounds: in vitro analyses.
Journal: Antiviral research 19971101
Title: Kinetic properties of saquinavir-resistant mutants of human immunodeficiency virus type 1 protease and their implications in drug resistance in vivo.
Journal: Biochemistry 19971007
Title: Emergence of resistant variants of HIV in vivo during monotherapy with the proteinase inhibitor saquinavir.
Journal: The Journal of antimicrobial chemotherapy 19970601
Title: In vitro effect of alpha1-acid glycoprotein on the anti-human immunodeficiency virus (HIV) activity of the protease inhibitor CGP 61755: a comparative study with other relevant HIV protease inhibitors.
Journal: The Journal of infectious diseases 19970501
Title: Antiviral activity of the dihydropyrone PNU-140690, a new nonpeptidic human immunodeficiency virus protease inhibitor.
Journal: Antimicrobial agents and chemotherapy 19970501
Title: Escape mutants of HIV-1 proteinase: enzymic efficiency and susceptibility to inhibition.
Journal: Biochimica et biophysica acta 19970425
Title: A mutation in human immunodeficiency virus type 1 protease at position 88, located outside the active site, confers resistance to the hydroxyethylurea inhibitor SC-55389A.
Journal: Antimicrobial agents and chemotherapy 19970301
Title: Selective biotransformation of the human immunodeficiency virus protease inhibitor saquinavir by human small-intestinal cytochrome P4503A4: potential contribution to high first-pass metabolism.
Journal: Drug metabolism and disposition: the biological fate of chemicals 19970201
Title: Cyclic urea amides: HIV-1 protease inhibitors with low nanomolar potency against both wild type and protease inhibitor resistant mutants of HIV.
Journal: Journal of medicinal chemistry 19970117
Title: Mutational anatomy of an HIV-1 protease variant conferring cross-resistance to protease inhibitors in clinical trials. Compensatory modulations of binding and activity.
Journal: The Journal of biological chemistry 19961213
Title: The anti-HIV activity and mechanisms of action of pure compounds isolated from Rosa damascena.
Journal: Biochemical and biophysical research communications 19961204
Title: Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor.
Journal: Journal of virology 19961201
Title: Profile of CGP 61755: a novel and potent HIV-1 protease inhibitor that shows enhanced anti-HIV activity when combined with other antiretroviral agents in vitro.
Journal: Schweizerische medizinische Wochenschrift 19961026
Title: HIV protease inhibitory bis-benzamide cyclic ureas: a quantitative structure-activity relationship analysis.
Journal: Journal of medicinal chemistry 19961011
Title: Nonpeptidal P2 ligands for HIV protease inhibitors: structure-based design, synthesis, and biological evaluation.
Journal: Journal of medicinal chemistry 19960816
Title: Paracyclophanes: a novel class of water-soluble inhibitors of HIV proteinase.
Journal: Journal of medicinal chemistry 19960816
Title: Aza-peptide analogs as potent human immunodeficiency virus type-1 protease inhibitors with oral bioavailability.
Journal: Journal of medicinal chemistry 19960802
Title: Bis tertiary amide inhibitors of the HIV-1 protease generated via protein structure-based iterative design.
Journal: Journal of medicinal chemistry 19960705
Title: Evaluation of reverse transcriptase and protease inhibitors in two-drug combinations against human immunodeficiency virus replication.
Journal: Antimicrobial agents and chemotherapy 19960601
Title: New arylpyrido-diazepine and -thiodiazepine derivatives are potent and highly selective HIV-1 inhibitors targeted at the reverse transcriptase.
Journal: Antiviral research 19960501
Title: Human immunodeficiency virus type 1 viral background plays a major role in development of resistance to protease inhibitors.
Journal: Proceedings of the National Academy of Sciences of the United States of America 19960220
Title: Antiviral and resistance studies of AG1343, an orally bioavailable inhibitor of human immunodeficiency virus protease.
Journal: Antimicrobial agents and chemotherapy 19960201
Title: In vitro antiviral activity of 141W94 (VX-478) in combination with other antiretroviral agents.
Journal: Antiviral research 19960101
Title: Reduced sensitivity to saquinavir: an update on genotyping from phase I/II trials.
Journal: Antiviral research 19960101
Title: Design, synthesis, and resistance patterns of MP-134 and MP-167, two novel inhibitors of HIV type 1 protease.
Journal: AIDS research and human retroviruses 19960101
Title: In vitro selection and characterization of human immunodeficiency virus type 1 (HIV-1) isolates with reduced sensitivity to hydroxyethylamino sulfonamide inhibitors of HIV-1 aspartyl protease.
Journal: Journal of virology 19950901
Title: Kinetic characterization and cross-resistance patterns of HIV-1 protease mutants selected under drug pressure.
Journal: Biochemistry 19950725
Title: Resistance of HIV type 1 to proteinase inhibitor Ro 31-8959.
Journal: AIDS research and human retroviruses 19950601
Title: Benzophenone derivatives: a novel series of potent and selective inhibitors of human immunodeficiency virus type 1 reverse transcriptase.
Journal: Journal of medicinal chemistry 19950512
Title: A simple and rapid method for preliminary evaluation of in vivo efficacy of anti-HIV compounds in mice.
Journal: Antiviral research 19950501
Title: Protein structure-based design of potent orally bioavailable, nonpeptide inhibitors of human immunodeficiency virus protease.
Journal: Proceedings of the National Academy of Sciences of the United States of America 19950411
Title: In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors.
Journal: Nature 19950406
Title: Characterization of a human immunodeficiency virus type 1 variant with reduced sensitivity to an aminodiol protease inhibitor.
Journal: Journal of virology 19950401
Title: The inhibition of human immunodeficiency virus type 1 in vitro by a non-nucleoside reverse transcriptase inhibitor MKC-442, alone and in combination with other anti-HIV compounds.
Journal: Antiviral research 19950301
Title: Antiviral properties of aminodiol inhibitors against human immunodeficiency virus and protease.
Journal: Antimicrobial agents and chemotherapy 19950201
Title: Characterization of human immunodeficiency virus type 1 mutants with decreased sensitivity to proteinase inhibitor Ro 31-8959.
Journal: Virology 19950110
Title: Inhibition of human immunodeficiency virus type 1 replication in cytokine-stimulated monocytes/macrophages by combination therapy.
Journal: The Journal of infectious diseases 19941201
Title: Synthesis and structure-activity relationships of a series of penicillin-derived HIV proteinase inhibitors: heterocyclic ring systems containing P1' and P2' substituents.
Journal: Journal of medicinal chemistry 19941028
Title: Structure-based design of HIV-1 protease inhibitors: replacement of two amides and a 10 pi-aromatic system by a fused bis-tetrahydrofuran.
Journal: Journal of medicinal chemistry 19940805
Title: Potency and selectivity of inhibition of human immunodeficiency virus protease by a small nonpeptide cyclic urea, DMP 323.
Journal: Antimicrobial agents and chemotherapy 19940701
Title: Aminodiol HIV protease inhibitors. 1. Design, synthesis, and preliminary SAR.
Journal: Journal of medicinal chemistry 19940610
Title: The development of cyclic sulfolanes as novel and high-affinity P2 ligands for HIV-1 protease inhibitors.
Journal: Journal of medicinal chemistry 19940415
Title: Characterization of human immunodeficiency virus type 1 variants with increased resistance to a C2-symmetric protease inhibitor.
Journal: Journal of virology 19940301
Title: Combinative interactions of a human immunodeficiency virus (HIV) Tat antagonist with HIV reverse transcriptase inhibitors and an HIV protease inhibitor.
Journal: Antimicrobial agents and chemotherapy 19940201
Title: A series of penicillin derived C2-symmetric inhibitors of HIV-1 proteinase: synthesis, mode of interaction, and structure-activity relationships.
Journal: Journal of medicinal chemistry 19931015
Title: In vitro isolation and identification of human immunodeficiency virus (HIV) variants with reduced sensitivity to C-2 symmetrical inhibitors of HIV type 1 protease.
Journal: Proceedings of the National Academy of Sciences of the United States of America 19930815
Title: Potent HIV protease inhibitors: the development of tetrahydrofuranylglycines as novel P2-ligands and pyrazine amides as P3-ligands.
Journal: Journal of medicinal chemistry 19930806
Title: Cyclic sulfolanes as novel and high affinity P2 ligands for HIV-1 protease inhibitors.
Journal: Journal of medicinal chemistry 19930402
Title: 3-Tetrahydrofuran and pyran urethanes as high-affinity P2-ligands for HIV-1 protease inhibitors.
Journal: Journal of medicinal chemistry 19930122
Title: Cell type-specific anti-human immunodeficiency virus type 1 activity of the transactivation inhibitor Ro5-3335.
Journal: Antimicrobial agents and chemotherapy 19921201
Title: A series of potent HIV-1 protease inhibitors containing a hydroxyethyl secondary amine transition state isostere: synthesis, enzyme inhibition, and antiviral activity.
Journal: Journal of medicinal chemistry 19920710
Title: Inhibitors of HIV-1 protease.
Journal: Journal of enzyme inhibition 19920101
Title: Antiviral properties of Ro 31-8959, an inhibitor of human immunodeficiency virus (HIV) proteinase.
Journal: Antiviral research 19911201
Title: Novel binding mode of highly potent HIV-proteinase inhibitors incorporating the (R)-hydroxyethylamine isostere.
Journal: Journal of medicinal chemistry 19911101
Title: The inhibitory activity of a peptide derivative against the growth of simian immunodeficiency virus in C8166 cells.
Journal: Biochemical and biophysical research communications 19910415
Title: Effect of two novel inhibitors of the human immunodeficiency virus protease on the maturation of the HIV gag and gag-pol polyproteins.
Journal: Virology 19901101
Title: Rational design of peptide-based HIV proteinase inhibitors.
Journal: Science (New York, N.Y.) 19900420
Title: Marco Donia, Danijela Maksimovic-Ivanic, Sanja Mijatovic, et al. In vitro and in vivo anticancer action of Saquinavir-NO, a novel nitric oxide-derivative of the protease inhibitor saquinavir, on hormone resistant prostate cancer cells. Cell cycle. 2011, 10(3): 492 - 499.
Title: Walmsley Sharon, Avihingsanon Anchalee, Slim Jihad et al. Gemini: A Noninferiority Study of Saquinavir/Ritonavir Versus Lopinavir/Ritonavir as Initial HIV-1 Therapy in Adults. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2009,50 (4) :367-374.
Title: Saquinavir
Title: Barillari Giovannia, Iovane Andréa, Bacigalupo Ilariaa, et al. Ritonavir or saquinavir impairs the invasion of cervical intraepithelial neoplasia cells via a reduction of MMP expression and activity. AIDS. 2012, 26 (8): 909-919.
Title: Martha Stefanidou, Carolina Herrera, Naomi Armanasco et al. Saquinavir Inhibits Early Events Associated with Establishment of HIV-1 Infection: Potential Role for Protease Inhibitors in Prevention. Antimicrob. Agents Chemother. 2012, 56 (8): 4381-4390.
Title: Qi Sun, et al. Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease. Signal Transduct Target Ther. 2021 May 29;6(1):212.